<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2025-10-27 09:16:57 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>109</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>65</td>
          <td>74</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79890359565389b73c061b8b182c8a9f91a90fcd" target='_blank'>
              Mechanisms of sex differences in acute and long COVID sequelae in mice
              </a>
            </td>
          <td>
            Jennifer A. Liu, Sabal Chaulagain, Patrick S. Creisher, Weizhi Zhong, Tianle Zhang, Maraake Taddese, Karly Shi, , Haley Hcnir, Arthur P. Arnold, Ralph S. Baric, Natasha B Barahona, Elizabeth Engler-Chiurazzi, Kevin J. Zwezdaryk, Chloe L. Thio, A. Balagopal, J.R. Harkema, Elizabeth A. Thompson, Andrew Pekosz, Andrea L Cox, S. Klein
          </td>
          <td>2025-10-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic neurological disorder characterized by demyelination of the central nervous system (CNS), leading to a broad spectrum of physical and cognitive impairments. Myeloid cells within the CNS, including microglia and border-associated macrophages, play a central role in the neuroinflammatory processes associated with MS. Activation of these cells contributes to the local inflammatory response and promotes the recruitment of additional immune cells into the CNS. SLAMF5 is a cell surface receptor that functions as a homophilic adhesion molecule, capable of modulating immune cell activity through both activating and inhibitory signals. In this study, we investigated the expression and function of SLAMF5 in CNS-resident and peripheral myeloid cells using the murine model of MS, experimental autoimmune encephalomyelitis (EAE). Our findings demonstrate that both total and brain-specific SLAMF5 deficiency in myeloid cells leads to decreased expression of activation and costimulatory molecules, including MHC class II (MHCII) and CD80. This downregulation is mediated, at least in part, through the transcription factor BHLHE40 and its regulation of CD52, resulting in delayed onset and reduced progression of the disease. Furthermore, pharmacological blockade of SLAMF5 in the brain halted disease progression and reduced the expression of myeloid activation markers. In human studies, SLAMF5 blockade in peripheral monocytes from MS patients and in induced pluripotent stem cell (iPSC)-derived microglia reduced the expression of HLA-DR, CD80, and CD52. Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1eaad9d55c9355e31611139c88a8cba723aec03" target='_blank'>
              The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosis
              </a>
            </td>
          <td>
            Laura Bellassen, K. David, Bar Lampert, Avital Sarusi-Portuguez, Michael Tsoory, Jazz Lubliner, E. Hornstein, M. Osherov, Ron Milo, O. Brenner, S. Becker-Herman, I. Shachar
          </td>
          <td>2025-09-01</td>
          <td>PLOS Biology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is an autoimmune and neuroinflammation disease characterized by axonal damage, inflammatory demyelination, and neurodegeneration. However, the precise mechanisms underlying MS pathogenesis remain largely unclear. Here, we identify ZNRF1, an E3 ubiquitin ligase, as a critical regulator of experimental autoimmune encephalomyelitis (EAE), a murine model that recapitulates the autoimmune demyelination features of MS. Mice lacking ZNRF1 exhibit increased susceptibility to EAE progression. Notably, ZNRF1 depletion in peripheral myeloid cells, but not in microglia, leads to enhanced immune cell infiltration into the central nervous system, resulting in demyelination and exacerbated disease severity. The heightened EAE severity in Znrf1-deficient mice is associated with increased polarization of Th1 and Th17 cells, elevated antigen-specific T helper cell proliferation, and amplified immune responses. Furthermore, following EAE induction, macrophages from Znrf1-deficient mice display elevated surface expression of MHC class II (MHC-II) molecules. Collectively, our findings suggest that ZNRF1 in peripheral myeloid cells plays a suppressive role in neuroinflammation by regulating MHC-II surface expression, thereby controlling antigen-specific T-cell proliferation and activation. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03550-z.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f962a55325851d781ba99d1de0343d57aac16244" target='_blank'>
              Myeloid ZNRF1 suppresses autoimmune demyelination and neuroinflammation by regulating MHC-II-mediated T cell activation
              </a>
            </td>
          <td>
            Yung-Chi Chang, Ching-Chih Wu, Fu-Ting Hsiao, You-Sheng Lin, Ting-Yu Lai, , Shiue-Cheng Tang, Chih-Yuan Lee, Shen-Ju Chou, Li-Chung Hsu
          </td>
          <td>2025-10-22</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background CNS infection by HIV-1 contributes to neuroinflammation, cognitive impairments, and the establishment of viral reservoirs. Although HIV-1 is known to enter the brain early in infection via “Trojan horse” leukocytes, including infected monocytes and CD4+T cells, the specific cellular phenotypes facilitating this process during acute infection remain incompletely characterized. Objective This study aims to characterize the roles of brain lymphocytes during acute infection and primary CD4+ T cell phenotypes seeding the SIV to the CNS. Methods scRNA-seq was performed on brain and blood cells of three acutely SIV-infected rhesus macaques. The transcriptomic data were analyzed using bioinformatics approaches and validated through in vitro co-culture assays and re-analysis of a publicly available scRNA-seq dataset. Results We found a distinct cell cluster in the brain co-expressing myeloid and lymphoid genes, suggesting brain myeloid cells may engulf CD4+ T cells entering from the blood. This finding was confirmed in by coculture studies of macrophages and T cells, and identified specific chemokines could distinguish such cells. Acute infection induced an increase in proliferating CD4+ cytotoxic-like T cells, which had high expression of viral entry receptors and adhesion molecules, indicating their role in CNS infection. Additionally, transcriptomic analysis revealed upregulation of cytotoxic genes, MHC class II molecules, ISG15, and USP18 in brain lymphocytes, indicating a robust immune response to acute infection. Conclusion Our findings suggest that CD4+cytotoxic-like T cells represent a key lymphocyte subset responsible for initiating SIV entry into the brain and triggering neuroinflammatory processes. Furthermore, interactions between infiltrating lymphocytes and brain-resident myeloid cells may facilitate viral propagation within the CNS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72fbfac68579326979ef04a1dc07549f993cb4aa" target='_blank'>
              T cell-mediated SIV dissemination into the CNS: a single-cell transcriptomic analysis
              </a>
            </td>
          <td>
            Xiaoke Xu, Meng Niu, Benjamin G. Lamberty, Kathleen M. Emanuel, L. D. Estrella, Howard S. Fox
          </td>
          <td>2025-05-09</td>
          <td>Research Square</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/22393b9ffca1a3471e0c12f80fd5127144012755" target='_blank'>
              A Human Alveolus-on-Chip Recapitulates SARS-CoV-2-mediated Lung Injury in an Organ-relevant Context for Pre-clinical Applications
              </a>
            </td>
          <td>
            M. Kiener, Lea Lara De Maddalena, Nuria Roldan, P. Chouvardas, Laurène Froment, M. De Menna, Thomas Geiser, J. Stucki, Nina Hobi, Marianna Kruithof-de Julio
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="While human autopsy samples have provided insights into pulmonary immune mechanisms associated with severe viral respiratory diseases, the mechanisms that contribute to a clinically favorable resolution of viral respiratory infections remain unclear due to the lack of proper experimental systems. Using mice co-engrafted with a genetically matched human immune system and fetal lung xenograft (fLX), we mapped the immunological events defining successful resolution of SARS-CoV-2 infection in human lung tissues. Viral infection is rapidly cleared from fLX following a peak of viral replication, histopathological manifestations of lung disease and loss of AT2 program, as reported in human COVID-19 patients. Infection resolution is associated with the activation of a limited number of hematopoietic subsets, including inflammatory monocytes and CD3-expressing macrophage-like cells, which are highly enriched in viral RNA and dissipate upon infection resolution. Specific human fibroblast and endothelial subsets also elicit robust antiviral and monocyte chemotaxis signatures, respectively. Notably, systemic depletion of human CD4 + cells, but not CD3 + cells, significantly abrogates infection resolution in fLX and induces persistent infection, supporting the dominant role of peripheral CD4 + monocytes over T-cells in the resolution of acute SARS-CoV-2 infection. Collectively, our findings unravel a comprehensive picture of the immunological events defining effective resolution of SARS-CoV-2 infection in human lung tissues, revealing markedly divergent immunological trajectories between resolving and fatal COVID-19 cases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6e1af04e87d357b99c68bde586cd0f8a84680b05" target='_blank'>
              Immune signatures of SARS-CoV-2 infection resolution in human lung tissues
              </a>
            </td>
          <td>
            Devin J. Kenney, A. O’Connell, Anna E. Tseng, J. Turcinovic, M. Sheehan, Adam D Nitido, P. Montanaro, H. Gertje, Maria Ericsson, John H. Connor, Vladimir D. Vrbanac, Nicholas A. Crossland, Christelle Harly, Alejandro B. Balazs, F. Douam
          </td>
          <td>2025-09-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d46811852497c54872a7282800dcab64fa68610f" target='_blank'>
              A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity
              </a>
            </td>
          <td>
            K. Slowikowski, P. Sen, C. Cosgriff, J. Tantivit, T. Eisenhaure, T. J. LaSalle, K. Manakongtreecheep, A. Tirard, B. Y. Arnold, A. Pacheco-Navarro, E. Y. Yang, M. Reyes, A. Gonye, I. Gushterova, B. Russo, M. Rojas-Lopez, N. Sharma, M. F. Thomas, T. Sharova, D. Frederick, K. Lavin-Parsons, B. Lilley, B. Mckaig, C. Lodenstein, H. Khanna, K. Kays, N. Charland, N. Smith, S. Ramesh, T. Delorey, D. Phillips, L. Amir-Zilberstein, E. M. Brown, M. Benson, S.-M. Park, B. Tusi, V. Pokatayev, C. Hecht, N. Pishesha, A. E. Woolley, L. Cosimi, Rozenblatt-Ro
          </td>
          <td>2025-09-21</td>
          <td>None</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Post-acute sequelae of SARS-CoV-2 (PASC) is characterized by persistent symptoms such as fatigue, respiratory complications and cognitive dysfunction, affecting approximately 13.5% of SARS-CoV-2-infected individuals. Despite its clinical significance, the mechanisms driving PASC remain poorly understood. Here, to address this, we utilized a Phodopus roborovskii hamster model to investigate the long-term effects of SARS-CoV-2 infection compared with influenza A virus. While 46.25–47.50% of hamsters survived SARS-CoV-2 or influenza A virus H1N1 infection, 13.75% of SARS-CoV-2 survivors exhibited impaired weight recovery, severe lung pathology and significant neutrophil accumulation, defining the PASC group. Single-cell RNA sequencing of bronchoalveolar lavage fluid, lung and spleen at 30 days post-infection revealed hallmark PASC gene signatures uniquely upregulated in the PASC group. This was accompanied by elevated neutrophil levels and reduced macrophage populations, indicative of disrupted myeloid cell differentiation. Immunohistochemistry further detected persistent SARS-CoV-2 S1 subunit antigen in the lungs of PASC hamsters at 30 days post-infection, coinciding with marked neutrophil infiltration, which probably drove prolonged inflammatory responses. Indeed, the neutrophils in the PASC group exhibited sustained upregulation of inflammation-related genes, including FPR2, MMP9 and S100A9, which are associated with neutrophil degranulation and extracellular trap formation. Importantly, targeting neutrophil-mediated inflammation with small-molecule inhibitors substantially reduced PASC phenotypes. Among these, Sivelestat, a neutrophil elastase inhibitor, demonstrated the most pronounced efficacy, reducing PASC incidence and mortality, and markedly reducing neutrophil levels. These findings underscore the critical role of neutrophil activation in driving lung damage and chronic inflammation during PASC, offering promising therapeutic strategies for mitigating long-term COVID-19 sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5dcbccf2e6ed52d16414de0e66bf2ff106122da5" target='_blank'>
              Prolonged immune activation in post-acute sequelae of SARS-CoV-2: neutrophil dynamics and therapeutic insights
              </a>
            </td>
          <td>
            Mina Yu, Suhee Hwang, Hobin Jang, Dongbin Park, Jaemoo Kim, J. Gil, Jeong Ho Choi, Seung-Gyu Jang, Isaac Choi, Yuri Jung, Woohyun Kwon, Se-Mi Kim, Young-Il Kim, Hyunjoon Kim, Taehwan Oh, Joo Sang Lee, Min-Suk Song, SangJoon Lee, Y. Choi
          </td>
          <td>2025-09-01</td>
          <td>Experimental & Molecular Medicine</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="BACKGROUND
Understanding age-associated differences in acute and memory adaptive immunity to SARS-CoV-2 and how this contributes to more favorable outcomes in children is critically important.


METHODS
We evaluated SARS-CoV-2-specific T cell, B cell, and antibody responses in 329 peripheral blood samples collected from non-hospitalized children, adolescents, and adults at three timepoints, including acute and memory timepoints.


RESULTS
Most children produced robust CD4+ T cell responses during infection and developed memory CD4+ T cells; however, young children <4 years old often had undetectable CD4+ T cell responses compared to older children and adults. Young children also generated reduced frequencies of memory B cells; despite this, they mounted substantial and durable neutralizing antibody responses. CD4+ T cell responses in children were biased towards non-spike epitopes, especially in asymptomatic cases. Memory B cells in children were preferentially classical memory or, paradoxically, CXCR3+.


CONCLUSION
These findings support the concept that the kinetics and composition of T and B cell responses shift across age groups and may be associated with milder COVID-19 outcomes in children.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e01e78207afcc9aac4f90480fca4bc42fee1194b" target='_blank'>
              Pediatric T cell and B cell responses to SARS-CoV-2 infection.
              </a>
            </td>
          <td>
            L. B. Hills, Numana Bhat, Jillian H. Hurst, Amber Myers, Thomas W. Burke, M. T. McClain, Elizabeth Petzold, A. T. Rotta, Nicholas A Turner, A. Grifoni, D. Weiskopf, Yvonne Dogariu, Genevieve Fouda, S. Permar, Alessandro Sette, C. Woods, Matthew S. Kelly, Shane Crotty
          </td>
          <td>2025-09-04</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>71</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05a71100671b244cc8f79397a31cb08b678438b9" target='_blank'>
              Patient-derived lymphocytes drive smoldering lesion pathology in a chimeric multiple sclerosis mouse model
              </a>
            </td>
          <td>
            O. Perrot, M. Nordbeck, C. Bachelin, A. Luong, D. Roussel, D. Akbar, N. Sarrazin, A. Tenenhaus, C. Louapre, V. Zujovic
          </td>
          <td>2025-09-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2ac7be7fefad26395dcc651024f1fe069018455" target='_blank'>
              Atlas of innate immune responses to experimental cholera and IL22 treatment demonstrates protection by mucus-secreting cells
              </a>
            </td>
          <td>
            Masataka Suzuki, Yuko Hasegawa, Hailong Zhang, M. Waldor
          </td>
          <td>2025-09-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>93</td>
        </tr>

        <tr id="Objective Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a significant global health burden, characterized by complex host–pathogen interactions that drive heterogeneous clinical outcomes. While pulmonary epithelial cells are increasingly recognized as active participants in innate immunity during Mtb infection, how host defense are altered when the epithelial barrier is compromised remains unclear. Methods In this study, we developed a murine model combining naphthalene-induced pulmonary epithelial injury with Mtb infection and mapped the pulmonary cells landscape through single-cell RNA sequencing (scRNA-seq), followed by in vitro stimulation assays to validate macrophage functional changes. Results Notably, we found a pronounced impairment in pulmonary bacterial clearance. Transcriptomic analysis revealed a widespread suppression of epithelial immune functions and showed that macrophages transitioned from an antimicrobial to an antigen-presenting phenotype, indicating waning pulmonary innate defenses and heightened adaptive immune activation. In vitro experiments further suggested that this macrophage transition may be linked to epithelial cell alterations. Conclusions These findings indicate that pulmonary epithelial integrity may influence early host immune responses to Mycobacterium tuberculosis and provide a transcriptomic framework for exploring epithelial–immune crosstalk as a potential therapeutic target. Supplementary Information The online version contains supplementary material available at 10.1007/s00011-025-02106-4.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e41984afd63dd846e210a4451e9fc159cd48e46" target='_blank'>
              Lung epithelial injury impairs early host immune responses to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Xuan Miao, Xue Li, Zuokuan He, Guiying Xu, Yu Li, Youwei Wang, Junping Wu, Qi Wu, Huaiyong Chen
          </td>
          <td>2025-10-03</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="ABSTRACT Cell cultures are widely used to study infectious respiratory diseases and to test therapeutics; however, they do not faithfully recapitulate the architecture and complexity of the human respiratory tract. Lung organoids have emerged as an alternative model that partially overcomes this key disadvantage. Lung organoids can be cultured in various formats that offer potential for studying highly pathogenic viruses. However, the effects of these different formats on virus infection remain unexplored, leaving their relative value unclear. In this study, we generated primary lung organoids from human donor cells and used them to derive monolayers and air-liquid interface (ALI) cultures with the goal of comparing the replication kinetics of two circulating highly pathogenic coronaviruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East respiratory syndrome coronavirus (MERS-CoV). Infection studies revealed that organoid-derived monolayers displayed limited infection, and the innate immune response was impaired against bacterial lipopolysaccharide (LPS) but not against virus-like double-stranded RNA (dsRNA) or poly(I:C). Meanwhile, organoids and organoid-derived ALI cultures retained viral permissivity, with ALI cultures displaying diverse antiviral immune responses against both coronaviruses. SARS-CoV-2 and MERS-CoV demonstrated differential replication kinetics in organoid and organoid-derived ALI cultures. Therefore, primary organoid-derived cells in two-dimensional monolayer or three-dimensional ALI formats influence virus infection and host antiviral responses. Our study informs the selection of culture conditions for organoid-based respiratory disease research and therapeutic testing. IMPORTANCE The COVID-19 pandemic heralded the upsurge in human-derived lung organoid-based studies due to their cellular heterogeneity that partly emulates the cellular complexity of the respiratory tract. A major disadvantage of organoid models resides in their apical-in conformation that “hides” cells and proteins that are typically exposed to the air-liquid interface (ALI) in the airways and are targets of viruses. Here, we generated monolayers and ALI cultures to facilitate cell exposure to highly relevant pathogens and compared them to parental organoids. Organoids at the ALI captured infection and immune responses better than organoids and organoid-derived monolayer cultures. Organoids at the ALI are a viable approach to improve identification and characterization of virus infection, host responses, and therapeutic testing.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/111d147f5c71ad716759861c6afa3c6e11d559e5" target='_blank'>
              MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures
              </a>
            </td>
          <td>
            Kim Lam Chiok, Kristof Jenik, Mark Fenton, D. Falzarano, Neeraj Dhar, Arinjay Banerjee
          </td>
          <td>2025-09-18</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Guillain-Barré syndrome (GBS) is an autoimmune disorder that causes weakness, sensory loss, autonomic dysfunction, and chronic neuropathic pain. The mediators responsible for driving early autoimmune injury in the most common GBS variant, acute inflammatory demyelinating polyradiculoneuropathy (AIDP), remain incompletely understood. We performed bulk and single-cell RNA sequencing on peripheral blood mononuclear cells collected from early untreated AIDP-variant GBS patients and healthy controls to comprehensively deduce leukocyte transcriptome alterations and predict disease-driving interactions between pathogenic leukocytes and peripheral nervous system cells. Bulk transcriptomics showed interferon- and JAK/STAT-driven proinflammatory signatures in myeloid cells. CD8+ T-cells were highly proliferative and expressed axon guidance genes. Single-cell transcriptomics revealed dysregulation of CD4+FOXP3+ regulatory and CD4+ effector memory T-cells indicative of poorly controlled type 1 and type 17 immune responses. Highly activated intermediate monocytes upregulated genes related to angiogenesis and oncostatin M. Interactome analysis between GBS leukocytes, Schwann cells, and sensory neurons predicted increased engagement of ligand-receptor pairs with nerve integrity and pain functions, including epiregulin, interferon-beta, adrenomedullin, clusterin, IL-6, IL-15, and CCL4. Functional validation demonstrated that CCL4 sensitizes human sensory neurons in vitro. These results unearth molecular interactions by which specific leukocyte populations in AIDP-variant GBS may induce peripheral nerve injury and drive neuropathic pain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f32750fba6dd394e7dec1bcd5d3da578effc6cef" target='_blank'>
              Peripheral nerve-targeting and pain-promoting transcriptomic signatures in early Guillain-Barré syndrome
              </a>
            </td>
          <td>
            Jayden A O'Brien, Joseph B. Lesnak, Ishwarya Sankaranarayanan, A. Arendt-Tranholm, Nikhil Inturi, Spoorthi Sadasivuni, Hemanth Mydugolam, Katelyn E. Sadler, Theodore J. Price, E. Ubogu
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec883431c99591b4cd41d48f53e730f5880a5601" target='_blank'>
              MIF-induced CD74+ microglia/macrophages are clinically relevant disease-associated subpopulations in brain metastasis and other CNS disorders
              </a>
            </td>
          <td>
            Laura Alvaro-Espinosa, Ángel Márquez-Galera, N. Priego, Virginia García-Calvo, M. Perea-García, C. Hernandez-Oliver, Diana Retana, Oliva Sanchez, Ana de Pablos-Aragoneses, P. García-Gómez, Osvaldo Graña-Castro, Óscar Lapuente-Santana, Fátima Al-Shahrour, Ana Cayuela, Isabel Peset, D. Megías, Mihaela Ola, D. Varešlija, Leonie Young, Yolanda Martí-Mateos, J. A. Enríquez, Elena Hernández-Encinas, C. Blanco-Aparicio, Marisol Soengas, J. Bernhagen, A. Antón-Fernández, Jesús Ávila, Miguel A Marchena, Maximiliano Torres, Fernando de Castro, Mar Márquez-Ropero, Amanda Sierra, J. López-Atalaya, M. Valiente
          </td>
          <td>2025-09-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="ABSTRACT Extracellular vesicles (EVs) are released from all cells of the body. They are considered to mirror the state of the cells from which they are released and circulate in the blood, suggesting a possible use of EV analysis for diagnostic purposes. Here, we report that the analysis of single EVs by flow cytometry can detect infection of cells with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by identifying expression of the SARS-CoV-2 spike (S) protein on the surface of EVs and the cellular origin of EVs by detecting cell-type-specific markers such as troponin (cTNT1) for cardiomyocytes. In coronavirus-associated disease 19 (COVID-19) patients, we detected a direct correlation of the frequencies of circulating S-expressing EVs, but not of cTNT/S-co-expressing EVs, with the subsequent development of a severe disease course. Detection of circulating S-expressing EVs indicates widespread SARS-CoV-2 infection in the body, which may contribute to the immune pathogenesis that triggers tissue and organ damage in COVID-19. Our findings suggest that detecting circulating viral antigen-expressing EVs may provide crucial predictive information on infection-associated disease courses in situations of a future viral pandemic. IMPORTANCE The ability to predict which patients infected with the SARS-CoV-2 virus will develop severe disease remains a significant clinical challenge. The present study demonstrates that EVs in the peripheral blood, carrying the SARS-CoV-2 spike protein, can be detected by flow cytometry and serve as early biomarkers of disease progression. In contradistinction to PCR or serology, this method provides insight into systemic viral spread and potential organ involvement. The early identification of spike-positive EVs at the time of hospital admission has the potential to facilitate the timely identification of high-risk patients, thereby enhancing the efficacy of triage and subsequent care. This approach may also be of value in terms of facilitating a more rapid and precise response to future virus pandemics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d3bf4cbba6828542814999291764b0f493b9010" target='_blank'>
              Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry
              </a>
            </td>
          <td>
            Evelyn Hammer, Charlotte Flynn, Johannes Rößler, Johanna Erder, Rudolf Napieralski, Lisa Fricke, Birgit Campbell, M. Feuerherd, Felix Esslinger, Albrecht von Brunn, Timm Weber, Siobhan King, Sisareuth Tan, Alain R Brisson, Ulrike Protzer, Gabriele Schricker, Kathrin Gärtner, Gregor Ebert, Allessandra Moretti, Florian Klein, Kèvin Knoops, Ron Heeren, Wolfgang Hammerschmidt, Reinhard Zeidler, Olaf Wilhelm, Percy A. Knolle, B. Höchst
          </td>
          <td>2025-09-23</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2affd9966e7d74eae7ebff40360fcc4663c6bf18" target='_blank'>
              Clonal expansion of cytotoxic CD8âº T cells in lecanemab-associated ARIA
              </a>
            </td>
          <td>
            Lance A. Johnson, Kai Saito, Akhil Pallerla, Jessica L Funnell, Ashley R. Ezzo, Chelsea L. Song, Douglas A Harrison, Noah J. Norton, Lauren C. Moore, L. Eldik, D. Fardo, Greg E. Cooper, Josh M Morganti
          </td>
          <td>2025-09-21</td>
          <td>None</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="Interferon alpha-inducible protein 27 like 2A (Ifi27l2a) was initially identified as an interferon-stimulated gene (Isg) involved in host-dependent mechanisms during viral invasion. We have recently shown that the Ifi27l2a protein also plays a critical role in microglia and the spreading of neuroinflammation. However, the detailed mechanisms of action of intracellular and extracellular Ifi27l2a in glial cells, particularly in inflammatory and neurodegenerative diseases, are not yet defined. We now report that systemic inflammation leads to an elevated level of circulating Ifi27l2a in the plasma of lipopolysaccharide (LPS)-treated mice, which is associated with elevated Il1b mRNA expression in the brain. Elevated IFI27L2 (human isoform) was also found in plasma of human stroke patients. To test whether extracellular (e.g. secreted) Ifi27l2a can contribute as an autocrine or paracrine inducer of microglial activation and inflammation, we treated microglial cells with recombinant Ifi27l2a (rIfi27l2a). Treatment with rIfi27l2a led to increased expression of proinflammatory cytokines and elevated reactive oxygen species (ROS) levels in microglial cells. These effects resulted from alterations in mitochondrial function and a metabolic shift from oxidative phosphorylation toward glycolysis for ATP synthesis. Additionally, Ifi27l2a led to increased caspase-1 activity, demonstrating that Ifi27l2a causes Nlrp3 inflammasome activation. RNA sequencing revealed that Ifi27l2a mediates transcriptional changes reflecting activated microglia. These data support an extracellular role of Ifi27l2a as a novel cytokine, in which it promotes a phenotypic shift in microglia toward a proinflammatory phenotype. Targeting Ifi27l2a may therefore provide an additional strategy to reduce microglia-mediated inflammation in the brain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd2010c6e0038f96da5055e23679983e49ae84e2" target='_blank'>
              Ifi27l2a acts as a cytokine that promotes a pro-inflammatory phenotype in microglia and enhances neuroinflammation
              </a>
            </td>
          <td>
            Sodam Kim, Haven Burrous, Elisabeth Harmon, Lauren Vance, Ting Wu, Alexander Andersohn, Andrea Doan, Darby Wolocko, Zachary Wise, Yuki Kitamura, Joo Eun Jung, G. Colpo, Lucy Couture, Frank Blixt, Louise McCullough, Sean P. Marrelli, G. Kim
          </td>
          <td>2025-09-24</td>
          <td>Research Square</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Parkinson’s Disease (PD) is a neurodegenerative disorder often preceded by gastrointestinal dysfunction. Mutations in leucine-rich repeat kinase 2 (LRRK2) are known risk factors for both PD and inflammatory bowel disease (IBD), suggesting a link between PD and the gastrointestinal tract. Using single-cell RNA-sequencing and spectral flow cytometry, we demonstrated that the Lrrk2 Gly2019Ser (G2019S) mutation is associated with an increased neutrophil presence in the colonic lamina propria during Citrobacter rodentium infection. This concurred with a Th17 skewing, upregulated Il17a, and greater colonic pathology during infection. In vitro experiments showed enhanced kinase-dependent neutrophil chemotaxis and neutrophil extracellular trap (NET) formation in Lrrk2 G2019S mice compared to wild-type counterparts. Our results add to the understanding of LRRK2-driven immune cell dysregulation and its contribution to PD, offering insights into potential biomarkers for early diagnosis and intervention in PD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/be3c3c2d6c736f3016502b7885c32784cb3973b9" target='_blank'>
              Lrrk2 G2019S mutation incites increased cell-intrinsic neutrophil effector functions and intestinal inflammation in a model of infectious colitis
              </a>
            </td>
          <td>
            J. Pei, N. Oliveira, S. Recinto, A. Kazanova, C. Queiroz-Junior, Ziyi Li, Katalina Couto, Susan Westfall, Ahmed M Fahmy, Camila Tiefensee-Ribeiro, Irah L. King, A. Milnerwood, M. Desjardins, A. Thanabalasuriar, J. Stratton, S. Gruenheid
          </td>
          <td>2025-08-29</td>
          <td>NPJ Parkinson's Disease</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7db095a53d3537670668dae17c6ccb821695327" target='_blank'>
              Dissecting the epigenome dynamics in human immune cells upon viral and chemical exposure by multimodal single-cell profiling
              </a>
            </td>
          <td>
            Irem B Gündüz, Bei Wei, Derek C Chen, Wenliang Wang, Manoj Hariharan, Todd Norell, Timothy J. Broderick, M. T. McClain, Lisa L. Satterwhite, Thomas W. Burke, Elizabeth A. Petzold, Xiling Shen, Christopher W. Woods, Vance G. Fowler, F. Ruffin, Parinya Panuwet, Dana B. Barr, Aaron J. Wilk, Madeline J. Lee, Catherine Blish, Flora Castellino, Anna Maria Walley, Thomas G Evans, Joseph R Ecker, Fabian Müller, W.J. Greenleaf
          </td>
          <td>2025-09-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="ABSTRACT Respiratory syncytial virus (RSV) is one of the major causes of severe lower respiratory tract infections, especially in children, the elderly, and immunocompromised individuals. Complications arising from viral infections in these age groups can present therapeutic challenges, as most of these individuals have impaired adaptive immunity. Using the T‐ and B cell‐deficient Rag2−/− mice, the mechanisms that mediate protection in immunocompromised hosts during RSV infection can be investigated. RSV‐infected Rag2−/− mice showed no symptoms of disease or chronic inflammation in the lungs and airways despite the presence of infectious virus in their lungs several months after infection. Interestingly, Natural Killer (NK) cells, the main innate cells with anti‐viral cytotoxic effector functions, were recruited 2 days earlier in the lungs of Rag2−/− mice compared with wildtype mice, resulting in early production of IFN‐γ. However, depletion of NK cells did not affect disease severity or viral load. Together, these results suggest that the NK cells are largely dispensable for virus control during primary RSV infection in Rag2−/− mice.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bcffcf6466cbc20d711ca1f437d587b3b514ba5a" target='_blank'>
              Natural Killer Cells Are Dispensable for Virus Control in Rag2−/− Mice During Primary RSV Infection
              </a>
            </td>
          <td>
            Joy Nakawesi, Tammie Sow Tao Min, Cecilia Johansson
          </td>
          <td>2025-09-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Background Traumatic spinal cord injury (SCI) is a severe clinical challenge, often leading to long-term sensory, motor, and autonomic dysfunction. The SCI cascade involves a primary physical damage phase, followed by a secondary phase of inflammatory signalling driven by microglia and other infiltrating immune cells. Immunomodulatory therapies may help promote healing and restrict secondary damage. We have previously demonstrated that interleukin (IL)-13 delivery improves functional and histopathological recovery after SCI in murine models, primarily by polarising macrophages towards an alternatively activated pro-reparative M2-like phenotype and reducing axonal contacts. Although microglia respond robustly to IL-13 in vitro, polarisation of microglia in vivo is more difficult. To better understand what conditions may restrict microglial responses to IL-13 in vivo, we sought to examine the effect of cellular context or microenvironment on IL-13 efficacy in forcing microglia polarisation in vitro. Methods BV2 and murine induced pluripotent stem cell (miPSC)-derived microglia were treated with IL-13 alone or in combination with lipopolysaccharide (LPS), acidic media, extracellular matrix components, high glutamate or high potassium concentrations. Following this phenotypic changes including morphology, gene/protein expression (TNFα, IL-1β, iNOS, Arg-1, CD206, F4-80) and cytokine release (TNFα) were measured using high-content screening, RT-qPCR, immunohistochemistry, and ELISA. Results IL-13 leads to increased expression of the anti-inflammatory marker Arg-1 while lowering expression and secretion of the pro-inflammatory markers IL-1β, iNOS, and TNFα, and expression of the microglia activation marker F4-80, signifying effective polarisation of microglia. Concomitant administration of LPS with IL-13 reduces IL-13 polarisation efficacy in microglia. Forced polarisation of microglia is also compromised by high glutamate tone, acidosis, hyperkalemia, and extracellular fibronectin, suggesting microenvironmental contexts seen in neurotrauma directly act on microglia to limit polarisation potential. Conclusions Our study demonstrates that the post-SCI environment dampens IL-13 efficacy on microglia. Taken together these data caution against simple immunomodulatory strategies and suggest that effective polarisation of microglia in vivo will require multimodal approaches.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5c9d5c1c52800333c93ab18452901901064a33b" target='_blank'>
              Forced polarisation of microglia by IL-13 is modified by inflammatory and microenvironmental context
              </a>
            </td>
          <td>
            E. D. Aiyegbusi, James P. Reynolds, Ross O'Carroll, Ruth Colbert, Christopher Carew, D. Dooley
          </td>
          <td>2025-09-16</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d02c6ef788d3f06d122c2a526528f66cd2e89e08" target='_blank'>
              Pre-Omicron Immunity Generates IgG⁺ but Not IgA⁺ Memory B Cells Reactive to Omicron Spike Protein
              </a>
            </td>
          <td>
            T. Tsoleridis, I. Singh, D. Onion, JG Chappell, A. Kelly, J. Nightingale, AM Valdes, B. Ollivere, Kenneth B. Hoehn, RA Urbanowicz, JK Ball
          </td>
          <td>2025-09-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="CD4+ T follicular helper (TFH) cells support tailored B cell responses against multiple classes of pathogens. To reveal how diverse TFH phenotypes are established, we profiled mouse TFH cells in response to viral, helminth and bacterial infection. We identified a core TFH signature that is distinct from CD4+ T follicular regulatory and effector cells and identified pathogen-specific transcriptional modules that shape TFH function. Cytokine-transcriptional TFH programming demonstrated that type I interferon and TGFβ signaling direct individual TFH phenotypes to instruct B cell output. Cytokine-directed TFH transcriptional phenotypes are shared within human germinal centers, but distinct TFH phenotypes dominate between donors and following immune challenge or in antibody-mediated disease. Finally, we identified new cell surface markers that align with distinct TFH phenotypes. Thus, we provide a comprehensive resource of TFH diversity in humans and mice to enable immune monitoring during infection and disease and to inform the development of context-specific vaccines.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a2b3b04af4219bd8ace503d4285d2c597f534c2b" target='_blank'>
              Divergent cytokine and transcriptional signatures control functional T follicular helper cell heterogeneity
              </a>
            </td>
          <td>
            Lennard Dalit, Chin Wee Tan, Amania A Sheikh, R. Munnings, Lauren J. Howson, Carolina Alvarado, Tabinda Hussain, Aidil Zaini, Lucy Cooper, Alana Kirn, Lauren Hailes, Angela Nguyen, Bailey E Williams, Ming Z M Zheng, C. E. van de Sandt, Laura K. Mackay, Katie L. Flanagan, K. Kedzierska, N.L. Harris, J. Juno, C. Zaph, Nicole L La Gruta, Melissa J Davis, S. Nutt, K. Good-Jacobson, Vanessa L. Bryant, J. Groom
          </td>
          <td>2025-09-09</td>
          <td>Nature Immunology</td>
          <td>2</td>
          <td>97</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/65799dca4a24e6fbcd774c66d4741d26a7a006c5" target='_blank'>
              Targeting a macrophage stemness factor to mitigate diseases post respiratory viral infection
              </a>
            </td>
          <td>
            Mohd Arish, A. Chaudhuri, Janli Tang, H. Narasimhan, An Fang, Jinyi Tang, Xiaoqin Wei, Chaofan Li, I. Cheon, Wei Qian, Farha Naz, Gislane Almeida-Santos, Samuel Young, T. Parimon, Y. Shim, Robert Vassallo, Peter Chen, Jie Sun
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely interacts with host cellular mechanisms, with mitochondria playing a crucial role in this process. As essential organelles that control cellular energy production, apoptosis, reactive oxygen species (ROS) metabolism, and innate immune responses, mitochondria are vital to the development of COVID-19. However, the exact molecular interactions between mitochondria and SARS-CoV-2 remain under active investigation. Gaining a comprehensive understanding of mitochondrial involvement in SARS-CoV-2 infection is therefore essential for uncovering complex disease mechanisms, identifying prognostic biomarkers, and developing effective treatments. Ultimately, exploring these virus–host interactions may provide new insights into the fundamental and complex aspects of mitochondrial physiology and pathophysiology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/14c37c435aca0f6081c81be5983a6d3cd20878ee" target='_blank'>
              Mechanisms of Mitochondrial Impairment by SARS-CoV-2 Proteins: A Nexus of Pathogenesis with Significant Biochemical and Clinical Implications
              </a>
            </td>
          <td>
            Marco Refrigeri, Alessandra Tola, Rosangela Mogavero, Maria Michela Pietracupa, Giulia Gionta, Roberto Scatena
          </td>
          <td>2025-10-11</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8b78da5097bce6125007e29bc3819f308beb1ea1" target='_blank'>
              Helminth infection induces neuroimmune remodeling and clinical remission in a mouse model of multiple sclerosis
              </a>
            </td>
          <td>
            N. Fettig, S. Popple, M. Portas, A. J. Sharon, Arman Sawhney, Thomas Worthington, B. Hardman, Morgan Coburn, Ukpong B. Eyo, M. Siracusa, M. Horwitz, L. Osborne
          </td>
          <td>2025-09-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Crohn’s disease pathology is modeled in TNFΔARE+/− mice that overproduce tumor necrosis factor (TNF) to drive disease through TNF receptors. An alternative ligand for TNF receptors, soluble LTα3, is produced by B cells, but has received scarce attention because LTα also partners with LTβ to generate membrane-tethered LTαβ2 that promotes tertiary lymphoid tissue—another feature of Crohn’s disease. We hypothesized that B cell-derived LTαβ2 would critically affect ileitis in TNFΔARE+/− mice. However, whereas deleting LTβ in B cells was essential for tertiary lymphoid tissue, disease pathology was minimally affected. By contrast, loss of B cell-derived LTα increased intestinal permeability, shrunk the pool of IgA+ ileal plasma cells, elevated cytokines and prompted weight loss, including loss of muscle mass—a systemic feature of Crohn’s disease. Neutralizing antibodies to LTα3 strongly augmented the cachexic-like effects of TNF. Thus, B cell-produced LTαβ2 and LTα3 have distinct roles in ileitis, with the role of LTα3 unexpectedly protective through counterbalancing TNF.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aa9dc1ddd15605e0c4b024a4e7d3684e6a625435" target='_blank'>
              Distinct roles for B cell-derived LTα3 and LTα1β2 in TNF-mediated ileitis
              </a>
            </td>
          <td>
            E. Erlich, Q. Alayo, Ayoung Kim, Jichang Han, Rachel L. Mintz, Christopher G Huckstep, Heather S Ruiz, Rachael L. Field, Taylor J Dunning, Leila Saleh, M. Hoofnagle, Alexei V. Tumanov, F. Guilak, Jonathan R. Brestoff, R. Czepielewski, Gwendalyn J Randolph
          </td>
          <td>2025-09-08</td>
          <td>Nature Immunology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a34b6d929a049357f2964e23e7d33976a5ca654" target='_blank'>
              DYNAMICS OF RHINOVIRUS SARS-COV-2 COINFECTIONS AND SUPERINFECTIONS IN HUMAN AIRWAY CULTURES REVEAL TYPE-DEPENDENT VIRAL INTERFERENCE
              </a>
            </td>
          <td>
            Romain Volle
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Microglia and CNS-associated macrophages (CAMs) are the primary targets of human immunodeficiency virus (HIV-1) in humans and simian immunodeficiency virus (SIV) infection in nonhuman primates, contributing to HIV-associated neurocognitive disorders and establishment of a persistent viral reservoir in the central nervous system (CNS). Despite antiretroviral therapy (ART), neurocognitive and other neurological disorders persist in people with HIV (PWH). Opioid users can suffer exacerbated disease progression and neurological complications. However, the impact of ART-treated infection and opioids on brain myeloid cells, the main targets for HIV/SIV in the brain, remains poorly understood. Using an SIV-infected rhesus macaque model and single-cell multi-omic sequencing, we show that ART promotes the restoration of homeostatic microglial states, while morphine exerts immunosuppressive effects on brain myeloid cells. Consistent with this immunosuppression, in morphine-treated, SIV-infected ART-suppressed macaques we found that myeloid cells exhibited reduced antiviral gene expression, including downregulation of MHC class II and interferon-stimulated genes, as well as decreased activity of AP-1 and ETS transcription factors. Furthermore, through the integration of single-cell data from PWH, we found that homeostatic microglial signatures were also evident in ART-treated PWH, although the microglia from PWH exhibited more activated/inflammatory phenotypes than those from the macaque model. These findings reveal distinct effects of ART and morphine on brain myeloid cell dynamics during SIV infection, indicating potential mechanisms underlying worsened neurocognitive outcomes in opioid-using PWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dbf3e359f11b660c49cf0e6f0056e5add76f6a24" target='_blank'>
              Opioid-induced immunosuppression of brain myeloid cells in SIV-infected rhesus macaques
              </a>
            </td>
          <td>
            Howard S. Fox, Xiaoke Xu, Meng Niu, Benjamin G. Lamberty, Kathleen M. Emanuel, Shannon E. Callen, Shilpa Buch, Arpan Acharya, S. Byrareddy
          </td>
          <td>2025-09-18</td>
          <td>Research Square</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="African swine fever virus (ASFV) is an important transboundary animal pathogen with significant impacts on the global swine industry. Overwhelming proinflammatory responses are a major virulence mechanism for ASFV, but the dynamics of these changes during clinical disease are not completely understood. We constructed a detailed portrait of the innate immune responses during acute African swine fever (ASF) at the cellular, transcriptomic, and cytokine levels. Samples serially obtained from infected piglets show progression of acute ASF is characterized by rapid increases in plasma type I interferons, TNF-α, IL-12p40, and IL-10, which coincide with the manifestation of clinical disease and viral DNAemia. Lymphocytes and natural killer (NK) cells progressively declined, with fluctuations in B cell, CD8+ T cell, and CD4+/CD8+ T cell populations. Blood monocytes and macrophages were highly variable throughout infection, with an abrupt spike in CD203+ mature macrophages immediately prior to death. Transcriptomic analysis of blood showed downregulation of cellular translation as early as 1 day post challenge (DPC), and significant upregulation of antiviral immune processes at 5 DPC and 7 DPC which overlapped with the onset of clinical disease. Together, these results present a highly detailed delineation of fatal ASF as involving an initial infection and damage of susceptible myeloid cells prior to symptomatic disease characterized by pro-inflammatory immune responses, lymphoid depletion, and clinical deterioration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/86a99b588597b8c01abeda0e39364b2249baf2e4" target='_blank'>
              Temporal dynamics of cytokine, leukocyte, and whole blood transcriptome profiles of pigs infected with African swine fever virus
              </a>
            </td>
          <td>
            Daniel W. Madden, B. Artiaga, J. Trujillo, Patricia Assato, Chester D. McDowell, Isaac Fitz, T. Kwon, K. Cool, Yonghai Li, N. Gaudreault, Igor Morozov, Juergen A Richt
          </td>
          <td>2025-08-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Objectives Serological monitoring of SARS-CoV-2 antibodies in children and adolescents has been crucial for pandemic surveillance and response, while the role of T cell response monitoring remains uncertain. This study aimed to assess the potential of T cell response monitoring in children and adolescents during the COVID-19 pandemic. Methods We compared antibody and T cell-mediated immune responses in a subpopulation (n = 109) of children and adolescents from the Ciao Corona cohort study. Participants were followed up over 6 months, from November/December 2021 to June/July 2022, during the Delta and Omicron waves in Switzerland. Results Circulating, virus-specific T cell responses in children and adolescents were generally low and heterogeneous. T cell-mediated responses were not consistent with SARS-CoV-2 infection status, with responses detectable in some seronegative individuals and not detectable in a considerable number of seropositive participants. Conclusion Circulating, virus-specific T cell responses to SARS-CoV-2 in children and adolescents from the general population offer limited additional insight. Monitoring humoral immunity is likely a more cost-effective approach and should be the primary focus of immunological surveillance in the general paediatric population.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/24e29d40efb47dd27db4c4bbde07715d160f1885" target='_blank'>
              Assessing the Value of T cell Monitoring in the General Population of Children and Adolescents – Insights From the Ciao Corona Cohort Study
              </a>
            </td>
          <td>
            A. Raineri, Sonja Rueegg, Thomas Radtke, Susi Kriemler, K. Zens, Giuseppe Pantaleo, C. Fenwick, C. Pellaton, M. Puhan
          </td>
          <td>2025-09-18</td>
          <td>International Journal of Public Health</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/61f2942696de914b8ddcd3d63d15f096d71ddb29" target='_blank'>
              Progenitor T cells drive chronic pulmonary type 2 inflammation
              </a>
            </td>
          <td>
            Radomir Kratchmarov, Xiaojiong Jia, Jun Nagai, Hiroaki Hayashi, Kinan Alhallak, Juying Lai, Chunli Feng, Jakob von Moltke, Joshua A. Boyce, Patrick J Brennan
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Intoduction T lymphocytes, along with cytokines and chemokines-dependent pathways are primarily responsible for regulating the immune response, controlling inflammation and eliminating viral infections. However, excessive immune activity can lead to pathological effects such as cytokine storm, which may cause severe respiratory distress syndrome and multi-organ damage in COVID-19. The aim of this study was to identify potential biomarkers of SARS-CoV-2 infection that could predict the severity of COVID-19 progression. Methods The cohort in this study included 52 hospitalized adult patients with SARS-CoV-2 infection from Warsaw, Poland admitted to the hospital during COVID-19 pandemic (February to November 2021). Based on clinical symptoms, patients were divided into two groups: (i) mild/moderate symptoms (non-severe) – 44 patients and (ii) severe respiratory failure (severe) – 8 patients. The control group consisted of 26 individuals without COVID-19. All COVID-19 patients and healthy controls underwent immunophenotyping of peripheral blood to assess the abundance of T lymphocytes and regulatory T lymphocytes, as well as measurement of selected cytokine and chemokine concentrations in corresponding serum samples. Data analysis was performed using CytoFLEX Flow Cytometer. Results and discussion Decreased percentages of total lymphocytes and T lymphocytes in peripheral blood were observed across all COVID-19 patients, with varying degrees between the non-severe and severe groups. A significant reduction was also noted in double-positive lymphocytes (CD4+CD8+), regulatory T lymphocytes ( CD4+ CD25HiCD127Lo and CD4+CD25HiCD127LoFoxP3+), as well as CD4+CD25+/-, CD4+CD45RA+/-, and CD8+CD45RA+/- subsets. Elevated levels of IL-6, IL-10, IL-17A, IFN-g, CCL2, CXCL8, and CXCL10 were observed in the non-severe and/or severe groups compared to healthy controls. Most importantly, only CXCL10 was significantly elevated in the severe group at admission compared to the non-severe group. In this study, we identified the chemokine CXCL10 as a crucial marker for distinguishing the severe course of COVID-19 from non-severe form at the time of admission. It may serve as an early indicator of diseases progression during hospitalization, potentially allowing prediction of the disease course. Moreover, elevated CXCL10 levels, in combination with decreased total lymphocytes counts and increased levels of IL-6, IL10, IFNg, CCL2 and CXCL9, may represent a more comprehensive biomarker panel suitable for predicting the severity of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/befe135670515a1bc53405d52fd1e7cbd7111080" target='_blank'>
              Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland
              </a>
            </td>
          <td>
            Monika Leśniak, A. Borkowska, Krzysztof Kłos, K. Aleksandrowicz, K. Porębska, Dagmara Kobza, K. Piwowarek, K. Plewka-Barcik, Marcin Niemcewicz, Anna Lutyńska, Jacek Z. Kubiak, Andrzej Chciałowski, R. Zdanowski
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Introduction Sepsis is a life-threatening condition characterized by immune dysregulation, yet the mechanisms underlying T cell dysfunction remain poorly understood. Methods We integrated multi-omics data from public GEO datasets and prospective cohorts. Single-cell transcriptomic analysis was applied to identify core genes, followed by diagnostic and prognostic validation. Cell–cell interaction networks were constructed to investigate signaling alterations, and cross-platform validation was conducted. Results Seven core genes (LTB, CD3D, TRAF3IP3, CD3G, GZMM, HLA-DPB1, CD3E) were identified, showing strong diagnostic value (AUC ≥ 0.86) and prognostic significance (HR=4.50 for CD3E). Network analysis revealed collapse of critical signaling axes (HLA-DRA-MHCII, ITGB2-CD226) and aberrant activation of inhibitory pathways (LGALS9-CD45), leading to a “co-stimulation inhibition–checkpoint activation” imbalance. Cross-platform validation confirmed conserved downregulation of these genes in sepsis, which contributed to immune exhaustion via disrupted T cell differentiation trajectories and impaired intercellular communication. Conclusion Our findings highlight novel biomarkers and potential therapeutic targets for sepsis immunotherapy by systematically deciphering core gene networks and immune interaction collapse in T cell dysfunction.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4507e6cde0317e8b062b7f1ee229b5df2a8fe7bf" target='_blank'>
              Single-Cell Multi-Omics Deciphers Core Gene Networks and Immune Interaction Collapse in Sepsis-Associated T Cell Dysfunction
              </a>
            </td>
          <td>
            Xiang Li, Zhibin Chen, Yandong Yao, Muhu Chen, Ying Hu
          </td>
          <td>2025-09-13</td>
          <td>Infection and Drug Resistance</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="A Cytokine storm is critical in severe dengue, significantly contributing to disrupted endothelial integrity, plasma leakage, and haemorrhage manifestations in affected patients. Various reports have demonstrated that mononuclear phagocytes, including monocytes, dendritic cells, and macrophages, are target cells of DENV infection. They contribute to viral spread into tissues and promote robust inflammatory responses and immunopathology. However, it remains unclear whether the early events of DENV infection play a role in triggering cytokine storms in infected mononuclear phagocytes. To address this knowledge gap, we conducted a comprehensive analysis of the transcriptomic profile of in vitro DENV-2-infected human monocyte-derived macrophages (MDMs) based on the kinetics of viral replication through a standard growth curve. To verify the accuracy of our approach, we used RT-qPCR, ELISA, and transcriptomic data from in vitro DENV-2-infected monocyte-derived dendritic cells (MDDCs) and monocytes obtained from acute dengue patients. RNA-Seq analysis revealed dynamic changes in the transcriptional profile of DENV-2-infected MDMs throughout the viral growth curve. Two waves of differentially expressed genes were observed: the first occurred during the eclipse period of viral replication (3 to 5.5 h.p.i) and was associated with the induction of NF-kB-dependent pro-inflammatory factors, while the second wave at 24 h.p.i coincided with peaks of DENV-2 replication and induction of both NF-kB- and STAT1-dependent pro-inflammatory responses. Additionally, DENV-2 infection promoted the dynamic activation of Toll-like receptors, RIG-like receptors, inflammasomes, and inflammatory pathways, triggering innate pro-inflammatory and antiviral responses. A robust multi-type IFN-dependent antiviral response was also observed at the late stage of infection. A similar transcriptomic profile was found in DENV-2-infected MDDCs and monocyte subsets from acute dengue patients, further confirming the reliability of our in vitro model of DENV-infected MDMs. Together, results suggest that recognizing viral PAMPs during the eclipse period of DENV-2 infection promotes a robust NF-kB-dependent pro-inflammatory response in MDMs. In addition, at later stages of infection, recognizing structural DENV-PAMPs and/or viral replication intermediates induces both NF-kB- and STAT1-dependent pro-inflammatory responses, leading to a cytokine storm. These findings highlight the critical role of monocytes, macrophages, and dendritic cells in detecting DENV infection and triggering a cytokine storm in vitro and in vivo. This suggests that these cell populations could be potential targets for future immunotherapies to modulate the inflammatory response to DENV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c8e6b905c480aedaab379a823d11d37d51023123" target='_blank'>
              Early events in dengue virus infection inducing cytokine storm: The dynamic interplay of pattern-recognition receptors, inflammasome activation, and biphasic NF-κB and STAT1-dependent inflammatory responses in human mononuclear phagocytes
              </a>
            </td>
          <td>
            Juan Felipe Valdés-López, Y. S. Tamayo-Molina, G. Fernandez, Lady Johana Hernández-Sarmiento, P. Velilla, S. Urcuqui-Inchima
          </td>
          <td>2025-09-01</td>
          <td>PLOS Neglected Tropical Diseases</td>
          <td>1</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2c5a6c1df254a1348f9af1511a5ed22d77b59bf3" target='_blank'>
              Virologic characteristics of SARS-CoV-2 infection across evolving omicron subvariants.
              </a>
            </td>
          <td>
            J. Boucau, Owen T. Glover, C. Marino, Gregory E. Edelstein, M. Choudhary, Yijia Li, Brooke M. Leeman, Zahra Reynolds, Karry Su, Dessie Tien, Chase B Mandell, E. Passell, Andrew Alexandrescu, Emory Abar, Mamadou Barry, Dibya Ghimire, T. Vyas, J. Vyas, Jacob E. Lemieux, Jonathan Z. Li, M. Siedner, A. Barczak
          </td>
          <td>2025-09-09</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fdbae78251ccd4fa8f2487fe48e2a546a3022eef" target='_blank'>
              Antiviral and Anti-inflammatory Effects of Cannabidiol in HIV/SIV Infection
              </a>
            </td>
          <td>
            AL Ellison, J. Rosado-Franco, L. Mamun, S. Knerler, M. Daniali, K. Mehta, S. Williams-McLeod, J. Alvarez, SS Joyner, R. Vandrey, Elise M. Weerts, Peter J. Gaskill, MJ Corley, LC Ndhlovu, DW Williams
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="People living with HIV suffer multiple comorbid conditions related to chronic inflammation at increased rates compared to the general population, even when on effective antiretroviral therapy. In particular, current data indicate that the increased incidence and severity of neurocognitive impairment (NCI) are associated with unresolved neuroinflammation. Attempts to treat NCI in people living with HIV by reducing inflammation have thus far been unsuccessful, suggesting that a more mechanistic understanding of inflammatory processes in the CNS during HIV is necessary. Here, we use iPSC-derived microglia (iMg) and astrocytes (iAst) to model HIV infection in the CNS. We show that our iMg robustly express markers associated with microglial identity and are susceptible to HIV infection, but exhibit lower HIV replication rates and weaker immune response to HIV challenge compared to monocyte-derived macrophages. Coculture of iAst with iMg leads to a much stronger pro-inflammatory immune response, and, surprisingly, a robust increase in rates of HIV replication. Increased replication in iMg/iAst cocultures is associated with higher levels of multiple pro-inflammatory cytokines, including TNFα, which is produced by iAst upon exposure to HIV-infected iMg. Addition of exogenous TNFα to iMg during HIV infection is also sufficient to increase rates of replication, and neutralization of TNFα via adalimumab/Humira treatment in iMg/iAst cocultures reduces replication. Blocking NF-kB signaling with iKK inhibitor Bay-11-7082 (Bay-11) demonstrates that increased HIV replication in iMg/iAst cocultures is due to increased NF-kB activity. Finally, we show that in HIV-infected iMg there is movement of lysosomes to the periphery of the cell membrane and release of lysosomal content into the extracellular space, suggesting that this dysregulated lysosomal flux could further contribute to the pro-inflammatory microenvironment. We propose that this altered lysosomal trafficking and increased cytokine production drives a pro-inflammatory phenotype in glia and represents a potential source of unresolved neuroinflammation in people living with HIV.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62a23e151af43cbde0f570f857bd4785e2a32648" target='_blank'>
              Neuroinflammatory crosstalk between microglia and astrocytes increases viral replication in an iPSC-derived model of CNS HIV infection
              </a>
            </td>
          <td>
            James D Gesualdi, Jude Prah, Shiden Solomon, Jayden Cyrus, Ernesto Baçi, P. J. Gaskill, C. Akay-Espinoza, Kelly L Jordan-Sciutto
          </td>
          <td>2025-09-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Aging is characterized by chronic low-grade neuroinflammation, which increases the risk of neurodegenerative disorders. Neuroinflammation, driven by the activation of astrocytes and microglia, underlies age-associated cognitive deficits. Amplified neuroinflammatory responses to immune challenges are attributed to microglial activation in the aged brain. Despite extensive clinical and experimental evidence linking neuroinflammation to aging, the molecular players that control age-associated neuroinflammatory responses in the brain are not fully understood. Genome-wide association studies (GWAS), proteomics, and transcriptomic datasets have revealed that Asrij/OCIAD1 is a novel aging and Alzheimer’s disease (AD)-associated factor. Asrij levels are increased in patients with AD and are known to promote amyloid-beta (Aβ) pathology and microglia-mediated neuroinflammation, which are associated with cognitive dysfunction in AD. Increased levels of Asrij are also reported in the brains of aged wild-type (WT) mice; however, whether this may promote neuroinflammation or be a protective response during aging is not known. To test this, we used young and aged WT and asrij KO mice and showed that normal aging is associated with increased microgliosis and astrocyte activation in WT mice. While young asrij KO mice do not display any differences in glial activation, aged KO mice have reduced microglial and astrocytic activation compared to aged WT mice. This is accompanied by reduced levels of pro-inflammatory mediators and downregulation of STAT3 and NF-κB signaling in the cortex and hippocampus of aged asrij KO mice. Additionally, asrij depletion inhibits LPS-induced microglial activation and neuroinflammation in aged mice. This indicates that Asrij is essential for the neuroinflammatory responses in the brains of aged mice. We propose that identifying pharmaceutical modulators of Asrij could provide novel means to control microglial activation and neuroinflammation during normal aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b05e7046c3b3a0c27c19a9838cb4c954fa499381" target='_blank'>
              Asrij/OCIAD1 contributes to age-associated microglial activation and neuroinflammation in mice
              </a>
            </td>
          <td>
            Prathamesh Dongre, Madhu Ramesh, T. Govindaraju, M. Inamdar
          </td>
          <td>2025-10-10</td>
          <td>Frontiers in Aging Neuroscience</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="ABSTRACT RNA viruses have high mutation frequency, quick generation periods and vast population numbers, which promote fast evolution and host environment adaptation. We integrated scRNA‐seq and spatial transcriptomics to profile immune cells and viral gene expression in COVID‐19. Cell types and interactions were identified using Seurat‐based tools. Spatial transcriptomics analysis revealed viral hotspots, and GISAID data were used to track SARS‐CoV‐2 mutations. Single‐cell and spatial transcriptomics analyses revealed that immune cells such as Neutrophils, Monocyte:CD14 + , and T cell:CD4+ central memory are highly abundant in COVID‐19 patients, particularly in mild and severe cases, and are concentrated in the central and upper regions of lung tissue. Pseudotime and CellChat analyses indicated that cell differentiation trajectories and communication networks shift toward heightened inflammatory responses in severe conditions. Spatial analysis of viral gene expression showed that SARS‐CoV‐2 genes, especially Nucleoprotein, Spike and Envelope were highly expressed in central and upper‐right tissue regions, suggesting active viral replication. This localized viral activity was strongly associated with areas of immune cell infiltration and inflammation. The top 10 sustainable mutants in SARS‐CoV‐2 genome with high frequency were observed in NSP12 (P323L, 99%, Switzerland), Spike (D614G, 97%, Switzerland), NSP4 (T492I, 79%, Switzerland), NSP6 (T77A, 70%, Guangdong), Orf9c (G50N, 64%, England), Nucleoprotein (D377Y, 62%, United States), Orf9b (T60A, 61%, France), NSP14 (I42V, 55%, United States), Envelope (T9I, 51.3%, Trinidad and Tobago), and NSP5 (P132H, 51.2%, United States). Following to this approach is crucial for a strong epidemiological reaction against the changing SARS‐CoV‐2 outbreak.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/41d4c6b68c2ba2cc60900b3817724ba0dc5ef871" target='_blank'>
              Spatial Transcriptomics and Single Cell‐RNASeq Reveals Cellular Heterogeneity of SARS‐CoV‐2 in Lung Tissues and Global Mutational Patterns in COVID‐19 Patients
              </a>
            </td>
          <td>
            Seyed Taleb Hosseini, M. Mahmanzar, K. Rahimian, Saleha Bayat, Amir Gholamzad, M. M. Sisakht, Amin Farhadi, D. L. Kuehu, Youping Deng
          </td>
          <td>2025-09-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e819f35bfc49ec2545e41780dc01e007f076a26d" target='_blank'>
              Immune Cell Dysfunction of SARS-CoV-2: Mathematical Modeling of the Within-Host Immune Dynamics
              </a>
            </td>
          <td>
            Pagnapech Ngoun, Nicolas Alvarez, Ayesh Awad, Hwayeon Ryu
          </td>
          <td>2025-10-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1cac498108b5305e7d2a1dde250a33c8a3e03b2" target='_blank'>
              Acute SARS-CoV-2 infection.
              </a>
            </td>
          <td>
            Amy C. Sherman, Glenda E Gray, Bin Cao, Kelvin K W To, Nadine G Rouphael, A. Henao-Restrepo, Anthony C Gordon, Lindsey Baden
          </td>
          <td>2025-10-24</td>
          <td>Nature reviews. Disease primers</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Background: The SARS-CoV-2 Omicron variant became the dominant driver during the COVID-19 pandemic due to its high transmissibility and immune escape potential. Although clinical outcomes are generally mild to moderate, the inflammatory mechanisms triggered by Omicron subvariants remain poorly defined. The goal of this study was to consider both viral evolution and the host immune response by assessing plasma cytokine levels in patients infected with SARS-CoV-2 Omicron subvariants. Methods: A total of 115 individuals were recruited, including 40 with laboratory-confirmed SARS-CoV-2 infection by RT-qPCR. Demographic, clinical, and comorbidity data were collected. Plasma levels of IL-6, TNF, IFN-γ, IL-4, IL-2, IL-10, and IL-17A were quantified using Cytometric Bead Array. Subvariant data were obtained from GISAID records and grouped into early (BA.1-lineage) and late (BA.4/BA.5-lineage) Omicron clusters. Statistical analysis included non-parametric and parametric tests, correlation matrices, and multivariate comparisons. Results: Pharyngitis, nasal discharge, cough, and headache were the most common symptoms among infected individuals. Despite no significant variation in symptom distribution across subvariants, infected patients showed higher levels of IFN-γ, TNF, IL-10, IL-4, and IL-2 compared to non-SARS-CoV-2 infected controls (p < 0.05). IL-4 and IL-10 levels were significantly higher in early Omicron infections. No associations were observed between cytokine levels and comorbidities. A significant correlation was found between reporting fewer symptoms and having received three vaccine doses. Conclusions: Infection with Omicron subvariants elicits a strong yet balanced cytokine response. Despite genetic divergence between lineages, immune and clinical patterns remain conserved, with vaccination appearing to mitigate the symptom burden.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92712f1f38ce3bab0b4fa1ac4965a49cdca82973" target='_blank'>
              Clinical Manifestations and Cytokine Profiles of the Th1, Th2, and Th17 Response Associated with SARS-CoV-2 Omicron Subvariants
              </a>
            </td>
          <td>
            Matheus Amorim Barreto, Amanda Mendes Silva Cruz, Delana Melo Volle, Wanderley Dias das Chagas Júnior, I. B. Costa, Juliana Abreu Lima Nunes, Aline Collares Pinheiro de Sousa, Izabel Keller Moreira Lima, Patrícia Yuri Nogami, Iami Raiol Borges, Luany Rafaele da Conceição Cruz, Paula Fabiane da Rocha Nobre, Edvaldo Tavares da Penha Junior, J. A. M. Siqueira, Victória Figueiredo Brito do Carmo, D. Oliveira, H. R. Resque, Marcos Rogério Menezes da Costa, Rita Catarina Medeiros Sousa, M. C. D. Santos, M. I. Jesus, Luana Soares Bargelata, Luciana Damascena da Silva, Igor Brasil-Costa
          </td>
          <td>2025-08-31</td>
          <td>Biomedicines</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ff39811b58af3141f8b13471490c1f390abe0d9" target='_blank'>
              Non-canonical inflammasome drives intrinsic anti-microbial responses in human Natural Killer cells
              </a>
            </td>
          <td>
            N. G. Leborgne, Jadie Acklam, Alexander J. Hogg, Zarema Albakova, Karen Hogg, K. Robinson, Grant Calder, Arnel Villamin, Callum Robson, Freya Pealing, Matthew A. Care, Monika Gonka, James M. Fox, James Iremonger, J. Hewitson, David G. Kent, Alison M. Layton, Frances E. Pearson, Max E. Noble, W. Grey, Jillian L. Barlow, Dave Boucher
          </td>
          <td>2025-10-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="
 The COVID-19 pandemic, caused by SARS-CoV-2, represents one of the most profound global public health challenges in modern history. While T cell immunity is crucial for viral clearance, the dynamics of the T cell receptor (TCR) repertoire during reinfection remain poorly understood. This study sought to characterize the TCR repertoire in peripheral blood T cells from healthy convalescent individuals (HC), patients with primary SARS-CoV-2 infection (PI), and reinfected individuals (RI), aiming to identify distinct TCR signatures linked to susceptibility or protection against reinfection. We enrolled 48 age- and sex-matched participants (18 PI, 18 RI, 12 HC), collecting blood samples during acute infection (PI/RI) or convalescence (HC). Deep TCRα/β sequencing was performed using the SMARTer Human TCR Profiling Kit with unique molecular identifiers (UMIs), followed by analysis of TCR repertoire diversity, clonal expansion, V(D)J gene usage, and CDR3 characteristics. Compared to HC, both PI and RI groups exhibited significantly reduced TCR diversity (
 p
 < 0.001), though no significant differences were observed between PI and RI. COVID-19 patients displayed skewed TCR repertoires dominated by expanded clones (>1%), whereas HC primarily harbored small clones (≤ 0.1%). RI patients demonstrated intermediate clonality, suggesting partial memory recall. Group-specific V(D)J pairings were identified, including TRAV27/TRAJ42 in RI, TRAV24/TRAJ42 in PI, and TRAV35/TRAJ42 in HC, while TRBV6-4/TRBD2/TRBJ2–3 was conserved across all groups. Additionally, HC-enriched and RI-exclusive CDR3 clusters were detected. Our findings indicate that SARS-CoV-2 reinfection is associated with impaired TCR diversity and distinct clonal expansion patterns, underscoring the role of T cell immunity in reinfection susceptibility. HC-enriched TCR clusters may represent protective memory responses, whereas RI-specific signatures suggest compromised immunity. These results offer valuable insights for vaccine design and risk stratification, though further functional validation of the identified TCRs is necessary.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d977242eab98e457279671a381065b9ee003f60" target='_blank'>
              Distinct characteristics of T cell receptor repertoire associated with the SARS-CoV-2 reinfection
              </a>
            </td>
          <td>
            Liling Zeng, Li Liu, Baolin Ren, Bing Feng, Xudong Lai, Xunxi Lai, Zhimin Chen, Yihui Huang, Wenxin Hong
          </td>
          <td>2025-10-23</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c799805d663665f46c0792b1fbd8a36839651112" target='_blank'>
              Characterization of immunosenescent alveolar macrophages in rhesus macaques
              </a>
            </td>
          <td>
            Jefferson G. C. Nagle, Raneesh Ramarapu, Laurent Zablocki-Thomas, Hai D. Nguyen, Dennis Hartigan-O’Connor, Amir Ardeshir, Elizabeth S. Didier, , Marcelo J. Kuroda
          </td>
          <td>2025-10-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Innate immune cells such as monocytes and macrophages provide the earliest defense against infection by intracellular pathogens by initiating signaling pathways and restricting pathogen replication. However, the full complement of proteins that mediate cell-autonomous immunity remains incompletely defined. Here, we applied cysteine-directed activity-based protein profiling (ABPP) to map proteome-wide cysteine reactivity changes in THP-1 monocytes and primary human monocyte-derived macrophages during Mycobacterium tuberculosis (Mtb) infection. Across both cell types, we quantified 148 cysteine residues with altered reactivity. Genetic perturbation of a subset of proteins harboring these changes significantly impacted Mtb replication, revealing functional links between site-specific cysteine reactivity and antimicrobial defense. These data define previously unrecognized host protein changes during Mtb infection and provide a resource for investigating post-translational events that regulate innate immune responses to intracellular bacteria.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cb6873ab0faeb5593c9cd0d1b53ae9ac2349199e" target='_blank'>
              Cysteine reactivity profiling identifies host regulators of Mycobacterium tuberculosis replication in human macrophages
              </a>
            </td>
          <td>
            John Neff, Kristen E. DeMeester, Paola K. Párraga, R. Suciu, M. Dix, Gabriel Simon, Max A. Gianakopoulos, Bruno Melillo, Benjamin F. Cravatt, M. Shiloh
          </td>
          <td>2025-09-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="


 COVID-19, including its post-acute sequelae (Long COVID), is increasingly recognized as involving persistent immune dysregulation and chronic inflammation. Severe and prolonged disease states are often accompanied by sustained cytokine release, immune cell exhaustion, and ongoing cell-cell communication that shapes the inflammatory milieu. Among immune subsets, CD8
 +
 T cells play a central role in antiviral defense, yet the molecular mechanisms linking their dysfunction to prolonged inflammation remain incompletely understood.




 We analyzed 73,110 peripheral blood mononuclear cells (PBMCs) from individuals across four disease states (Healthy, Exposed, Infected, and Hospitalized) using single-cell RNA sequencing. Immune cell subsets were annotated, and T cell heterogeneity was profiled. Cytokine and inflammatory scores were calculated to assess immune activation. Differentially expressed genes (DEGs) underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Cell-cell communication was evaluated to map ligand-receptor networks. Additionally, nine machine learning models were trained on a bulk RNA-seq cohort, and the SHapley Additive exPlanations (SHAP) framework was applied to interpret key predictive genes.




 Progressive disease severity was associated with a decline in T cell proportions, enrichment of pro-inflammatory myeloid cells, and elevated cytokine expression, particularly IL-32. Memory CD8
 +
 T cells showed increased exhaustion and inflammatory scores while maintaining a central position in MHC-I-mediated communication networks. Persistent activation of immune and metabolic pathways, including antigen presentation and oxidative phosphorylation, was observed in prolonged disease states. Seven genes (RPS26, RPS29, RPL36, RPL39, RPS28, RPS21, and CD3E) were identified as strong predictors of chronic immune dysregulation, with the XGBoost model achieving the highest AUC. SHAP analysis confirmed their contributions to disease classification.





 This study maps the immune landscape of COVID-19 and Long COVID at single-cell resolution, revealing that persistent immune cell communication, particularly involving memory CD8
 +
 T cells, may sustain chronic inflammation beyond the acute phase. The identified molecular signatures offer potential biomarkers and therapeutic targets for mitigating post-viral inflammatory syndromes.

">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/536000d345ef1e6f7663efc28145b0e979e70e7b" target='_blank'>
              Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID
              </a>
            </td>
          <td>
            Hengrui Liu, Zewen Xu, Ilayda Karsidag, Panpan Wang, Jieling Weng
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Abstract Background While highly efficacious for numerous cancers, immune checkpoint inhibitors (ICIs) can cause unpredictable and potentially severe immune-related adverse events (irAEs), underscoring the need to understand irAE biology. Methods We used a multidimensional approach incorporating single-cell RNA sequencing, mass cytometry, multiplex cytokine assay, and antinuclear antibody (ANA) profiling to characterize the peripheral immune landscape of patients receiving ICI therapy according to irAE development. Results Analysis of 162 patients revealed that individuals who developed clinically significant irAEs exhibited a baseline proinflammatory, autoimmune-like state characterized by a significantly higher abundance of CD57+ T and natural killer (NK) T cells, plasmablasts, proliferating and activated CXCR3+ lymphocytes, CD8+ effector and terminal effector memory T cells, along with reduced NK cells and elevated plasma ANA levels. In irAE cases, we identified distinct baseline proinflammatory gene signatures, including markedly higher expression of IL1B and CXCL8 in monocytes and CXCR3, TNF, and IFNG in T/NK cells. TNF signaling was the most enriched pathway, while immunosuppressive genes SIGLEC7 and CXCR4 were downregulated. Following ICI initiation, these patients exhibited an enhanced shift toward an activated and inflammatory immune phenotype, including monocyte reprogramming characterized by upregulation of IL18 and elevated gene expression levels of CXCL10. Conversely, post-treatment levels of CXCL8 were decreased in irAE patients. Notably, in patients who did not develop clinically significant irAE, we identified increased baseline abundance of a TGFBIhigh myeloid cluster enriched in immunosuppressive markers such as STAB1. In addition, patients without irAE exhibited upregulation of TNF and AIRE, accompanied by distinct myeloid protumorigenic reprogramming. Conclusions A pre-existing activated, autoimmune-like proinflammatory state drives the development of irAE during ICI therapy through three key axes: increased plasmablast/ANA, heightened interferon-gamma/CXCL10/CXCR3 axis, and amplified TNF signaling. These findings may serve as potential peripheral immune biomarkers for predicting irAE and provide biological insights into the mechanisms governing and mitigating irAE.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c3ee5a19a83fa740345e914d6f17a5f886c87b78" target='_blank'>
              Innate and adaptive immune features associated with immune-related adverse events
              </a>
            </td>
          <td>
            Shaheen Khan, V. Malladi, Mitchell S. von Itzstein, Hong Mu-Mosley, Farjana J Fattah, Yang Liu, Mary E. Gwin, Jason Y Park, Suzanne Cole, Sheena Bhalla, J. Lohrey, D. Hsiehchen, Angela Moses, Tao Wang, Yaming Xue, Angela B. Mobley, J. D. Farrar, Marjaan Imam, Michelle Wu, Q. Li, E. Wakeland, Yang Xie, J. SoRelle, David E. Gerber
          </td>
          <td>2025-09-01</td>
          <td>Journal for Immunotherapy of Cancer</td>
          <td>0</td>
          <td>74</td>
        </tr>

        <tr id="Background and Objectives: SARS-CoV-2 infection initiates at mucosal surfaces, and mucosal immunity may influence the nature and severity of infection. Little is known about the induction of mucosal immunity by vaccination in COVID-19 convalescents. Methods: Sera from 205 healthcare workers were collected one month after the first Covishield vaccination and 1/3/6 months after the second vaccination, while paired sera and stimulated whole-mouth fluid (SWMF) was collected 1/3/6 months after the third vaccination (N = 10) and at 0/30/90 days after a COVID-19 episode (N = 8). Anti-SARS-CoV-2 spike antibody detection by ECLIA/ELISA and cytokine detection by ELISA/CBA were performed. Results: One month post-second vaccination, serum antibodies had increased significantly (6-fold) in the COVID-19-naïve group (CNG) but declined (1.5-fold) in the previously COVID-19-exposed group (CEG), who already had high antibody titres. The serum regulatory cytokine IL-10 levels were higher after three antigen exposures (p = 0.0002). New infections (breakthrough infections—BTIs) or reinfections (RIs) with asymptomatic/mild disease occurred in 44% of the CNG and 27% of the CEG (p < 0.01). The mucosal cytokine IL-17 levels were significantly higher in the CEG. Salivary IgG/IgA and secretory IgA antibodies were detectable both after vaccination and COVID-19. Innate cytokines (MIG, MCP-1, IL-8, IL-1β) were higher and sustained in SWMF in contrast to serum. Conclusions: Two vaccinations in the CNG resulted in an antibody boost, but the second vaccination in the CEG induced antibody anergy. Serum/mucosal antibodies declined by six months after vaccination, but the rapid increase at subsequent exposures were indicative of a good T cell/B cell memory response to SARS-CoV-2. A higher percentage of BTI among the CNG than RI among the CEG may indicate better protection due to higher antibody responses in the latter group.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3543ef5e1d0508c28bcbc54cf4e588dce6e8f8a2" target='_blank'>
              Impact of COVID-19 on Mucosal Immunity and Antibody Responses in COVID Vaccinees
              </a>
            </td>
          <td>
            P. Kannian, Muruganantham Lillimary Eniya, P. Mahanathi, A. Gracemary, N. Kumarasamy, Stephen J Challacombe
          </td>
          <td>2025-09-01</td>
          <td>Vaccines</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e56b0f654aeb93a046a73a7a4da19670e8d180d9" target='_blank'>
              Single-cell multiomics reveals archetypal regulatory programs shared across CD4 and CD8 T cell subsets in viral infection
              </a>
            </td>
          <td>
            , J. van der Veeken, Alexander Rudensky, Yuri Pritykin
          </td>
          <td>2025-09-13</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>19</td>
        </tr>

        <tr id="ABSTRACT Invasive candidiasis, primarily caused by Candida albicans, poses a significant threat to immunocompromised patients, with high mortality rates. Understanding how immune responses to Candida albicans are mounted and controlled is fundamental to developing new therapeutic strategies. Protein tyrosine phosphatase 1B (PTP1B) is a regulator of immunoreceptor signaling and downstream inflammatory and metabolic responses and a pharmaceutical target. Here, we reveal a critical role for myeloid cell-intrinsic PTP1B in antifungal immunity. Mice lacking PTP1B in myeloid cells (LysM PTP1B−/−) were significantly more susceptible to systemic C. albicans infection, exhibiting lower survival, greater weight loss, and elevated fungal burdens in the kidney, liver, and brain. These mice also showed heightened proinflammatory mRNA expression in organs and increased kidney tubular inflammation, with increased leukocyte infiltration and chemokine production, contributing to immunopathology. Neutrophils from LysM PTP1B−/− mice displayed impaired maturation in infected kidneys and reduced reactive oxygen species production in vitro. Proteomic profiling of infected bone marrow-derived macrophages (BMDMs) revealed significant enrichment of type I interferon-regulated proteins in the absence of PTP1B. These BMDMs showed impaired phagocytosis, reduced killing capacity, and lower viability during infection, phenotypes recapitulated in human macrophages treated with a pharmacological PTP1B inhibitor. Collectively, our findings highlight PTP1B as a key modulator of innate immune responses to C. albicans, balancing antifungal activity and systemic toxicity with inflammation and metabolic fitness. Boosting specific PTP1B-dependent pathways may offer new strategies for enhancing host defense while minimizing fungal-induced immunopathology. IMPORTANCE Systemic Candida albicans infections are a leading cause of hospital-acquired morbidity and mortality, particularly in immunocompromised individuals and patients receiving immunosuppressive treatments. Despite antifungal therapies, outcomes remain poor, underscoring the need to better understand host factors that control fungal clearance. Protein tyrosine phosphatase 1B (PTP1B) is a key intracellular regulator of immune and metabolic signaling. This study identifies a critical role for myeloid PTP1B in antifungal defense and susceptibility to systemic C. albicans infection. Loss of PTP1B impairs neutrophil and macrophage function, disrupts inflammatory balance, and compromises pathogen clearance. These findings reveal PTP1B as a central modulator of immune responses to C. albicans and highlight its potential as a target for host-directed therapies to improve outcomes in systemic fungal infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7a2deb22112f33ec698219d562bcccbd96af29a" target='_blank'>
              PTP1B deficiency in myeloid cells increases susceptibility to Candida albicans systemic infection by modulating antifungal immunity
              </a>
            </td>
          <td>
            Bethany Allen, Ivy M. Dambuza, Susan H. Berry, Delyth M. Reid, Sam M. McVey, Martina Mesiarikova, L. John, Moira Davie, Christa P. Baker, J. S. C. Arthur, M. Delibegović, G. D. Brown, Heather M. Wilson
          </td>
          <td>2025-08-29</td>
          <td>mBio</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6db7c438373e1be32f3e8f8962c7eb002d2e0ff" target='_blank'>
              Single-cell profiling reveals that dynamic lung immune responses distinguish protection from susceptibility to tuberculosis
              </a>
            </td>
          <td>
            Fergal J. Duffy, M. L. Neal, Courtney R. Plumlee, Sarah Cohen, B. Gern, A. Diercks, Michael Y Gerner, K. Urdahl, J. Aitchison
          </td>
          <td>2025-10-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="SARS-CoV-2, the virus behind the COVID-19 pandemic, is primarily a respiratory pathogen, with host entry mediated by the ACE2 receptor that determines viral tropism. Notably, in humans, ACE2 is highly expressed in the gastrointestinal (GI) tract, particularly the small intestine (SI), prompting us to examine GI infectivity of SARS-CoV-2 variants of concern (VOCs). We found that ACE2 expression in Syrian hamsters closely resembles humans, supporting their use in studying GI tropism. Using this model, we compared infection and pathology of the ancestral Wuhan-like strain (Hong Kong), Delta, and Omicron variants. Despite high ACE2 expression, GI infection and pathology were generally low relative to the respiratory tract. However, the Delta variant showed markedly enhanced GI infectivity and pathology, especially in the SI, and caused the greatest disruption of the gut microbiome. These findings link SARS-CoV-2 virulence with GI infection and microbiome disturbance, establishing Syrian hamsters as a relevant model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/77df6d4abd298647386ce524f503a92d8f222d56" target='_blank'>
              Gut infection and dysbiosis are hallmarks of severe SARS-CoV-2 variants
              </a>
            </td>
          <td>
            S. K. Nagaraj, Christy M. Joy, Rishad Shiraz, R. Narayan, Sumandeep Kaur, Oyahida Khatun, Sagar Dubey, James Ng, N. Mishra, Shashank Tripathi
          </td>
          <td>2025-10-24</td>
          <td>npj Viruses</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Abstract Background Alveolar macrophages (AMs) are crucial innate immune cells that play important roles during infection with severe acute respiratory syndrome coronavirus type 2 (SARS‐CoV‐2). Ex vivo human precision‐cut lung slices (PCLSs) are well‐suited models to study immune reactions and biochemical changes within host cells as well as to follow functional macrophage phenotype plasticity within complex tissue environment. Raman spectroscopy emerged in recent years as a powerful method for label‐free cell characterization. Methods Human PCLSs from one donor were infected with either the SARS‐CoV‐2 delta or omicron variant. Immunofluorescence microscopy localized AMs and virus particles. Cytokine levels of interferon‐gamma (IFN‐γ) and interleukin 18 (IL‐18) were quantified. The lung slice model was optimized for label‐free Raman spectroscopic imaging and for the characterization of single AMs within the three‐dimensional structure of the PCLS model. Results Fluorescence microscopy confirmed the location of AMs and virus particles within the PCLS model. Raman spectroscopic imaging generated false‐colour images, revealing distinct spectroscopic differences between AMs in the uninfected control PCLS model and those in PCLS models infected with SARS‐CoV‐2. These differences included variations in intracellular RNA, carotenoid, triacyl glyceride, and glucose levels, consistent in interpretation with cytokine quantification data. A linear discriminant analysis (LDA) classification model achieved an 83% accuracy in distinguishing cells from infected lung slices from those of the uninfected controls. The LDA loadings pointed to spectral bands that had been previously identified in an in vitro stimulation study of macrophages. Conclusions Raman spectroscopy can characterize the cellular immune response and phenotype plasticity of AMs to infection with SARS‐CoV‐2 within a PCLS model in a label‐free and non‐invasive manner. The ability to distinguish cells from infected PCLSs from cells of the uninfected control PCLS based on intracellular biochemical changes highlights the potential of Raman spectroscopy as a powerful diagnostic tool in immunology and clinical diagnostics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d85073ddb60ee9cd389c20a82c3a429e01c4becd" target='_blank'>
              Investigating alveolar macrophages in an human ex vivo precision‐cut lung slice model of SARS‐CoV‐2 infection using Raman spectroscopy—A case study
              </a>
            </td>
          <td>
            Max Naumann, Franziska Hornung, S. Eiserloh, Astrid Tannert, Antje Häder, Rustam R. Guliev, Tim Sandhaus, Stefanie Deinhardt‐Emmer, Ute Neugebauer
          </td>
          <td>2025-08-31</td>
          <td>Clinical and Translational Medicine</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Jellyfish stings induce a range of symptoms, from localized irritation to life-threatening systemic reactions, yet the underlying immune mechanisms remain poorly understood. This study employed single-cell RNA sequencing (scRNA-seq) to analyze peripheral blood mononuclear cells (PBMCs) from a severely affected patient and healthy controls, uncovering the immune landscape at single-cell resolution and identifying the signaling pathways. We identified 11 major immune cell types, with a marked increase in CD14+ monocytes (81.86% of total cells) and significant reductions in T cells, B cells, and CD16+ monocytes in the envenomated patient. Subclustering revealed six monocyte and four neutrophil subsets, each displaying distinct functional profiles. Patient monocytes were enriched for MMP9+ and RETN+ subsets, associated with leukocyte migration and inflammation, whereas healthy controls exhibited CD74+ monocytes linked to oxidative phosphorylation. Neutrophils in the patient were predominantly LTF+ and S100A12+, implicating inflammatory and immune regulatory pathways. These findings provide a detailed single-cell atlas of immune dysregulation post-jellyfish sting, highlighting the pivotal roles of MMP9+ monocytes and S100A12+ neutrophils in driving inflammation. This study offers potential therapeutic targets for mitigating severe immune responses in jellyfish envenomation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/886a782da235e6fcc2a7af44db53341761437a05" target='_blank'>
              Single-Cell Transcriptomic Analysis Reveals Cell Heterogeneity and Altered Signaling Pathways in Jellyfish Sting Patients
              </a>
            </td>
          <td>
            Zhen Qin, Zhengfeng Hao, Chun Wang, Ning Lu, Peiju Qiu, Su Wang, Rilei Yu
          </td>
          <td>2025-09-01</td>
          <td>Marine Drugs</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/93e0c85fbf1c44be881c2143fd5458fbd774e153" target='_blank'>
              Impaired IFNγ responsiveness of lung monocyte-derived cells limits immunity to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Weihao Zheng, J. Limberis, Zachary P. Howard, Alexander Mohapatra, Enzo Takagi, J. Ernst
          </td>
          <td>2025-10-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4e3d0776a5b09846be76b81d965adce480ef8f11" target='_blank'>
              Interstitial macrophages prevent tuberculosis relapse by restricting Mycobacterium tuberculosis immune evasion
              </a>
            </td>
          <td>
            Valerie Vinette, Anthony Castro, Heather Kim, C. Trujillo, Min Xie, Martin Gengenbacher, T. Ioerger, S. Ehrt
          </td>
          <td>2025-08-31</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>62</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/17651de6c46a00b78395437afc40e239fdbc6f6f" target='_blank'>
              Neonatal Microglia and Their Secretome as Mediators of Brain Repair
              </a>
            </td>
          <td>
            Gabriela Lyszczarz, Eydís Sigurðardóttir Schiöth, A. Benmamar-Badel, Dominika Rusin, David Ramonet, Marco Anzalone, Thalissa Caers, Lejla Vahl Becirovic, Kirstine Nolling Jensen, S. G. Verberk, Fleur Mingneau, Martyna Makowska, Kate Lykke Lambertsen, Amy F. Lloyd, Jerome J. A. Hendriks, Agnieszka Wlodarczyk
          </td>
          <td>2025-09-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Abstract Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and immune dysregulation, including expansion of pro-inflammatory monocytes and effector T cells, alongside reduced regulatory T cells (Tregs). Bacillus subtilis natto, a spore-forming probiotic, has shown anti-atherosclerotic effects, though its systemic immunomodulatory mechanisms remain unclear. In this study, we employed an AAV-mPCSK9-induced murine atherosclerotic model to investigate the effects of daily B. subtilis natto NTU-18 administration over 16 weeks. High-dimensional flow cytometry using two 13-marker panels enabled longitudinal profiling of 18 peripheral immune cell subsets across lymphoid and myeloid compartments. While no significant changes in serum cholesterol and mild decrease of body weight were observed, B. subtilis natto NTU-18-treated mice presented a significant reduction in aortic lesion area compared to PBS-treated controls. Immune profiling revealed a transient expansion of peripheral myeloid cells and CD44⁺ trained CD8⁺ T cells, followed by increased frequencies of naïve CD8⁺ T cells and reduced central/effector memory subsets at longer time point treatment. In the CD4⁺ T cell compartment, a transient increase in trained cells was accompanied by a sustained enrichment of CD25⁺CD4⁺ Tregs throughout the daily B. subtilis natto NTU-18 treatment. In contrast, no significant differences were observed in Ly6C⁻ or Ly6C⁺ monocytes, neutrophils, or eosinophils. These findings suggest that B. subtilis natto NTU-18 attenuates atherosclerosis progression not through lipid lowering or broad myeloid modulation, but via targeted reprogramming of peripheral T cell responses. This work provides mechanistic insight into the immunotherapeutic potential of B. subtilis natto NTU-18 in atherosclerosis prevention and treatment. Key points • B. subtilis natto NTU-18 significantly reduces aortic plaque burden in atherosclerotic mice without affecting serum cholesterol levels. • B. subtilis natto NTU-18 induces transient immune remodeling, marked by early expansion of trained CD8⁺ and CD4⁺ T cells, followed by increased naïve and regulatory T cells. • The atheroprotective effect is primarily mediated through adaptive immunity as myeloid subsets remain unchanged throughout B. subtilis natto NTU-18 treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/45dd339de260cb5a70cef21d3c450ab6682f7820" target='_blank'>
              Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations
              </a>
            </td>
          <td>
            Jian-Da Lin, Yu-Zhen Ye, Sin-Ren Wang, Wen-Yi Kao, Kung-Ta Lee
          </td>
          <td>2025-10-17</td>
          <td>Applied Microbiology and Biotechnology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Long COVID (LC), also known as post-acute sequelae of COVID-19 infection (PASC), is a heterogeneous and debilitating chronic disease that currently affects 10 to 20 million people in the U.S. and over 420 million people globally. With no approved treatments, the long-term global health and economic impact of chronic LC remains high and growing. LC affects children, adolescents, and healthy adults and is characterized by over 200 diverse symptoms that persist for months to years after the acute COVID-19 infection is resolved. These symptoms target twelve major organ systems, causing dyspnea, vascular damage, cognitive impairments (“brain fog”), physical and mental fatigue, anxiety, and depression. This heterogeneity of LC symptoms, along with the lack of specific biomarkers and diagnostic tests, presents a significant challenge to the development of LC treatments. While several biological abnormalities have emerged as potential drivers of LC, a causative factor in a large subset of patients with LC, involves reservoirs of virus and/or viral RNA (vRNA) that persist months to years in multiple organs driving chronic inflammation, respiratory, muscular, cognitive, and cardiovascular damages, and provide continuous viral antigenic stimuli that overstimulate and exhaust CD4+ and CD8+ T cells. In this review, we (i) shed light on persisting virus and vRNA reservoirs detected, either directly (from biopsy, blood, stool, and autopsy samples) or indirectly through virus-specific B and T cell responses, in patients with LC and their association with the chronic symptomatology of LC; (ii) explore potential mechanisms of inflammation, immune evasion, and immune overstimulation in LC; (iii) review animal models of virus reservoirs in LC; (iv) discuss potential T cell immunotherapeutic strategies to reduce or eliminate persistent virus reservoirs, which would mitigate chronic inflammation and alleviate symptom severity in patients with LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3796710d45738cf5a8e99e8ba1c550198cbdf88b" target='_blank'>
              Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID
              </a>
            </td>
          <td>
            Swayam Prakash, Sweta Karan, Yassir Lekbach, D. Tifrea, Cesar J. Figueroa, Jeffrey B. Ulmer, James F. Young, Greg Glenn, Daniel Gil, Trevor M. Jones, Robert R. Redfield, L. BenMohamed
          </td>
          <td>2025-09-27</td>
          <td>Viruses</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c5336a170abce4fbd66bbc29071f8086acba824" target='_blank'>
              Early endothelial activation at the blood–nerve barrier defines a hallmark of ALS
              </a>
            </td>
          <td>
            Ganesh Parameshwar Bhat, Santo Diprima, Cristian G Beccaria, Paola Podini, A. Badaloni, Alessia Motta, Ilaria Brambilla, Luis Martins, D. Boselli, Stefano de Pretis, Giovanni Nardo, Caterina Bendotti, Nilo Riva, Matteo Iannacone, Angelo Quattrini, D. Bonanomi
          </td>
          <td>2025-09-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="ABSTRACT Host resilience to bacterial infection depends on tightly regulated immune responses, which can be shaped by metabolic cues, including the contribution from bioactive lipids. The endocannabinoid system (ECS), a lipid signaling network known for its neuromodulatory roles, also influences immunity; however, the receptor-specific contributions of cannabinoid receptor 1 (CB1R) and cannabinoid receptor 2 (CB2R) in host–pathogen interactions remain incompletely defined in this context. Using receptor-deficient mouse models, we investigated how CB1R and CB2R modify immune responses to Salmonella Typhimurium. CB1R-deficient (CB1R-KO) mice exhibited heightened systemic inflammation, impaired bacterial clearance, and reduced survival in systemic infection, associated with dysregulated macrophage polarization and diminished neutrophil recruitment. In contrast, CB2R-KO mice showed increased susceptibility in both systemic and mucosal infection models, marked by a pro-inflammatory macrophage profile, enhanced neutrophilia, and microbiota dysbiosis. Shotgun metagenomic analysis revealed a reduced abundance of specific protective commensals and altered microbial metabolic pathway profiles in CB2R-KO mice, suggesting a role for CB2R in maintaining mucosal immune–microbiota homeostasis. Collectively, these findings highlight non-redundant roles for CB1R and CB2R in regulating immune dynamics and salmonellosis disease severity, and they point to the ECS as a potential target for host-directed immunomodulatory therapies. IMPORTANCE Effective immunity against bacterial pathogens requires a delicate balance between microbial clearance and the containment of inflammatory damage encountered during many infections. The molecular pathways that regulate this equilibrium remain incompletely defined, and the involvement of bioactive lipid signaling mechanisms also needs to be better described. Here, we show that the endocannabinoid receptors CB1R and CB2R play non-redundant roles in host defense against Salmonella infection. CB1R deficiency results in exacerbated systemic inflammation, defective bacterial clearance, and dysregulated macrophage polarization. In contrast, CB2R deficiency leads post-infection to gut dysbiosis and has been found to negatively affect the outcome for the host in both systemic and mucosal infection with Salmonella. By describing cannabinoid receptor-specific contributions to immune regulation and microbiota dynamics, our findings reveal a previously underappreciated axis of host–pathogen interaction. This study broadens our understanding of lipid-mediated immune modulation and identifies CB1R and CB2R as potential targets for therapies aimed at restoring immune homeostasis and improving infectious disease outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/807bf880e53822e18dd6bce5ebaaab6c3409fd1a" target='_blank'>
              Deficiency of cannabinoid receptors enhances host susceptibility to bacterial infection
              </a>
            </td>
          <td>
            Hailey A. Barker, Saloni Bhimani, Deyaneira Tirado, Jorge J. Canas, Leandro Nascimento Lemos, Luiz F. W. Roesch, Mariola J. Ferraro
          </td>
          <td>2025-09-18</td>
          <td>mBio</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e63b1279f51d73cda78726f8cc10b215549aa1ac" target='_blank'>
              NK cells undergo transcriptional and functional reprogramming following Streptococcus pneumoniae infection
              </a>
            </td>
          <td>
            Júlia Torné, Claudia Chica, Tiphaine Camarasa, Bernd Jagla, Matilde Diaz Enes, Aymeric Zellner, S. Mella, V. Libri, M. Hamon
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Chikungunya fever (CF), caused by the Chikungunya virus (CHIKV), is characterized by disabling symptoms such as joint pain that can last for months. Monocytes play a central role in immune modulation and viral replication during infection. This study evaluated the clinical and immunological profiles of patients with laboratory-confirmed CF. Fever and joint pain were the most frequently reported symptoms, whereas edema was more common in women. CHIKV-infect individuals exhibited increased TLR4 expression in non-classical monocytes (CD14+CD16++). Additionally, intermediate (CD14+CD16+) and non-classical (CD14+CD16++) monocytes expressing TLR7 were enriched during the acute phase and in some chronic patients, thereby suggest prolonged TLR7 pathway activation. Levels of soluble CD163 (sCD163)—a marker of monocyte/macrophage activation—were elevated as well, indicating sustained immune activation. Coagulation-related mediators—including Tissue factor (TF) and Tissue factor pathway inhibitor (TFPI)—also increased, despite the rarity of hemorrhagic events or thrombocytopenia. Patients with arthritis demonstrated higher frequencies of TLR7+ intermediate monocytes and elevated Epidermal growth factor (EGF) levels, whereas those with edema exhibit increased Vascular endothelial growth factor (VEGF) levels. Overall, these findings highlighted the differential activation of CD16+ monocytes and suggested that sCD163 is a marker of monocyte/macrophage activation during CHIKV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3ada9cc6aaf561e1d3f8385616a220852e2f4594" target='_blank'>
              Monocyte Dynamics in Chikungunya Fever: Sustained Activation and Vascular-Coagulation Pathway Involvement
              </a>
            </td>
          <td>
            Caroline Fernandes dos Santos, P. Nunes, V. Fiestas-Solórzano, M. Gandini, F. D. dos Santos, Roberta Olmo Pinheiro, Luís Jose de Souza, P. Damasco, Luzia Maria de Oliveira Pinto, E. D. de Azeredo
          </td>
          <td>2025-09-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Functional T cell responses are crucial for protective immunity induced by COVID-19 vaccination, but factors influencing the quality of these responses are incompletely understood. We used an activation-induced marker (AIM) assay and single-cell transcriptomic sequencing to analyze SARS-CoV-2 spike-responsive T cells after mild SARS-CoV-2 infection or after one or two doses of mRNA-lipid nanoparticle (mRNA-LNP) or adenoviral-vectored COVID-19 vaccines. Our findings revealed broad functional and clonal heterogeneity in T cells generated by vaccination or infection, including multiple distinct effector populations. T cell function was largely conserved between COVID-19 vaccine platforms but was distinct compared with SARS-CoV-2 infection. Notably, the dosing interval greatly influenced the quality of T cells after two vaccine doses, particularly after mRNA-LNP vaccination, where a longer interval led to reduced inflammatory signaling and increased secondary proliferation. These insights enhance our understanding of SARS-CoV-2-specific T cells and inform the optimization of mRNA vaccination regimens.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f1800fe36136de8ed3b27811e49144271651615d" target='_blank'>
              Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines.
              </a>
            </td>
          <td>
            Sam M. Murray, Ali Amini, Helen Ferry, Lucy C. Garner, M. Pudjohartono, B. Kronsteiner, S. Bibi, A. Pollard, Ellie Barnes, Teresa Lambe, Susanna J . Dunachie, Paul Klenerman, N. Provine
          </td>
          <td>2025-08-29</td>
          <td>Science immunology</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Alveolar macrophages are well known as the first responders to pulmonary cryptococcosis; however, their dynamic molecular responses to Cryptococcus gattii infection in vivo remain limited. Here, we investigated the transcriptional profiles of lung alveolar macrophages purified from mice intranasally infected with C. gattii and compared them to those infected with C. neoformans using RNA sequencing analysis. Alveolar macrophages from C. gattii-infected mice exhibited distinct transcriptional alterations, particularly in genes associated with sterol biosynthesis, whereas those from C. neoformans-infected mice showed enrichment in interferon and cytokine signaling pathways. Treatment with the sterol biosynthesis inhibitor lovastatin significantly reduced cholesterol accumulation in C. gattii-infected RAW 264.7 cells. Furthermore, lovastatin treatment of C. gattii-infected RAW 264.7 and bone marrow-derived macrophages suppressed intracellular cryptococcal proliferation and augmented inflammatory response, as evidenced by increased expression of Nos2 and Il6. Lovastatin also potentiated the antifungal effect of fluconazole by promoting intracellular fungal clearance and increasing nitric oxide activity in macrophages. In C. gattii-infected mice, lovastatin treatment enhanced the efficacy of fluconazole, resulting in improved pulmonary fungal clearance, increased lung CD4 ⁺ T cell numbers, and elevated nitric oxide activity. Collectively, these findings reveal a unique macrophage response to C. gattii infection and highlight the role of sterol metabolism in modulating host defense, offering potential avenues for therapeutic intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/361ffc878c85e98584a1bba17834f9329df4592a" target='_blank'>
              Transcriptomic profiling of lung alveolar macrophages reveals distinct contribution of sterol metabolism in macrophage response to Cryptococcus gattii infection
              </a>
            </td>
          <td>
            Siranart Jeerawattanawart, Adithap Hansakon, Rudi Alberts, Yongliang Zhang, P. Angkasekwinai
          </td>
          <td>2025-09-30</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Understanding the immune response to SARS-CoV-2 vaccination in cancer patients remains a critical priority given their immunocompromised status. In this prospective observational study, we evaluated humoral and cellular immunity across three time points—baseline, post-second dose, and post-booster—in 23 breast cancer patients undergoing active treatment. IgG antibody levels showed a significant increase following vaccination, with a 300-fold rise after the second dose and a 2200-fold increase post-booster, indicating a strong humoral response. CD19+ B cells also increased significantly, supporting B cell-mediated activation. Although overall T cell frequencies remained stable, we observed a shift toward memory phenotypes, with decreased naïve CD4+ and CD8+ T cells and increased central and peripheral memory subsets after the booster. Notably, CD8+ TEMRA cells expanded significantly, suggesting cytotoxic memory formation. Correlation analyses linked peripheral memory CD4+ T cells with anti-SARS-CoV-2 IgG titers, while CD8+ TEMRA cells showed an inverse association. Antigen-specific CD8+ T cell response was evaluated using APC-labeled MHC I Dextramer reagents. After the booster, 55.5% of patients developed detectable antigen-specific CD8+ T cells, whereas 44.5% did not. Importantly, one patient who failed to develop antigen-specific CD8+ T cells experienced a mild SARS-CoV-2 infection, suggesting that the absence of this response may increase susceptibility despite high IgG levels. These findings indicate that antigen-specific CD8+ T cell responses and antibody levels may act as complementary but not directly correlated arms of immunity. Microbiota profiling via sPLS-DA suggested weak but distinct microbial signatures associated with immune responsiveness, particularly enrichment of taxa such as Alistipes and Romoutsia among high-antibody responders. These findings emphasize that SARS-CoV-2 vaccination is immunogenic and well tolerated in breast cancer patients under therapy and highlight the need to further explore microbiota–immune interactions to optimize vaccination strategies in oncology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8ef1a3c71886f2e8c6c821ff973693020b8f5a7" target='_blank'>
              Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study
              </a>
            </td>
          <td>
            M. L. Fernández-Murga, Lucía Serrano-García, G. D’Auria, María Portero Hernández, L. Martínez-Priego, Loreto Ferrús-Abad, Griselda de Marco, María Victoria Domínguez-Márquez, A. Llombart-Cussac
          </td>
          <td>2025-09-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="The COVID-19 pandemic has caused over 7 million deaths, but its legacy extends beyond mortality. SARS-CoV-2 infection induces immune alterations that persist post-recovery, manifesting not only in long COVID (LC) but also in healthy individuals. Cytokines serve as critical orchestrators of these processes. The goal of this study is to investigate post-pandemic immune remodeling through cytokine assessment in both patients with LC and healthy donor, and to compare the post-pandemic population with pre-pandemic controls to find changes in the immune responses and cytokine profiles. A panel of 47 immune mediators (cytokines, chemokines, and growth factors) was measured with the MAGPIX multiplex analysis. LC was characterized by an increase in IL-7, IL-8, IL-17F, IL-18, EGF, FGF-2, PDGF-AA, sCD40L, and MCP-3 and a decrease in IL-4, IL-13, IL-22, IL-27, and FLT-3L. Comparing post-pandemic recovered individuals with pre-pandemic healthy cohort, we saw an upregulation of IL-13 and MCP-3 and a downregulation of MDC, M-CSF, IL-12, and IL-17F. While LC is characterized by persistent immune imbalance—particularly in cytokine networks—our data emphasize the critical need to study healthy donors in both pre- and post-pandemic eras when analyzing and interpreting these changes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2e48f13c00a2f5e0495ca6dbf817e5b656692480" target='_blank'>
              Redefining Normal: Cytokine Dysregulation in Long COVID and the Post-Pandemic Healthy Donors
              </a>
            </td>
          <td>
            Z. Korobova, N. Arsentieva, N. E. Lyubimova, A. Totolian
          </td>
          <td>2025-08-29</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c48ccb41d3f252f85b5277e853ac6cb2ae72c91e" target='_blank'>
              Human immune response to primary cryptosporidiosis parallels murine infection models
              </a>
            </td>
          <td>
            Dana M. Van Fossen, Haroldo J. Rodriguez, Farha Naz, Carol A. Gilchrist, Justin J. Taylor, W. A. Petri, Audrey C. Brown
          </td>
          <td>2025-10-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d1250d29d7374ebca7719549a2dd260ee1ecf40" target='_blank'>
              Divergent Macrophage-Regulated T cell States Determine Response to Bacillus Calmette-Guérin (BCG) in High-Risk Bladder Cancer
              </a>
            </td>
          <td>
            Ryan J. Brown, , Hongshen Niu, Joseph R. Podojil, B. Choy, Weiguo Cui, Joshua J. Meeks
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="BACKGROUND
Parkinson's disease (PD) is characterized by a progressive decline in dopaminergic neurons within the substantia nigra (SN). Although its underlying cause has yet to be fully elucidated, accumulating evidence suggests that neuroinflammation contributes substantially to disease development. Treatment strategies targeting neuroinflammation could improve PD outcomes. Monocyte-derived tolerogenic dendritic cells (tolDCs) modulate immune responses and induce regulatory T cells (Tregs) during various inflammatory diseases. However, the mechanisms underlying tolDC-mediated immunoregulation in PD remain unclear.


METHODS
We investigated the immune modulatory role of tolDCs by analyzing gene expression patterns and identified that the C-type lectin domain family 5 member A (Clec5a) was highly induced in tolDCs. To assess its function, we generated Clec5a-knockdown tolDCs and measured cytokine production, including interleukin (IL)-10 and IL-6, forkhead box protein P3 (Foxp3)+ Treg induction, and nuclear factor kappa B (NF-κB) signaling activity. Furthermore, we evaluated the therapeutic effects of Clec5a-expressing dendritic cells (DCs) in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. Dopaminergic neuron survival, α-synuclein (α-syn) accumulation, neuroinflammatory markers, and locomotor behavior were analyzed following DC administration.


RESULTS
Clec5a-knockdown tolDCs exhibited reduced immunomodulatory function and IL-10 levels but enhanced IL-6 levels. In addition, these cells induced fewer Foxp3+ Tregs and showed significantly enhanced NF-κB signaling activity. In the MPTP-induced PD model, administration of Clec5a-expressing DCs ameliorated dopaminergic neuron loss and α-syn accumulation. Furthermore, Clec5a-expressing DCs reduced the number of CD45highCD11b+CD86+ macrophages in the brain, reduced brain inflammatory cytokine expression, and improved locomotor activity.


CONCLUSIONS
These findings suggest that Clec5a plays a critical role in the immunomodulatory function of tolDCs. The administration of Clec5a-expressing DCs effectively reduced neuroinflammation and protected dopaminergic neurons in an MPTP-induced PD model. Therefore, Clec5a-expressing tolDCs may demonstrate therapeutic potential by managing PD symptoms by suppressing inflammatory responses associated with neurodegeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9594389b504a5fb2d141ff30031038ea1e6dd820" target='_blank'>
              Dendritic Cells Induce Clec5a-mediated Immune Modulation in MPTP-induced Parkinson's Disease Mouse Model.
              </a>
            </td>
          <td>
            Soojin Choi, Ji-Hee Nam, Min-Seon Song, Jun-Ho Lee, Kyung-Eun Noh, Ji-Soo Oh, Nam-Chul Jung, Jie-Young Song, Dae-Seog Lim
          </td>
          <td>2025-08-30</td>
          <td>Frontiers in bioscience</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/42649e5799d217ae2a59e14c7eb9e6893e79caba" target='_blank'>
              Pathogenicity and Transcriptomic Profiling Revealed Activation of Apoptosis and Pyroptosis in Brain of Mice Infected with the Beta Variant of SARS-CoV-2.
              </a>
            </td>
          <td>
            Han Li, Bao-Ying Huang, Gao Qian Zhang, Fei Ye, Li Zhao, Wei Bang Huo, Zhong Xian Zhang, W. Wang, W. Wang, Xiao Ling Shen, Chang Cheng Wu, Wen Jie Tan
          </td>
          <td>2025-09-20</td>
          <td>Biomedical and environmental sciences : BES</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the global coronavirus disease 2019 (COVID-19) pandemic, frequently induces olfactory dysfunction (OD), a symptom that significantly impacts patients' quality of life. Understanding the variability in OD and nasal tissue pathology across different SARS-CoV-2 variants may provide insights as to the mechanisms underlying this symptom and inform therapeutic strategies for COVID-19-related sequelae. This study examines the OD and associated nasal pathology in Syrian hamsters infected with SARS-CoV-2 variants, including Wuhan (WA-1), Alpha, Beta, Gamma, Delta, and Omicron, at 5 days post-infection. Olfactory function was assessed using buried food detection tests. Hamsters infected with the WA-1, Alpha, Beta, and Gamma variants exhibited prolonged discovery times as compared to controls, indicating severe OD. In contrast, those infected with the Delta and Omicron variants showed minimal or mild delays. Pathological examination of the lateral turbinate (LT) revealed severe olfactory epithelial damage in WA-1, Alpha, Beta, Gamma, and Delta variant infections, while the Omicron variant caused minimal damage. Viral antigens were detected in retained and/or sloughed epithelial cells in the LT across all variant infections. These results demonstrate significant differences in OD severity and nasal tissue damage among SARS-CoV-2 variants, providing critical insights for understanding the pathogenesis of this symptom and guiding treatment development for COVID-19 sequelae. IMPORTANCE Olfactory dysfunction (OD) is a prominent and distinctive symptom of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection that significantly affects patients' quality of life. This study reveals that Syrian hamsters infected with different SARS-CoV-2 variants (WA-1, Alpha, Beta, Gamma, Delta, and Omicron) exhibit varying degrees of OD and nasal tissue pathology. Hamsters infected with the WA-1, Alpha, Beta, and Gamma variants experienced significant OD, while those infected with Delta and Omicron showed milder symptoms. Severe epithelial damage in the nasal turbinate was observed in hamsters infected with WA-1, Alpha, Beta, Gamma, and Delta variants, whereas Omicron variant infection resulted in minimal tissue injury. Despite the variability in OD and tissue damage, viral antigen was detected in all infected hamsters. These findings underscore the diverse impact of SARS-CoV-2 variants on olfactory function and nasal tissue pathology, providing important insights into the pathogenesis of OD and guiding potential therapeutic strategies for coronavirus disease 2019-related olfactory sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c18f6d1b92426cff487c165ee63ff6de26440d36" target='_blank'>
              Differential olfactory dysfunction and nasal tissue pathology in Syrian hamsters infected with SARS-CoV-2 variants
              </a>
            </td>
          <td>
            Takeshi Saito, Marina Hosotani Saito, Rachel A. Reyna, Satoshi Taniguchi, Kirsten Littlefield, Rebecca Cook, Preston Underbrink, Amy Wang, Tomoko Makishima, Slobodan Paessler, Junki Maruyama
          </td>
          <td>2025-09-03</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="The Coronavirus disease 2019 (COVID-19) pandemic had a profound global impact, yet children exhibited distinct clinical and epidemiological patterns compared to adults. Pediatric cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were generally characterized by milder disease, lower hospitalization rates, and few long-term sequelae. However, a subset of children developed severe complications such as multisystem inflammatory syndrome in children (MIS-C), highlighting the heterogeneity in disease presentation. Differences in immune system maturity and comorbidities likely contribute to the age-dependent manifestation of SARS-CoV-2 and other respiratory viruses. Persistent SARS-CoV-2 infection, particularly in immunocompromised individuals, has been implicated in the emergence of new viral variants with immune escape characteristics due to ongoing viral replication in the presence of selective pressure. While SARS-CoV-2 evolution in persistently infected adults has been well-documented, it is less clear how the virus evolves during persistent infection in the pediatric population. To address this question, we performed viral whole genome sequencing of longitudinal specimens collected from immunocompetent and immunocompromised pediatric COVID-19 patients. Similarly to what has been observed in adult cohorts, mutations associated with enhanced viral fitness and immune escape arose intra-host over time. Intra-host diversity accumulated at similar rates in immunocompetent and immunocompromised children, though more mutations overall were observed in the immunocompromised cohort due to the longer infection time courses. Overall, we identified similar viral evolutionary trends over the course of infection despite clinical differences in pediatric COVID-19 manifestation and severity. This similarity suggests that persistent infection in children may be an additional, but not unique, source of ongoing viral diversification.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ffe2a38114a8ac606db5b1f233ceadfdc7d62ca" target='_blank'>
              Intra-Host Evolution of SARS-CoV-2 During Persistent Infection of Pediatric COVID-19 Patients
              </a>
            </td>
          <td>
            Charlie R. Boyle, Tien Doan, Estefany Rios-Guzman, Jessica Maciuch, Lacy M. Simons, Dulce S. Garcia, David B. Williams, A. Alisoltani, E. Ozer, R. Lorenzo-Redondo, J. Hultquist
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Cryptococcal meningitis is a fungal infection in patients with compromised CD4 T cell function. CD4 T cells provide killing signals to macrophages, principally IFNγ, to limit intracellular fungal replication. However, CD4 T cells may also drive inflammatory tissue damage. Yet, it is not fully understood how fungal-specific CD4 T cells infiltrate the brain and how they influence functional phenotypes of CNS-resident myeloid cells. In the current work, we develop a mouse model to track fungal-specific CD4 T cells and determine their influence on microglia. We found IFNγ+ fungal-specific CD4 T cells have limited TCR signalling and characterise a population of inflammatory microglia that upregulate MHCII and IFNγ-regulated genes during infection. Inflammatory microglia have poor fungicidal capacity and significantly expand during infection, a process that depends on CD4 T cell infiltration. Taken together, these data identify the early inflammatory consequences of fungal-specific CD4 T cell infiltration and identify proliferating microglia as important drivers of brain inflammation during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37f4633c141c3226368499b170bc53f8df43b779" target='_blank'>
              Brain-infiltrating CD4 T cells drive inflammatory microglia proliferation during cryptococcal meningitis in mice
              </a>
            </td>
          <td>
            Sofia Hain, Man Shun Fu, Lucy Wigg, Lorna S. George, D. Lecky, Alexander J Whitehead, Erin Clipston, Ko Sato, Masahiro Ono, Marcel Wuthrich, Bruce Klein, Kazuyoshi Kawakami, J. Rayes, D. Bending, Rebecca A. Drummond
          </td>
          <td>2025-10-09</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="A 48-year-old patient underwent lung transplantation because of severe COVID-19, which aggravated his underlying interstitial lung disease, despite the presence of detectable SARS-CoV-2. Subsequently, the graft is re-infected early in the post-procedural phase, leading to viral persistence for more than five months. By analyzing viral evolution and effector immune response within the transplanted organ, we observe three main findings. First, virus evolution differs in the transplanted organ compared to that in the upper respiratory tract and is affected by monoclonal SARS-CoV-2-specific antibodies and molnupiravir. Second, we show the potential clinical relevance of T cell HLA restriction that may facilitate viral clearance in the upper respiratory tract compared to the ongoing viral replication in the HLA mismatch organ. Third, close monitoring and modulation of immunosuppressive and antiviral therapy enables viral clearance in a lung transplantation setting despite incomplete SARS-CoV-2 clearance prior to transplantation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/569199782c3445155a7ccd2d640593b92abe836a" target='_blank'>
              SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient
              </a>
            </td>
          <td>
            Jonas Fuchs, V. Karl, Ina Hettich, Jaime Alvarado, Daniel Eckert, Lena Jaki, Ann-Kathrin Kohl, Anastasia Kremser, Anastasija Maks, C. Terschluse, P. Agarwal, F. Emmerich, Sebastian Fähndrich, Annabelle Flügler, D. Hornuss, Johannes Kalbhenn, N. Kneidinger, Inga Lau, A. Lother, I. Moneke, David Schibilsky, Elisabeth Schygulla, N. Venhoff, Gernot Zissel, M. Czerny, D. Huzly, Georg Kochs, Christoph Neumann-Haefelin, Bernward Passlick, Daiana Stolz, R. Thimme, M. Panning, M. Hofmann, Björn C. Frye
          </td>
          <td>2025-09-16</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="ABSTRACT Since the COVID-19 pandemic, there has been a notable resurgence of Mycoplasma pneumoniae pneumonia (MPP) in children, with a concerning rise in the severity of cases. Although changes in post-pandemic respiratory infection patterns have been documented, the reasons behind the increased severity of MPP, especially concerning shifts in the respiratory microbiota, are not well understood. This study aims to explore how pandemic-associated disruptions in respiratory microbiota contribute to MPP severity. Through analysis of multiple independent cohorts, we found that the depletion of protective respiratory microbiota exacerbates MPP severity by reducing colonization resistance against M. pneumoniae. We identified two antagonistic microbiota modules with distinct metabolic features and community structures that regulate pathogen colonization and disease severity. Using a Susceptible-Infected-Recovered (SIR) model, we simulated M. pneumoniae infection dynamics across different microbiota states. Additionally, a machine-learning model based on eight key microbes effectively distinguished between cases and controls and predicted infection severity, offering insights into post-pandemic respiratory infections. This study underscores the essential role of the respiratory microbiota in influencing the severity of M. pneumoniae infections. Our findings offer a framework for managing respiratory infections in the post-pandemic era, highlighting the significance of understanding microbial community dynamics in determining disease outcomes. These insights could guide the development of therapeutic strategies focused on restoring or enhancing the protective microbiota, which may offer an effective strategy for the management of MPP and other respiratory infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5135993eab74980ff7611c3603fc5faaf64d3e01" target='_blank'>
              Post-COVID-19 disruption of the respiratory microbiome modulates Mycoplasma pneumoniae: a multi-center retrospective investigation study
              </a>
            </td>
          <td>
            Shiyu Huang, Shengkai Li, Ruike Zhao, Huajiang Yang, Yina Liu, Xinyi Wang, Jiaqi Zhang, Chen Shen, Feina Li, Hua Xu, Changyuan Guo, Xin Ni, Heng Li, Qing Cao, Zhemin Zhou
          </td>
          <td>2025-09-15</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1566aab3aa003f1116a60b08f46f073a5f754602" target='_blank'>
              Single-cell multi-omics show disruption of blood and airway T-cells in pulmonary long COVID
              </a>
            </td>
          <td>
            E. Guinto, I-Chih Kuo, S. Chopra, S. B. Shin, F. V.gerayeli, J.-W. Yoo, H. Y. Park, M. Messing, X. Li, C. Gilchrist, D. Yehia, R. Eddy, S. Milne, T. Stach, C. Cheung, J. S. Yang, W. Yip, T. Shaipanich, J. Leipsic, K. McNagny, J. Leung, D. Sin
          </td>
          <td>2025-09-19</td>
          <td>None</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="As the pediatric COVID-19 landscape evolves, it is essential to evaluate whether SARS-CoV-2 infection predisposes children to allergic disorders. This narrative review synthesizes current epidemiological and immunological evidence linking pediatric COVID-19 with new-onset atopy. Epidemiological data remain heterogeneous: large Korean and multinational cohorts report increased risks of asthma and allergic rhinitis following COVID-19, whereas U.S. cohorts show neutral or protective associations, highlighting geographic and methodological variability. Mechanistic insights provide biological plausibility: epithelial injury and the release of alarmin cytokines (IL-33, IL-25, TSLP) promote Th2 polarization and ILC2 expansion, while epigenetic “scars” (e.g., LMAN2 methylation changes) and hematopoietic stem cell reprogramming may sustain long-term Th2 bias. Cytokine memory involving IL-7 and IL-15 contributes to altered T- and B-cell homeostasis, whereas disrupted regulatory T-cell function may reduce tolerance thresholds. Paradoxical trade-offs exist, such as ACE2 downregulation in allergic airways, which may lower viral entry but simultaneously amplify type-2 inflammation. Together, these processes suggest that SARS-CoV-2 infection could foster a pro-allergic milieu in susceptible children. Although current evidence is inconclusive, integrating epidemiological surveillance with mechanistic studies is crucial for predicting and alleviating post-COVID allergic outcomes. Longitudinal pediatric cohorts and interventions targeting epithelial alarmins or microbiome restoration may hold promise for prevention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/915e70de93eed337c1055b8bcb1c32ceec3aa48b" target='_blank'>
              Immunological Mechanisms Underlying Allergy Predisposition After SARS-CoV-2 Infection in Children
              </a>
            </td>
          <td>
            Filippos Filippatos, Dimitra-Ifigeneia Matara, Athanasios Michos, K. Kakleas
          </td>
          <td>2025-09-28</td>
          <td>Cells</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19) patients have a 1.7-fold higher arrhythmia risk with rates of cardiac complications ranging from 2% non-ICU patients to 59% in non-survivors. Atrial fibrillation (AF), the most common arrhythmia, is a frequent complication of acute and long COVID-19. The high expression of ACE2 in the heart suggested that infectious virus may underlie cardiac complications. However, we recently reported in human cardiac tissue from fatal COVID-19 cases perivascular spike protein, elevated pro-inflammatory cytokines, vascular damage, and cardiac remodeling without evidence for direct infection of cardiac cells by SARS-CoV2. Mislocalization of intercalated disc (ID) components, connexin-43 (Cx43) gap junctions and NaV1.5 sodium channels, was also evident in patients’ hearts, recapitulating structural remodeling we previously identified as providing a substrate for atrial arrhythmias following an acute inflammatory insult. Therefore, we hypothesized that the inflammatory response elicited by SARS-CoV2 spike protein is sufficient to provoke atrial arrhythmias. Structural and functional assessments of WT murine hearts were performed five days following a single bolus intravenous injection of the viral spike protein. In vivo ECGs demonstrated increased atrial arrhythmia burden in spike-injected mice vs. control. Immunohistochemistry studies revealed elevated expression of inflammatory markers and evidence of vascular damage in these mice. Additionally, we observed disruption of ID ultrastructure and mislocalization of Cx43 and NaV1.5 in the atria of spike protein-injected mice. Our results suggest that vascular-leak inducing inflammatory insult from viral spike protein, and not direct infection by SARS-CoV2 results in the pathophysiology of cardiac dysfunction in fatal COVID-19. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-12807-9.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c153f00606118d9f8c8e5f0644e86dd859e1dd6c" target='_blank'>
              SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19
              </a>
            </td>
          <td>
            Louisa Mezache, Andrew M. Soltisz, Esmerina Tili, Gerard J. Nuovo, R. Veeraraghavan
          </td>
          <td>2025-09-30</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Since its emergence, the coronavirus (SARS-CoV-2) outbreak has been a pandemic responsible for about 7 million deaths worldwide. Numerous studies have been conducted to determine the virus’s multiorgan system involvement, particularly its relation to cancer biology. Spontaneous regression of cancer has been observed in some patients with the coronavirus, which may be attributed to the virus’s ability to trigger specific immune responses that can be oncolytic and help reduce and eliminate oncogenic cells. This study aims to explore the paradoxical effects of COVID-19 in inducing cancer regression. The paradoxical effect of SARS-CoV-2 infection has been attributed to the possibility of a heightened immune activation possibly triggered by the virus, and some of these include increased levels of cytokines such as interferon and tumor necrosis factor-alpha (TNF-α), as well as the activation of T cells and natural killer (NK) cells. COVID-19-induced cancer regression presents new perspectives on the relationship between viral infections and the immune system’s antitumor capabilities. This would help foster future research investigating specific immune pathways activated during SARS-CoV-2 and discover how these can be therapeutically harnessed to aid cancer regression. Supplementary Information The online version contains supplementary material available at 10.1186/s13027-025-00704-9.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b70234ee10e35d21e82680c57b0003d8503d4e0" target='_blank'>
              COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon
              </a>
            </td>
          <td>
            I. Ogieuhi, V. Ajekiigbe, C. Agbo, Chidera Stanley Anthony, Adegbesan Abiodun Christopher, Jennifer Chinaecherem Onyehalu, M. C. Agu, Sylvia Mmesomachi Mbaji, Adewunmi Akingbola, Bisharat Ahmed, Owa Ogieuhi, Olufemi Akinmeji
          </td>
          <td>2025-10-23</td>
          <td>Infectious Agents and Cancer</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Background: The COVID-19 pandemic prompted investigation into the interaction between SARS-CoV-2 infection and immune checkpoint inhibitor (ICI) therapy in lung cancer patients. Understanding this interplay is crucial for optimizing cancer immunotherapy. Methods: A retrospective analysis was conducted on lung cancer patients, characterizing changes in peripheral immune cells and plasma cytokines (including IL-10 and IL-12p70) before, during, and after SARS-CoV-2 infection. Progression-free survival (PFS) was compared between ICI-treated patients with and without COVID-19. Cytokine dynamics were further analyzed in a non-infected cohort. Results: SARS-CoV-2 infection induced a prolonged systemic cytokine storm, with elevated IL-10 and IL-12p70 levels and reduced monocyte proportions lasting up to 10 weeks post-recovery. Despite this immune perturbation, COVID-19 did not impair long-term PFS; instead, a transient improvement in disease control was observed in infected patients. In non-infected patients, sustained or increased IL-10 and IL-12p70 levels during ICI therapy were associated with longer PFS (p < 0.05). Conclusions: SARS-CoV-2 infection transiently alters the immune landscape in lung cancer patients without compromising ICI efficacy. The sustained elevation of IL-10 and IL-12p70 may contribute to short-term clinical benefits. Monitoring cytokine dynamics could serve as a prognostic tool for predicting ICI response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/751116a96b162ead6a92605da6ef16112bc11bf9" target='_blank'>
              SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes
              </a>
            </td>
          <td>
            Yanjing Peng, Panjian Wei, Meng Gu, Guirong Wang, Teng Ma, Jinjing Tan
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5e2e52376db45ae8ae1fb36b3df906a784ecabbe" target='_blank'>
              Dengue NS1 Antibodies drive Immune Complex Formation, Hyperglycaemia and systemic pathology in a murine NS1 plasmid challenge model
              </a>
            </td>
          <td>
            Chiroshri Dutta, Debrupa Dutta, S. Sukla, S. Biswas
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/292362db790b9a963540f1df313674226a489443" target='_blank'>
              Efficacy of Lactococcus lactis Strain Plasma in Patients with Mild COVID-19: A Multicenter, Double-Blinded, Randomized-Controlled Trial (PLATEAU Study).
              </a>
            </td>
          <td>
            Kazuko Yamamoto, Tsuyoshi Inoue, Takaya Ikeda, T. Sawai, Yosuke Nagayoshi, Koji Hashiguchi, Yoji Futsuki, Yuichi Matsubara, Yosuke Harada, N. Ashizawa, Susumu Fukahori, N. Iwanaga, T. Takazono, T. Kido, H. Ishimoto, N. Hosogaya, N. Sakamoto, M. Tashiro, Takeshi Tanaka, C. Fukushima, K. Jounai, R. Tsuji, Daisuke Fujiwara, K. Ota, K. Kosai, A. Furumoto, Katsunori Yanagihara, Koichi Izumikawa, H. Mukae
          </td>
          <td>2025-10-25</td>
          <td>Infectious diseases and therapy</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Although inflammatory complications are common in preterm infants, their effects on neonatal immune development remain poorly defined. We therefore investigated whether severe bronchopulmonary dysplasia (BPD) and systemic infection, two major complications of prematurity, produce distinct immune signatures and change immune composition over time. We performed longitudinal high-dimensional immune profiling of residual whole blood from 38 preterm infants sampled every two weeks, along with 10 term infants at birth. Preterm infants with severe BPD showed a progressive increase in Th17-polarized CD4+ T cells, neutrophils, and Th17-related cytokines compared to age-matched infants with moderate BPD. In contrast, some preterm infants with systemic bacterial or viral infections mounted robust CD8+, CD4+, and {gamma}{delta} T cell responses, with oligoclonal expansion, terminal differentiation, and coordinated plasma cytokine shifts that persisted well beyond resolution of infection. These findings demonstrate that different preterm comorbidities imprint the neonatal immune system in divergent ways. Longitudinal immune profiling offers a powerful tool to uncover these trajectories and identify potential targets for intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0492dc931a4a2783a47191cbbaa70058c13425a8" target='_blank'>
              Perturbation of the Preterm Human Immune System in Early Life
              </a>
            </td>
          <td>
            Benjamin A. Fensterheim, Michelle L. McKeague, D. Mathew, Shwetank, A. Pattekar, Sean Nasta, Macy Kee, Cynthia Clendenin, Zachary Martinez, Caroline Diorio, A. Greenplate, Krithika Lingappan, E. Wherry
          </td>
          <td>2025-09-05</td>
          <td>medRxiv</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="The SARS-CoV-2 pandemic had unprecedented impacts on public health and the economy. Many studies have focused on the mechanisms of SARS-CoV-2 entry into host cells, particularly the spike (S) protein mediated receptor engagement and subsequent virus-host membrane fusion dynamics. However, the mechanistic contribution of cholesterol within spike-incorporated viral envelopes to infectivity has not been well characterized. Herein, we show that targeted cholesterol depletion from the viral envelopes of SARS-CoV-2, SARS-CoV, and MERS-CoV directly impaired viral infectivity in a dose-dependent manner. Although modulation of host cell membrane cholesterol exerted relatively minor effects on viral entry, host cellular cholesterol homeostasis critically governs progeny virion infectivity by determining cholesterol content within nascent viral envelopes. Virions derived from cells with reduced plasma membrane cholesterol demonstrate significantly attenuated infectivity in SARS-CoV-2 and related coronaviruses. In addition, we detected that exogenous cholesterol replenishment restored SARS-CoV-2 entry efficiency by augmenting virus attachment. Collectively, our data demonstrate that biophysical properties of human coronavirus envelopes, particularly cholesterol stoichiometry, function as a key molecular determinant regulating host cell susceptibility. These findings position viral lipidome remodeling as a viable therapeutic target for developing host-directed broad-spectrum antivirals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b66bac5249cf5d92ba8f485c839bbe27a7cb1e6" target='_blank'>
              Cholesterol in viral envelope determines infectivity of SARS-CoV-2 and other coronaviruses
              </a>
            </td>
          <td>
            Xiaoying Xu, Xueyan Wang, Xiafeng Zhang, Xin Jin, Yun Tan, Lin Huang, Mingqian Zhou, Chengping Wen
          </td>
          <td>2025-09-18</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="HIV-associated neurocognitive impairment (HIV-NCI), a comorbidity of human immunodeficiency virus (HIV) infection, affects up to 50% of people with HIV (PWH). HIV-infected monocytes that transmigrate across the blood–brain barrier and mature into macrophages establish a central nervous system (CNS) viral reservoir that activates and infects parenchymal cells, contributing to neuronal damage that characterizes HIV-NCI. Methamphetamine (meth) use is prevalent in PWH and further impairs cognitive functioning. To examine whether meth-mediated dysregulation of macrophage functions may contribute to increased HIV-NCI, we characterized differential gene expression in primary human HIV-infected macrophages treated daily with meth for five days by RNA-sequencing. We identified increases in multiple gene isoforms of metallothionein 1 (MT1), a heavy metal binding protein involved in protective mechanisms against metal toxicity and oxidative stress. Nuclear localization of MT1 protein was previously shown to either positively or negatively affect nuclear factor κB (NF-κB) activity in a cell type specific manner, with nuclear MT1 contributing to LPS-induced TNF-α and IL-6 in macrophages. We found that daily meth treatment for one to five days increased nuclear localization of MT1 in macrophages acutely infected with HIV which was associated with increased LPS-induced CXCL8 and CCL8, and a trend towards increased basal and/or LPS-induced expression of other cytokines/chemokines, including TNF-α and IL-6, that was donor specific. Reactive oxygen species (ROS) levels were not changed with meth treatment although there was a donor specific trend towards increased ROS with multiple days of meth treatment. These data indicate that repeated exposure of macrophages to meth in the context of HIV increases nuclear MT1 localization, which is associated with increased inflammatory mediator production, and therefore may be a mechanism that contributes to meth-mediated exacerbation of HIV-NCI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f9329bb1c83ed1fd2d8eb8fde23d750ee8b8e128" target='_blank'>
              Methamphetamine Induces Metallothionein 1 Expression and an Inflammatory Phenotype in Primary Human HIV-Infected Macrophages
              </a>
            </td>
          <td>
            Jessica Weiselberg, Meng Niu, Cristian A. Hernandez, Howard S. Fox, T. Calderon, Joan W. Berman
          </td>
          <td>2025-09-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>1</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/183f309102020194c23f7f4fa2e0b4a0bcc44a55" target='_blank'>
              Whole-genome DNA methylation profiling in COVID-19 positive patients reveals alterations in pathways linked to neurological dysfunction
              </a>
            </td>
          <td>
            S. Zameer, Ehraz Anis, Qiang Sha, Martha L. Escobar Galvis, Sanam Khan, Jennifer A. Steiner, M. Milčiūtė, Ieva Kerševičiūtė, Migle Gabrielaite, Juozas Gordevičius, Andrew Pospisilik, Nazia Saiyed, Stewart F. Graham, Patrik Brundin, L. Brundin
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Coronavirus Disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a novel member of the Coronaviridae family. The viral genome encodes both structural proteins, such as spike, membrane, hemagglutinin, and envelope, as well as non-structural proteins that include auxiliary proteins and replicase essential for viral replication. While immunization campaigns have mitigated the spread of the virus, therapeutic interventions remain critical for managing outbreaks and preventing long-term health consequences. Despite extensive global research into the genome, structure, entry process, and replication mechanisms of SARS-CoV-2, key aspects such as the roles of membrane lipids in viral entry, packaging, and release, as well as the metabolic alterations in infected cells, remain poorly understood. Epigenetics, the study of heritable phenotypic changes driven by genetic and non-genetic factors, plays a pivotal role in shaping host responses to SARS-CoV-2 infection. Epigenetic modifications, such as histone methylation and acetylation, DNA and RNA methylation, chromatin remodeling, and non-coding RNA regulation, significantly influence gene expression in infected host cells. These reversible changes orchestrate the host’s antiviral responses and potentially alter susceptibility to COVID-19. This review delves into the immuno-epigenetic modifications occurring in hosts infected with SARS-CoV-2, providing insights into how these changes trigger viral replication and infection processes. By examining the current state of research on the immune-epigenetic landscape of SARS-CoV-2 infections, we highlight the mechanisms by which these modifications affect the host-viral interplay. Furthermore, we propose potential therapeutic targets within the immune-epigenetic pathways that could enhance ongoing efforts to combat COVID-19. Understanding these mechanisms will not only provide a deeper perspective on the virus’s pathogenic strategies but also offer innovative approaches to improve therapeutic interventions. By addressing the gaps in knowledge surrounding immune-epigenetic factors, this review aims to contribute to the development of novel strategies for preventing and managing coronavirus infections and its variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f1a8f4f7d0bcafc3f4ec967b1036044133b3037c" target='_blank'>
              Immuno-epigenetic paradigms in coronavirus infection
              </a>
            </td>
          <td>
            Swati Gupta, H. Hemeg, F. Afrin
          </td>
          <td>2025-09-03</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="The COVID-19 pandemic has highlighted long-term health concerns of viral pneumonia, yet its potential impact on cancer development and growth remains poorly understood. Here, we demonstrate that prior infection with SARS-CoV-2 or influenza virus promoted lung tumor progression by reprogramming the local immune landscape. Retrospective clinical analysis revealed that patients hospitalized with COVID-19 exhibited increased lung cancer incidence. Using multiple murine lung cancer models, we show that prior severe respiratory viral infections accelerated tumor growth and reduced survival. Mechanistically, prior viral pneumonia epigenetically remodeled the lung to establish a pro-tumor microenvironment, including the local accumulation of SiglecFhi tumor-associated neutrophils, a transcriptionally reprogrammed, immunosuppressive population whose signature predicted poor prognosis in human lung adenocarcinoma. In parallel, epithelial compartments exhibited altered differentiation trajectories, with persistence of injury-associated alveolar intermediates positioned along tumorigenic lineages. We observe sustained chromatin remodeling at key cytokine loci in immune and structure cells, linking inflammatory memory to persistent immune suppression. Therapeutically, combined inhibition of neutrophil recruitment via CXCR2 and PD-L1 signaling restored CD8⁺ T cell infiltration and suppressed tumor growth. Together, our findings establish a direct causal relationship between viral pneumonia, including COVID-19, and lung tumorigenesis, highlighting the urgent need to monitor survivors for elevated cancer risk and to develop targeted interventions and therapies aimed at preventing potential cancer bursts in COVID-19 convalescents. Graphic Abstract">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f5c02dc28314c51c85a1830d8f386c201cf18563" target='_blank'>
              Respiratory viral infections prime accelerated lung cancer growth
              </a>
            </td>
          <td>
            Wei Qian, Xiaoqin Wei, Andrew J Barros, Xiangyu Ye, Qing Yu, Samuel Young, Eric V Yeatts, Yury Park, Chaofan Li, Gislane Almeida-Santos, Jinyi Tang, H. Narasimhan, Nicole Kirk, Ying Li, Li Li, Peter Chen, Jeffrey M Sturek, Kwon-Sik Park, Wei Chen, I. Cheon, Jie Sun
          </td>
          <td>2025-09-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Sindbis virus (SINV) is a mosquito-borne alphavirus capable of causing neurological and immunological symptoms in humans, yet its effects on neural/immune systems remain insufficiently characterized. This study aimed to examine SINV replication, UV-C light inactivation, apoptosis induction, and immune gene modulation in human SH-SY5Y neuroblastoma cells. Following viral adaptation and infectious dose determination, SINV replication and inactivation were assessed using RT-qPCR and dsRNA immunofluorescence. Apoptotic markers (caspase-3, Bax, Bcl-2) were analyzed by immunofluorescence and immune genes expression kinetics (TLR3/7, RIGI, MDA5, IL-1β, IL-6, TNFα, IL-10, IFNβ and β-catenin) were measured at defined time points post-infection by RT-qPCR. SH-SY5Y cells supported productive SINV infection, with viral RNA detectable as early as 3 hpi and marked cytopathic effects by 24 hpi. A custom-built UV-C chamber achieved complete viral inactivation following 3 × 30 s exposures. We observed SINV time-course replication and UV-C inactivation with conspicuous morphological alterations in SH-SY5Y cells. Furthermore, SINV triggered caspase-dependent apoptosis and robust transcriptional upregulation of innate immune genes, peaking between 12–16 hpi and declining by 30 hpi. These findings elucidate the temporal dynamics of SINV replication, cell death mechanisms, and immune activation in a neuronal context, contributing to a better understanding of SINV neuropathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/83e2cc5a51197d9fec1538c92303d5084a961763" target='_blank'>
              Sindbis Virus–Host Interactions in Human Neuroblastoma Cells: Implications for Viral Pathogenesis and Replication
              </a>
            </td>
          <td>
            Kornélia Bodó, Zoltán Kopasz, Viktória Nyári, Krisztina Leiner, Péter Engelmann, Brigitta Zana, R. Hetényi, Dániel Hanna, Krisztián Bányai, M. Madai, Gréta Varga, A. Kuczmog
          </td>
          <td>2025-10-07</td>
          <td>Viruses</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="ABSTRACT Background Immune induction under B‐cell depletion is complex and far from being fully understood. Methods We investigated clinical and immunological responses after dual homologous mRNA vaccination with BNT162b2 and after booster vaccination or infection in 14 B‐cell depleted patients with inflammatory central nervous system disease in comparison to 28 healthy controls. Spike‐specific IgG were determined using ELISA and neutralizing activity by surrogate assay. Reactive T cells were flow‐cytometrically analyzed after spike‐specific and polyclonal stimulation. Reactogenicity was self‐reported using a questionnaire. Results Vaccination was well tolerated, with slightly more systemic events reported by patients. Spike‐specific antibodies were induced in all controls, but only 43% of patients with significantly lower IgG levels and reduced neutralizing capacity (p < 0.0001). In contrast, spike‐reactive T cells were induced in both groups with similar CD4 and higher CD8 T‐cell levels in patients. Functional characterization of spike‐reactive T cells revealed equally high CTLA‐4 expression in both groups, but higher proportions of polyfunctional, triple‐cytokine expressing CD4 and CD8 T cells in patients especially after the third immunization. Three patients experienced mild breakthrough infections after second vaccination. Conclusions Despite limited ability of B‐cell depleted patients to mount a humoral immune response after multiple doses of SARS‐CoV‐2 mRNA vaccination, the vaccine‐induced T‐cell response is robust, which may have implications for protection against severe disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/959568548ec7d2a80f6671db410d6c7a64e8594f" target='_blank'>
              De Novo Immune Induction After COVID‐19 Vaccination Under B‐Cell Depletion Is Characterized by Robust T‐Cellular Immunity in Patients With Inflammatory Central Nervous System Disease
              </a>
            </td>
          <td>
            Mathias Fousse, V. Klemis, Saskia Bronder, R. Urschel, F. Hielscher, Klaus Faßbender, U. Sester, M. Sester, T. Schmidt
          </td>
          <td>2025-09-01</td>
          <td>Brain and Behavior</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Ending of COVID-19 pandemic does not exclude subsequent breakthrough infections caused by SARS-CoV-2 mutant strains. The rate of SARS-CoV-2 mutations increased with emerging omicron strain and exceeds those of the influenza virus. It remains unclear what IgG antibody levels are able to protect against new mutant SARS-CoV-2 strains, and how long the immune protection will last. The objective of this study was to monitor the maintenance of humoral and cellular immunity to SARS-CoV-2 viral antigens over 4 years after the infection. Thirty-two adult reconvalescents after COVID-19 were annually examined for humoral and cellular immunity markers to the SARS-CoV-2 S protein. Humoral immunity was assessed by ELISA; cellular immunity was evaluated by expression of CD107a on CD8hi lymphocytes after recognition of S protein antigens. A four-year observation of a group of patients who recovered from COVID-19 in 2020 (SARS-CoV-2, Wuhan strain) and were in contact with a novel, freely circulating mutant VoCs showed that, 1 year later, all subjects retained the IgG antibodies to S protein, mainly the IgG1 subclass, but the antibody avidity index barely exceeded 50%. After a breakthrough infection caused by the omicron strain, the level of IgG antibodies to S protein increased significantly, along with sufficient increase of antibody avidity. The IgG2, IgG3, and IgG4 antibodies to S protein occured in the spectrum of subclasses. The level of specific IgA decreased 1 year after the disease against their level after the primary disease. However, it was significantly increased to 4-5 PR after breakthrough infections. Cellular immunity to the SARS-CoV-2 S protein was detected in all subjects at 1 year after the primary disease. After repeated infection with the omicron strain, it increased significantly and remained at this level for the next year. By 4 years, it decreased to the level that was a year after the disease. Hence, humoral and cellular immunity to S protein does not fade away, but continues to persist, maturate, being maintained at a sufficient level. Upon exposure to a new VoC, it allows to endure such a meeting either asymptomatically, or as a mild clinical infection. In view of frequent mutations in the S protein, the role of T-cell responses in anti-infectious protection seems to increase significantly. When developing new vaccines, one should rely on development of cellular immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e639b1e50968635421ab873cef8a370649bdc963" target='_blank'>
              Immunological memory to SARS-CoV-2 S protein persists 4 years after the disease
              </a>
            </td>
          <td>
            Z. Afridonova, A. Toptygina, E. Semikina
          </td>
          <td>2025-09-28</td>
          <td>Russian Journal of Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="We performed a large-scale immunogenomic analysis of ∼13,000 transcriptomic profiles from 10 autoimmune diseases, integrating publicly available datasets from both blood and tissue. Using meta-analysis, we identified core immune mechanisms underlying autoimmunity, including strong interferon responses, inflammation, and adaptive immune suppression, alongside disease-specific signatures. To enhance biological interpretability, we derived higher-order immune features - such as cell type proportions, cytokine levels, pathway activity, transcription factor regulation, and miRNA activity - and organized them into 15 coherent immune modules. These modules enabled systematic cross-disease comparisons, revealing shared and distinct immunopathological patterns. The inflammation module, in particular, was associated with disease severity and predicted treatment response across multiple conditions. This modular framework offers a powerful tool for understanding immune dysregulation and advancing precision medicine in autoimmune diseases. To support reproducibility and enable others to build upon this work, we developed an interactive app to explore and download the complete dataset and associated results.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33657b128cad4b7bef3c91009696d7561897ed33" target='_blank'>
              The Integrated Cellular and Molecular Landscape of Autoimmunity
              </a>
            </td>
          <td>
            R. Appierdo, G. Pepe, M. Helmer-Citterich, Marina Sirota, Francesco Vallania, P. Gherardini
          </td>
          <td>2025-09-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Key Points Question What are patterns of olfactory dysfunction in adults after SARS-CoV-2 infection? Findings In this cohort study, 1111 of 1393 SARS-CoV-2–infected participants who reported loss in or change of smell or taste a mean of 2 years after infection (80%) had hyposmia on formal testing, a total of 321 (23%) had severe microsmia or anosmia, and the mean age- and sex-standardized score was at the 16th percentile. Hyposmia was also present in 1031 of 1563 participants (66%) with prior infection but no self-reported change or loss (mean: 23rd percentile). Meaning These findings suggest that occult hyposmia following infection with SARS-CoV-2 is common, and olfactory testing should be considered after infection to diagnose olfactory dysfunction and counsel patients about the risks of smell loss.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f19f18a1abecce1876eae37e7cf10bbdb3b9a70b" target='_blank'>
              Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort
              </a>
            </td>
          <td>
            Leora I. Horwitz, Jacqueline H Becker, Weixing Huang, Teresa Akintonwa, Maxwell M Hornig-Rohan, Gabrielle Maranga, Dara R Adams, Mark W Albers, Mirna Ayache, Jasmine Berry, H. Brim, Tanner W. Bryan, Alexander W. Charney, Robert A. Clark, Melissa M Cortez, Brian D’anza, Hannah Davis, Sarah E Donohue, Nathaniel Erdmann, Valerie Flaherman, Tamara G Fong, Jennifer Frontera, M.P. Goldberg, Jason D. Goldman, Michelle S Harkins, Sally L. Hodder, Vanessa L. Jacoby, Prasanna Jagannathan, Xiaolin K. Jia, J. Kelly, Jerry A. Krishnan, Andre Kumar, A. Laiyemo, Emily B. Levitan, Jeffrey N. Martin, Kathryn M McCaffrey, Grace A. McComsey, Torri D. Metz, Ganesh Murthy, Helen Nguyen, Megumi Okumura, Samuel I. Parry, Sairam Parthasarathy, Thomas F. Patterson, Michael J. Peluso, Christina Sorochinsky, Tiffany Walker, Samantha L Wiegand, Zanthia Wiley, Juan Wisnivesky, Hassan Ashktorab, Andrea S. Foulkes, Joyce K Lee-Iannotti
          </td>
          <td>2025-09-01</td>
          <td>JAMA Network Open</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Progressive multiple sclerosis (PMS) represents a distinct clinical and biological entity characterized by compartmentalized neuroinflammation, chronic glial activation, and resistance to conventional immunotherapies. Unlike relapsing MS, PMS is sustained by resident CNS immune networks, where activated microglia and astrocytes orchestrate persistent cytokine signaling—particularly involving TNF-α, IL-1β, and IL-6—through self-amplifying feedback loops. In this narrative review, we explore how these cytokines interact with oxidative stress, iron accumulation, mitochondrial dysfunction, and impaired autophagy to drive neurodegeneration. Human-based evidence is integrated with insights from experimental models to clarify translational mechanisms. We also highlight fluid biomarkers (e.g., GFAP, NfL) and imaging modalities (e.g., TSPO-PET, QSM) that reflect glial activity and disease progression in vivo. Age, sex hormones, and immunosenescence are discussed as modulators of cytokine expression. Finally, we review emerging therapeutic strategies that target glial metabolism and cytokine networks rather than peripheral immune cells, offering a systems-based framework for future PMS interventions and personalized disease monitoring.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b95aee20640777431b2cd302ca1ff620ae824601" target='_blank'>
              Glial Cytokine and Metabolic Networks in Progressive Multiple Sclerosis: From Pathophysiology to Biomarkers and Therapeutic Strategies
              </a>
            </td>
          <td>
            Henry Leonard Hohm, Rasmus Schuster, Victor-Bogdan Buciu, D. Șerban, Sebastian Ciurescu, A. Cornea, Abhinav Sharma, D. Nistor, N. Kundnani
          </td>
          <td>2025-09-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3df3053146eb6fe4acc7c294faedb4aa2b0b1d59" target='_blank'>
              Differential methanogenic archaea-induced TLR8-dependent signaling is governed by NF-κB p65- and STAT1/2-controlled gene classes
              </a>
            </td>
          <td>
            Fan Xu, Johann Sieverding, Viktoria Weinberger, Christine Moissl-Eichinger, Inken Wohlers, Holger Heine
          </td>
          <td>2025-10-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Simple Summary This review examines the role of heat shock protein 60 (Hsp60) in COVID-19, highlighting its impact on immune modulation, inflammation, and endothelial dysfunction. Hsp60, a chaperone protein essential for protein folding and protection against cell stress, has been linked to COVID-19 pathogenesis through its interactions with the immune system and potential involvement in post-infectious autoimmune processes. One of the key aspects discussed is the phenomenon of molecular mimicry, wherein Hsp60 exhibits epitope similarity with a number of SARS-CoV-2 proteins, a circumstance that may potentially culminate in the induction of autoimmune responses. This mimicry has the potential to contribute to the development of autoimmune conditions, including Guillain–Barré syndrome and autoimmune thyroiditis, in patients infected with SARS-CoV-2. The document discusses Hsp60’s role in endothelial damage and thromboembolic complications, suggesting it could serve as a biomarker for disease severity and a therapeutic target. It raises concerns about vaccine safety due to Hsp60’s structural similarity to SARS-CoV-2 proteins, which may trigger autoimmune responses. The potential for Hsp60 to generate anti-tumor immunity is explored, indicating that immune responses to SARS-CoV-2 might also target tumor cells with similar epitopes. Further research is necessary to understand Hsp60’s role in disease fully and to develop effective therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/546ca21602945cbccdd4f51e65af7b87096e3cf7" target='_blank'>
              HSP60 and SARS-CoV-2: Les Liaisons Dangereuses
              </a>
            </td>
          <td>
            Adelaide Carista, M. I. Gratie, Francesco Cappello, S. Burgio
          </td>
          <td>2025-09-01</td>
          <td>Biology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a25bd4e13e314528eeb87010827676d25dd344a5" target='_blank'>
              Excitability as a Design Principle in the Immune System
              </a>
            </td>
          <td>
            Yael Lebel, U. Alon
          </td>
          <td>2025-09-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Emerging evidence underscores the critical role of Toll-like receptor 7 (TLR7)-mediated interferon (IFN) signaling in host defense against viral infections including SARS-CoV-2, through the modulation of both innate and adaptive immunity. However, the specific mechanisms by which TLR7 activation shapes SARS-CoV-2-specific immune responses, particularly via IRF-IFN pathways, remain incompletely elucidated. This review synthesizes current findings on how intrinsic TLR7-driven IFN signaling influences viral clearance, modulates adaptive immunity, and contributes to autoantibody production in COVID-19. A deeper understanding of these processes is essential for developing targeted therapeutic interventions and improved vaccines aimed at mitigating severe COVID-19 and preventing post-acute sequelae of SARS-CoV-2 infection (PASC).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2bd6dead6a1a78751a4bbff0555654ffbab2b138" target='_blank'>
              Unraveled role of TLR7-mediated interferon signaling activation in COVID-19
              </a>
            </td>
          <td>
            Junjian Xue, Xiaoyin Wang, Hui Wang, Bin Qiao, Pengfei Gao, Bin Ren, Shushan Yan
          </td>
          <td>2025-10-08</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Abstract Introduction Abnormal immune responses are common clinical features in septic patients. γδ T cells, as innate immune cells, play an important role in host defense, immune surveillance, and homeostasis. However, the immune characteristics of γδ T cells in pediatric sepsis remain poorly understood. Methods In this study, we analyzed single-cell RNA high-throughput sequencing data of peripheral blood mononuclear cells from pediatric septic patients. Results It demonstrates that γδ T cells exhibit a pro-inflammatory state with heightened immune responsiveness to pathogens in pediatric sepsis, as confirmed by the results of flow cytometric analysis showing elevated Th1 cytokine secretion, increased activation, and a propensity to differentiate into IL-17-producing (γδT17) cells during disease progression. Pseudotime analysis identified seven key genes potentially regulating the differentiation of γδ T cells to γδT17 subtype. Furthermore, cell-cell communication analysis revealed enhanced RETN-CAP1 binding between neutrophils and γδ T cells in pediatric sepsis, suggesting that neutrophil-derived resistin may promote γδ T-cell differentiation into the γδT17 subtype via CAP1 receptor binding. Conclusion This study presents analysis of a single-cell study on the immune status of γδ T cells in pediatric sepsis, highlighting their pivotal roles in pathogen response, inflammation propagation, and immune regulation. The observed differentiation toward the γδT17 subtype may facilitate neutrophil recruitment in this life-threatening condition. Elucidating the molecular mechanisms of γδ T cells in pediatric sepsis could offer a new theoretical basis for novel therapeutics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92d555cf8a765485e83760992e7ac0e0618b72ab" target='_blank'>
              Single-Cell RNA Sequencing in Pediatric Sepsis: γδ T Cell Exhibits a Differentiation to γδT17 Subtype along with Significantly Enhanced Cell Communication with Neutrophils
              </a>
            </td>
          <td>
            Wenjie Zhou, T. Feng, Yueli Mu, Zhuoxu He, Dong Liu, Mei-Xing Yu, Hong Li
          </td>
          <td>2025-09-02</td>
          <td>Journal of Innate Immunity</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Sepsis is a life-threatening syndrome caused by a dysregulated host response to infection. It follows a dynamic course in which early hyperinflammation coexists and overlaps with progressive immune suppression, a process best described as immunodynamic disruption. Key mechanisms include extensive lymphocyte death, expansion of regulatory T cells, impaired antigen presentation, and persistent activation of inhibitory checkpoints such as programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte–associated protein 4 (CTLA-4). These changes reduce immune competence and increase vulnerability to secondary infections. Clinically, reduced expression of Human Leukocyte Antigen–DR (HLA-DR) on monocytes and persistent lymphopenia have emerged as robust biomarkers for patient stratification and timing of immunomodulatory therapies. Beyond the acute phase, many survivors do not achieve full immune recovery but instead develop a Persistent Immune Remnant, defined as long-lasting immune, metabolic, and endothelial dysfunction despite apparent clinical resolution. Recognizing PIR emphasizes the need for long-term monitoring and biomarker-guided interventions to restore immune balance. To integrate these observations, we propose the SIMMP–Sepsis model (Sepsis-Associated Persistent Multiorgan Immunometabolic Syndrome), which links molecular dysfunction to clinical trajectories and provides a framework for developing precision immunotherapies. This perspective reframes sepsis not only as an acute crisis but also as a chronic immunometabolic syndrome, where survival marks the beginning of active immune restoration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5490da6ba7dc9d9448aa18cd1f1ad592e9be5a01" target='_blank'>
              Immunodynamic Disruption in Sepsis: Mechanisms and Strategies for Personalized Immunomodulation
              </a>
            </td>
          <td>
            Jhan S. Saavedra-Torres, María V. Pinzón-Fernández, H. A. Nati-Castillo, Valentina Cadena Correa, Luis Carlos Lopez Molina, Juan Estaban Gaitán, Daniel Tenorio-Castro, Diego A. Lucero Guanga, Marlon Arias-Intriago, Andrea Tello-De-la-Torre, Alice Gaibor-Pazmiño, J. Izquierdo-Condoy
          </td>
          <td>2025-09-01</td>
          <td>Biomedicines</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="COVID-19 causes a wide range of complications in the central nervous system, including encephalitis and other neurological symptoms such as memory problems, psychological disorders, depression, and anxiety. We present comprehensive data on the changes in gene expression levels in astrocytes infected with the Delta or Omicron variants of SARS-CoV-2. In RNA-seq data, we found 346 genes that were significantly evoked (197 up- and 149 down-regulated) in astrocytes challenged with the Omicron variant, compared to 341 evoked genes (215 up- and 126 down-regulated) in the Delta variant. A surprisingly large number of genes were exclusively evoked by Delta (82 up- and 48 downregulated) and Omicron variants (65 up and 60 downregulated). Numerous pathways, including those pertaining to the neuronal system, metabolism, response to viral infection, signal transduction, cytokine signaling, and homeostasis, were dysregulated in infected astrocytes. In this report we have dissected major pathways that are related to pathogen recognition, integrity of the BBB and glia limitans, and neurological disorders that could lead to neurological symptoms listed above. Our findings also reveal dysregulation of a large number of non-coding RNAs. The data presented here may help us better understand the role of astrocytes in the neurological disorders seen in COVID-19 patients. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-20851-8.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c339992734ddc6d228d9b0178084b42909087023" target='_blank'>
              Comprehensive mapping of the signaling events evoked by SARS-CoV-2 variants delta and omicron in human astrocytes
              </a>
            </td>
          <td>
            K. Bhide, M. Sláviková, Lea Talpašová, Katarína Kucková, Boris Klempa, Punit Tyagi, Mangesh Bhide
          </td>
          <td>2025-10-22</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Abstract Background Survivors of COVID-19 frequently report psychiatric and cognitive sequelae. The origin of such sequelae has not been determined, as it has been a challenge to resolve whether these symptoms have a viral origin or are related to the contextual stressors associated with the pandemic. Using a mouse model of post-acute sequelae of SARS-CoV-2 infection (PASC), we examined neurobiological mechanisms underlying these effects without the confounding influence of contextual factors. Results SARS-CoV-2 infection induced cognitive, but not anxiety- or depression-like, behavioral deficits. Cognitive impairments correlated with severity of the acute disease. Infected mice showed significant alterations in brain cytokine levels, as well as in kynurenine pathway (KP) metabolites, both of which were associated with acute disease severity. Microbiome taxonomic profiling revealed group-specific differences, indicating that certain bacterial species may contribute to PASC development. Conclusions Our findings suggest that SARS-CoV-2 infection causes cognitive deficits in PASC, modulated by acute disease severity, while anxiety- and depression-like behaviors appear unrelated to the viral infection itself. This supports the idea that such psychiatric symptoms may stem from pandemic-related stressors rather than infection. Altered cytokine signaling and KP metabolism may play key roles in the pathophysiology of PASC, identifying potential biomarkers and therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fb3ed4fe779a93447277b5e14c32a1a056c5b57" target='_blank'>
              Neuropsychiatric- and cognitive post-acute sequelae of SARS-CoV-2 infection – evidence from K18-hACE C57BL/6 J mice
              </a>
            </td>
          <td>
            Marco Maria Santi, Eleonora Genovese, T. Schou, Matheus da Silva, Sophie Erhardt, L. Schwieler, Jacob Ahlberg Weidenfors, Giorgia Marino, S. R. Paludan, Sâmia Joca, G. Wegener, L. Reinert, C. Bay-Richter
          </td>
          <td>2025-09-30</td>
          <td>International Journal of Neuropsychopharmacology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Early studies on the evolution of SARS-CoV-2 revealed mutations that favored host transmission of the virus and more efficient viral entry. However, cell-free virus spread is vulnerable to host-neutralizing antibodies. As population immunity developed, mutations that confer escape from neutralization were selected. Notably, cell syncytia formation wherein an infected cell fuses with a noninfected cell is a more efficient route of transmission that bypasses humoral immunity. Cell syncytia formation has been implicated in the pathogenicity of SARS-CoV-2 infection whilst compromising host transmission due to impaired whole virion release. Therefore, understanding the mechanisms of virus-mediated cell–cell fusion will aid in identifying and targeting more pathogenic strains of SARS-CoV-2. Whilst the general kinetics of cell–cell fusion have been known for decades, the specific mechanisms by which SARS-CoV-2 induces fusion are beginning to be elucidated. This is partially due to emergence of more reliable, high throughput methods of quantifying and comparing fusion efficiency in experimental models. Moreover, the ongoing inflammatory response and emerging health burden of long COVID may point to cell–cell fusion in the pathogenesis. In this review, we synthesize current understanding of SARS-CoV-2-mediated cell–cell fusion and its consequences on immune escape, viral persistence, and the innate immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4f095dbd1f23fd0e176cf55b71219bd14507420b" target='_blank'>
              Mechanisms of Cell–Cell Fusion in SARS-CoV-2: An Evolving Strategy for Transmission and Immune Evasion
              </a>
            </td>
          <td>
            Kate Chander Chiang, Cheng En Nicole Chiu, Mazharul Altaf, Mark Tsz Kin Cheng, 
          </td>
          <td>2025-10-22</td>
          <td>Viruses</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/91dba3cd2a7fdfc78162376e64466be7581539f4" target='_blank'>
              Humoral correlates of protection in a mouse model of echovirus infection
              </a>
            </td>
          <td>
            Patrick S. Creisher, James W Abell, Kaila A. Cooley, Carolyn B. Coyne
          </td>
          <td>2025-09-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="ABSTRACT The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in 2020 led to the immediate development of vaccines to combat SARS-CoV-2 infections and coronavirus disease 2019 (COVID-19). First-generation (2020–2021) COVID-19 vaccines demonstrated high immunogenicity and efficacy, successfully reducing hospitalization, disease severity and COVID-19 related deaths. However, the initial clinical trials for these vaccines focused on overall healthy individuals, and generally excluded high risk populations, such as people with cancer. The SARS-CoV-2 VaccinE Response, Immunological eFfects and safetY in patients with Cancer (VERIFY-C) study formed a unique cohort in early 2021, to capture the initial immune response to BNT162b2 mRNA (Pfizer) vaccination in people with cancer, with or without ongoing/recent exposure to systemic cancer treatment. Fifty-three participants diagnosed with cancer were enrolled. Majority were non-Hispanic, Caucasian females. Patients under cancer treatment had significantly lower antibody responses than those without treatment at pre-second dose and 1-month post-second dose. The levels at 6-months post-second dose were similar between both groups. Patients under treatment had a significantly lower immune response 1-month post-second dose, with an increased immune response at 6-months post-second dose, suggesting a delayed immune response. Further investigations are needed to understand antibody functionality post-vaccination in these individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e45420f0ba45dea4c651f1e55f885e82dbe1ff7e" target='_blank'>
              Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment
              </a>
            </td>
          <td>
            Christine M Dang, Troy J. Kemp, Nancy V. Roche, Katarzyna Haynesworth, Sarah A Loftus, Benjamin J Borski, Ziad El Bakouny, C. Labaki, Gwo-Shou Mary Lee, Rachel Trowbridge, Sarah Strauss, Melissa E Hughes, Nancy U Lin, T. Choueiri, Ligia A. Pinto
          </td>
          <td>2025-10-14</td>
          <td>Human Vaccines & Immunotherapeutics</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Chronic lymphocytic leukemia (CLL) is associated with immune dysfunction, but how disease-intrinsic mechanisms in treatment-naive patients influence the coordination of adaptive responses to novel antigens remains unclear. Here, we assessed SARS-CoV-2-specific antibody and T cell immunity in 38 treatment-naive CLL patients and 13 healthy controls (HCs) following vaccination. Despite significantly reduced total immunoglobulin levels compared to HCs, 94.7% of CLL patients developed SARS-CoV-2-specific IgG, and 89.5% mounted IgA responses, with serum titers comparable to those of HCs. Virus-specific T cell responses, measured by IFN-γ release following antigen stimulation, were detected in 78.9% of patients. CLL patients had significantly more circulating CD4+ T follicular helper (Tfh) and T follicular regulatory (Tfr) cells than HCs. These expansions correlated with B cell abundance, which, in untreated CLL, predominantly reflects malignant B cells. Notably, Tfh cell frequencies and absolute counts were highest in patients lacking a SARS-CoV-2-specific T cell response, indicating a decoupling between Tfh expansion and functional antiviral immunity. Overall, these findings demonstrate that while SARS-CoV-2-specific immune responses are largely preserved in treatment-naive CLL patients, disease-driven alterations in T cell composition may compromise the coordination and quality of antigen-specific T cell-mediated immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380a2444f13a61f76a9c9706f853d8210212d10f" target='_blank'>
              Attenuated SARS-CoV-2-Specific T Cell Responses Are Associated with T Follicular Helper Cell Expansion in Treatment-Naive Chronic Lymphocytic Leukemia Patients
              </a>
            </td>
          <td>
            B. Šlisere, R. Kārkliņš, A. Rivkina, Sandra Lejniece, K. Oļeiņika
          </td>
          <td>2025-09-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Abstract Multisystem inflammatory syndrome in children (MIS-C) is a severe SARS-CoV-2-associated condition that shares clinical features with Kawasaki disease (KD), characterised by a distinct polyclonal expansion of Vβ21.3+ T cells. We report five patients diagnosed with breakthrough MIS-C despite COVID-19 immunisation, all within a limited time period at the beginning of the Omicron wave, to assess whether breakthrough MIS-C cases share the same TCR Vβ21.3 skewing seen in non-vaccinated MIS-C cases. We retrospectively reviewed five MIS-C patients hospitalised between December 2021 and April 2022 despite previous immunisation against SARS-CoV-2 (BNT162b2, an mRNA vaccine against S-protein). Immunophenotyping, including TCR Vβ subset distribution, was performed in four patients.Patients (100% male, 12.2–17.2 years) had a natural breakthrough SARS-CoV-2 infection following prior immunisation (between August 2021 and February 2022). Recent infection was proven by positive SARS-CoV-2 PCR and/or IgG antibodies against the nucleocapsid protein. Blood samples of four patients were available. All presented with Vβ21.3+ T cell expansion, similar to MIS-C patients and in contrast to vaccinated historical KD patients (n=10). The two patients with the earliest sampling post-illness displayed frequencies of Vβ21.3+ T cells exceeding the reference mean value+10×SD. These Vβ21.3+ T cells showed increased surface expression of activation (HLA-DR, CD38) and exhaustion (PD-1, TIM-3) markers.In conclusion, breakthrough MIS-C patients presented with features consistent with unvaccinated MIS-C patients, including the hallmark Vβ21.3+ T cell expansion, indicating that prior immunisation with an mRNA vaccine targeting the Wuhan strain did not fully protect against MIS-C at the wave of a novel emerging variant early 2022. Trial registration number: NL41023.018.12.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1af3c466152d5c925ad6fc0d085e42b25a328ffa" target='_blank'>
              Polyclonal Vβ21.3 expansion in multisystem inflammatory syndrome in children despite SARS-CoV-2 vaccination
              </a>
            </td>
          <td>
            Stejara A. Netea, Liliane Khoryati, S. Nagelkerke, S. Benezech, J. Keijser, M. Gruppen, Giske Biesbroek, Roel Lubbers, Naomi Ketharanathan, E. Buddingh, Nikki J. Schoenmaker, Arianne Brandsma, T. Rispens, Irene Kuipers, Alexandre Belot, T. Kuijpers
          </td>
          <td>2025-10-01</td>
          <td>RMD Open</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and limited therapeutic options. Conventional preclinical models, such as the bleomycin (BLM)-induced lung fibrosis (BILF) model in immunocompetent mice, fail to replicate the complexity of the human immune environment and are thus unsuitable for evaluating human-specific antibody and cell therapies. To overcome this limitation, we developed two humanized mouse models with functional human immune components: one engrafted with peripheral blood mononuclear cells (PBMCs) and the other with hematopoietic stem cells (HSCs). Pulmonary fibrosis was induced using BLM in both humanized models. In the PBMC-humanized model, human T cells accounted for 79.9% ± 9.7% of CD45+ cells; however, this model was limited by high incidence of graft-versus-host disease (GvHD). In contrast, the HSC-humanized model demonstrated stable multilineage engraftment (T cells: 20.1% ± 28.3%; B cells: 56.8% ± 25.4%), absence of GvHD, and consistent fibrotic pathology. Both models exhibited increased inflammatory infiltration, fibroblast activation, and collagen deposition following BLM induction. Nintedanib treatment significantly ameliorated fibrotic changes in both models. These findings establish the HSC-humanized BILF model as a clinically relevant platform for investigating human immune responses in IPF and for preclinical evaluation of human-targeted therapies. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-18370-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2890462f433181640b7e42a4dcbcaa3bfbbdfbc8" target='_blank'>
              Establishment of a humanized mouse model of pulmonary fibrosis for advancing drug validation strategies
              </a>
            </td>
          <td>
            Md. Nakibul Hasan, Yuri Chae, Su Yeon Lee, Young Mo Kang
          </td>
          <td>2025-10-06</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4affc89bf67fc05b617d2d032b1ac2bfae33c8c8" target='_blank'>
              The effects of denifanstat on hepatitis E virus replication and triggered inflammatory response
              </a>
            </td>
          <td>
            Jiahua Zhou, M. Peppelenbosch, Qiuwei Pan, I. Ayada
          </td>
          <td>2025-10-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4e5a14c609aa9f92eea767388572753854ade406" target='_blank'>
              MicroRNAs in SARS-CoV-2 infection: emerging modulators of inflammation, pathogenesis, and therapeutic potential.
              </a>
            </td>
          <td>
            M. Fayyad-kazan
          </td>
          <td>2025-08-29</td>
          <td>Inflammopharmacology</td>
          <td>1</td>
          <td>20</td>
        </tr>

        <tr id="Virus-specific CD4+ T cells typically undergo T helper (Th) 1 differentiation and contribute to a type 1 immune response in infection with lymphocytic choriomeningitis virus (LCMV). Using this model pathogen, we performed an in-depth analysis of the quantitative expression stability of the Th1 key transcription factor T-bet. Previously, it was shown that virus-specific Th1 cells arising in acute infections expressed T-bet at distinct intensities and maintained their T-bet expression differences after viral clearance as memory cells for weeks in the steady state. However, it was unclear whether differential T-bet expression was associated with heterogeneity inside the Th1 population and if the quantitative T-bet memory, particularly of those cells expressing T-bet at low levels, could withhold the strong and continuous stimulation present during chronic infection. Using T-bet-ZsGreen reporter mice, virus-specific Th1 cells were characterized phenotypically at protein, RNA, and DNA/chromatin accessibility levels. The Th1 cells arising during acute LCMV Armstrong infection showed a continuous spectrum of T-bet expression, ranging from cells with very high T-bet to cells with low T-bet. Even though the cells with low T-bet expression clearly possessed Th1 characteristics, they additionally showed certain Tfh-like features at protein and RNA level. When virus-specific Th1 cells were sorted according to T-bet-ZsGreen reporter expression intensity, adoptively transferred, and rechallenged by infecting the host animals with the chronic Clone 13 strain of LCMV, they maintained quantitative differences in T-bet reporter and IFN-γ expression levels. A subpopulation of the progeny of the former T-betlow cells still showed a mild Tfh-associated phenotype. Independent of their past and present T-bet expression level, all virus-reactive CD4+ T cells acquired phenotypic signs of exhaustion as characterized by upregulation of PD-1, LAG3, and TOX and vast absence of effector cytokine co-expression in the chronic infection environment. Collectively, our findings highlight the heterogeneity of T-bet+ antiviral CD4+ T cells and the stability of quantitative differences in individual virus-specific CD4+ T cells during chronic viral challenge infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bc9e88d2fafc16f74c1bf59bb61267ab8fcd6cb4" target='_blank'>
              Stable characteristics of intrapopulation heterogeneity in virus-specific Th1 cells during chronic viral challenge infection
              </a>
            </td>
          <td>
            V. Plajer, A. Madrigal-Avilés, Maria Dzamukova, Nayar Durán-Hernández, Philippe Saikali, Vivien Holecska, Isabel Panse, Katrin Lehmann, Jinfang Zhu, Mir-Farzin Mashreghi, Ahmed N. Hegazy, Caroline Peine, M. Löhning
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/db70b2570d7101d2b0e5cf47bdfd6e799a249b9a" target='_blank'>
              From infection to intervention: post-acute sequelae of SARS-CoV-2 infection and cardiovascular risk.
              </a>
            </td>
          <td>
            Rufaida Wasim
          </td>
          <td>2025-10-13</td>
          <td>Inflammopharmacology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="INTRODUCTION
Cytokine storm can result from uncontrolled proinflammatory cytokines released in SARS-CoV-2 infection that cause damage to several organs. Il-6 is one of the major mediators of cytokine storm. IFN-α2 has been reported to have anti-viral potential and the pre-infection levels of proinflammatory cytokines have been suggested to drive the fate of the disease. There is a paucity of information on how anti-viral cytokines at the onset of infection affect the disease progression. This study aims to profile IL-2, IL-6, IL-10, and IFN-α2 expression levels for 44 days post-diagnosis and their effects on recovery.


METHODS
Peripheral venous blood was collected from 38 SARS-CoV-2 infected participants who came for diagnosis at the Center for Research on Emerging and Reemerging Diseases. IL-2, IL-6, IL-10, and IFN-α2 levels were measured using a Luminex panel.


RESULTS
Males had higher SARS-CoV-2 viral load than females, although the difference was not statistically significant (p=0.08). Age-related variation was also observed, with individuals aged 40-60 showing significantly higher viral load than those over 60 (p=0.045). Cytokines analysis revealed that males had significantly higher levels of IFNα-2, IL-2, and IL-6 (p=0.0031, p=0.009, and p=0.022 respectively) than females upon diagnosis, with cytokines levels decreasing over time in males but increasing in females. Cytokine levels trended higher in symptomatic individuals, although differences were not significant.


CONCLUSION
These findings highlight the influence of sex, clinical status, and viral load on cytokine dynamics in COVID-19, with potential implications for understanding disease severity and immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a96153529dbc58b976dae603414f6f5491296d91" target='_blank'>
              Cytokines dynamics and biological sex differences in SARS-CoV-2 infected people in Cameroon.
              </a>
            </td>
          <td>
            Hillary Tene, Romuald Ngamaleu, R. Djounda, Rachel Minomo, Sabine Ngale, Micheal Besong, Honore Awanakam, Krystelle Nganou Makamdop, Rene Essomba, Jude Bigoga, Daniel C. Douek, L. Esemu
          </td>
          <td>2025-09-22</td>
          <td>Clinical and experimental immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Background: Vaccination against SARS-CoV-2 has been pivotal in controlling the COVID-19 pandemic. However, understanding vaccine-induced immunity in immunocompromised individuals remains critical, particularly how prior exposure to other coronaviruses modulates immune responses. The influence of previous infections with endemic human coronaviruses (HCoVs), such as OC43, on SARS-CoV-2 immunity is not fully understood. This study evaluates antibody responses to COVID-19 vaccination in hemodialysis patients (HD), transplant recipients (TR), and healthy controls (CO), accounting for prior SARS-CoV-2 infection and baseline human coronavirus (HCoV) reactivity. Methods: We obtained longitudinal antibody measurements from 70 subjects (CO: n = 33; HD: n = 13; TR: n = 24) and assessed antibody kinetics across multiple post-vaccination time points using multivariate linear mixed modeling (MLMM). Results: Limited but measurable cross-reactivity was observed between SARS-CoV-2 and endemic HCoVs, particularly the β-coronavirus OC43. Pre-existing immunity in healthy individuals modestly enhanced vaccine-induced anti-spike (S) IgG responses, supported by post-vaccination increases in SARS-CoV-2 IgG. Prior SARS-CoV-2 infection significantly influenced anti-S and nucleocapsid (N) IgG responses but had limited impact on endemic HCoVs responses. Vaccine type and immune status significantly affected antibody kinetics. mRNA vaccination (BNT162b2) elicited stronger and more durable SARS-CoV-2 anti-S IgG responses than the inactivated CoronaVac vaccine, especially in immunocompetent individuals. Immunocompromised groups showed delayed or attenuated responses, with modest anti-S IgG cross-reactive boosting. Elevated anti-N IgG in CoronaVac recipients raised questions about its origin—infection or vaccine effects. MLMM identified key immunological and clinical predictors of antibody responses, emphasizing the critical role of host immune history. Conclusions: These findings highlight a constrained but meaningful role for HCoV cross-reactivity in SARS-CoV-2 immunity and vaccine responsiveness, underscore the need for infection markers unaffected by vaccination, and support development of broadly protective pan-coronavirus vaccines and tailored strategies for at-risk populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9c7958710194b455bf33b85b55c083a943548fb2" target='_blank'>
              Antibody Responses to SARS-CoV-2 and Common HCoVs in Hemodialysis Patients and Transplant Recipients: Data from the Dominican Republic
              </a>
            </td>
          <td>
            Lisette Alcantara Sanchez, Eloy Alvarez Guerra, Dongmei Li, Samantha M King, S. Hilchey, Qian Zhou, Stephen Dewhurst, Kevin A. Fiscella, Martin S. Zand
          </td>
          <td>2025-09-01</td>
          <td>Vaccines</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Background Long COVID manifests with heterogeneous clinical outcomes, potentially linked to immune dysfunction. However, the recovery of immune-cell subsets during convalescence remains incompletely understood. Methods In this longitudinal cohort, 279 unvaccinated patients with confirmed SARS-CoV-2 infection (13 mild, 218 moderate, 48 severe) were enrolled. Peripheral lymphocyte subsets were analyzed by flow cytometry at admission and at 50 days post-symptom onset (DPSO 50). Results Total T-cell counts normalized in 90–98% of patients in the moderate and severe groups by DPSO 50. Nevertheless, a subgroup exhibited persistent B-cell lymphopenia (<90 cells/µL) in 7.3% of moderate cases (median 77.1 cells/µL, IQR 51.9–83.8) and 12.5% of seltvere cases (median 54.5 cells/µL, IQR 28.4–79.3). Patients with B-cell deficiency also showed concurrent reductions in total T cells, CD4+ T cells, and CD4+CD25+CD127low/FOXP3+ regulatory T cells (Tregs). In moderate cases, CD4+ T cell and Treg counts correlated positively (r = 0.72, p < 0.001), independent of B-cell status, whereas this relationship was absent in severe cases, indicating severity-dependent immune dysregulation. Conclusions Approximately 7–12% of moderate-to-severe COVID-19 survivors displayed persistent lymphopenia affecting B cells, CD4+ T cells, and Tregs at ~50 days post-symptom onset. These findings highlight distinct recovery trajectories and provide insights into Long COVID pathogenesis that may inform therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c165191a2e09a44e33a7c7b9cf17e00475d7457f" target='_blank'>
              Persistent lymphocytopenia in convalescent patients with COVID-19: dysregulated B cell, CD4+ T cell, and treg compartments in 7–12% of moderate-severe cases
              </a>
            </td>
          <td>
            Hui An, Tongtong Yu, Anlan Wang, Hao Hu, Chen Zhang, Yongyu Wang, Ming Li
          </td>
          <td>2025-10-09</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="SARS-CoV-2 variants have demonstrated distinct epidemiological patterns and clinical presentations throughout the COVID-19 pandemic. Understanding variant-specific differences at the respiratory epithelium is crucial for understanding their pathogenesis. Here, we utilized human nasal organoid air–liquid interface (HNO-ALI) cell cultures to compare the viral replication kinetics, innate immune response, and epithelial damage of six different strains of SARS-CoV-2 (B.1.2, WA, Alpha, Beta, Delta, and Omicron). All variants replicated efficiently in HNO-ALIs, but with distinct replication kinetic patterns. The Delta variant exhibited delayed replication kinetics, achieving a steady state at 6 days post-infection compared to 3 days for other variants. Cytokine analysis revealed robust pro-inflammatory and chemoattractant responses (IL-6, IL-8, IP-10, CXCL9, and CXCL11) in WA1, Alpha, Beta, and Omicron infections, while Delta significantly dampened the innate immune response, with no significant induction of IL-6, IP-10, CXCL9, or CXCL11. Immunofluorescence and H&E analysis showed that all variants caused significant ciliary damage, though WA1 and Delta demonstrated less destruction at early time points (3 days post-infection). Together, these data show that, in our HNO-ALI model, the Delta variant employs a distinct “stealth” strategy characterized by delayed replication kinetics and epithelial cell innate immune evasion when compared to other variants of SARS-CoV-2, potentially explaining a mechanism that the Delta variant can use for its enhanced transmissibility and virulence observed clinically. Our findings demonstrate that variant-specific differences at the respiratory epithelium could explain some of the distinct clinical presentations and highlight the utility of the HNO-ALI system for the rapid assessment of emerging variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2a66e6213ba7653ae3a1d826608bc43258345cb7" target='_blank'>
              Strain-Specific Variability in Viral Kinetics, Cytokine Response, and Cellular Damage in Air–Liquid Cultures of Human Nasal Organoids After Infection with SARS-CoV-2
              </a>
            </td>
          <td>
            G. Aloisio, Trevor McBride, Letisha Aideyan, Emily M. Schultz, Ashley M. Murray, Anubama Rajan, Erin G Nicholson, D. Henke, Laura Ferlic-Stark, Amal Kambal, Hannah L. Johnson, Elina A. Mosa, F. Stossi, S. Blutt, Pedro A. Piedra, V. Avadhanula
          </td>
          <td>2025-10-06</td>
          <td>Viruses</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="Interleukin-24 (IL-24) is a cytokine known for its role in immune regulation and apoptosis, with potential implications in viral infections like COVID-19. This study aimed to investigate the association between IL-24 serum levels and the severity of COVID-19 disease. In this prospective bi-center cross-sectional study, we enrolled 41 COVID-19 patients from two hospitals in Germany. Serial blood samples were collected from a subset of patients, resulting in 88 total blood samples. Patients were categorized into critical, severe, moderate, and mild disease groups based on WHO criteria. IL-24 serum levels were measured during the acute or convalescent phase using an ELISA assay. Inflammatory markers, and kidney and liver function parameters were also evaluated. Statistical analysis included non-parametric tests and correlation analysis. Elevated IL-24 serum levels were observed in ambulant patients (mild disease), compared to hospitalized patients (critical, severe, moderate disease, p < 0.05). IL-24 levels were also significantly higher in patients without oxygenation disorder compared to those with oxygenation therapy (p < 0.05). A negative correlation was found between IL-24 levels and markers of inflammation and liver/kidney function. Elevated IL-24 serum levels were associated with milder COVID-19 courses, suggesting a protective role in modulating immune responses and promoting antiviral apoptosis. Conversely, reduced IL-24 in severe cases may reflect impaired immune regulation, highlighting its potential as a biomarker and therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f5f9f71c023098f96d2d19d55b8849e073ef83ea" target='_blank'>
              IL-24 in COVID-19 Patients: Correlations with Disease Progression
              </a>
            </td>
          <td>
            R. Vollenberg, Katharina Schütte-Nütgen, Markus Strauss, Jonel Trebicka, J. Fischer, Phil Tepasse
          </td>
          <td>2025-08-29</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="The SARS-CoV-2 pandemic presents a broad clinical spectrum from asymptomatic cases to severe respiratory failure with high mortality. Severe COVID-19 is characterized by immune dysregulation, including lymphopenia and alterations in the counts of T, B, and NK cells in peripheral blood. Due to the limited data on long-term outcomes related to immune dysregulation, we aimed to analyze immunologic features at baseline in severe and mild COVID-19 cases and assess follow-up characteristics associated with later mortality and long-COVID signs. We included adult patients consecutively hospitalized with COVID-19 between June and November 2020 at the University Hospital in Kraków, corresponding to the first and second waves of COVID-19 in Poland. We enrolled only those who had been thoroughly assessed in terms of clinic and laboratory data, including immunological workups, and survived the acute phase of the disease. In 2025, between February and April (median time of follow-up: 54 months), we conducted a telephone questionnaire on long-COVID symptoms among survivors who had given their consent. Statistical analyses were performed to compare groups with severe and mild disease in terms of dysregulation in lymphocyte subpopulations and the follow-up outcomes. The study included 103 COVID-19 patients, comprising 53 severe (based on the need for at least high-flow nasal oxygen therapy) and 50 mild cases, with no differences in age, sex, and body mass index. Severe COVID-19 patients compared to mild cases had lower CD3+ T cells (count and percentage), CD4+ T cells (count and percentage), CD8+ T cells (count), and NK cells (count), but higher CD19+ B cells (percentage) at baseline (p < 0.05, all). At the time of follow-up, we evaluated 80 patients (77.7% of the baseline participants), with 23 (22.3%) patients lost to follow-up. Among patients analyzed in the follow-up, 23 (28.8%) had died, and 29 of the 57 survivors (50.9%) reported persistent long-COVID symptoms. Patients who died had significantly lower baseline counts of CD3+ T cells (377 vs. 655 cells/µL), CD4+ T cells (224 vs. 372 cells/µL), CD8+ T cells (113 vs. 188 cells/µL), and NK cells (118 vs. 157 cells/µL) compared to survivors (p < 0.05, all). Notably, the percentage of CD19+ B cells was higher in deceased individuals (19.2% vs. 13.5%; p = 0.049). In contrast, we did not document differences in baseline immunological data among survivors with and without long-COVID signs. Our study suggests that dysregulation in lymphocyte subpopulations during the COVID-19 acute phase may be associated with increased late mortality, but not with the persistence of long-COVID symptoms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/de8b75924f0ad1abad27efe7fa8b5e02ab64f1f4" target='_blank'>
              Baseline Dysregulation in B, T, and NK Cells in COVID-19 Predicts Increased Late Mortality but Not Long-COVID Symptoms: Results from a Single-Center Observational Study
              </a>
            </td>
          <td>
            Aleksandra Matyja-Bednarczyk, Radosław Dziedzic, Anna Drynda, Ada Gradzikiewicz, Monika Bociąga-Jasik, Krzysztof Wójcik, Sabina Lichołai, K. Górka, N. Celejewska-Wójcik, Tomasz Stachura, K. Polok, L. Zarȩba, Teresa Iwaniec, Krzysztof Sładek, S. Bazan-Socha
          </td>
          <td>2025-10-21</td>
          <td>Viruses</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3ce82e1a14462949bdb77758ec90d76e4d6623a3" target='_blank'>
              Urinary Peptidomic Profiling in Post-Acute Sequelae of SARS-CoV-2 Infection: A Case-Control Study
              </a>
            </td>
          <td>
            Dilara Gülmez, J. Siwy, Katharina Kurz, R. Wendt, M. Banasik, B. Peters, E. Dudoignon, François Dépret, Mercedes Salgueira, Elena Nowacki, Amelie Kurnikowski, Sebastian Mussnig, S. Krenn, Samuel Gonos, Judith ‐ Löffler ‐ Ragg, Günter Weiss, H. Mischak, M. Hecking, Eva Schernhammer, Andrzej Konieczny, Magdalena Krajewska, Justyna Zachciał, D. Bartoszek, Patryk Wawrzonkowski, Krzysztof Wiśnicki
          </td>
          <td>2025-10-17</td>
          <td>None</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Parrots, valued companion animals with a concerning conservation status, can act as reservoirs for zoonotic diseases. During various infections, systemic inflammation significantly impairs host health. However, the regulation of inflammatory responses in birds, particularly in cognitively advanced parrots, remains poorly understood. Here, we examine parrot systemic inflammation in response to virus-mimicking stimulation. In budgerigars (Melopsittacus undulatus), a novel model for neuroinflammation research, we induced sterile inflammation with synthetic poly(I:C) RNA and analysed dose-, time- and tissue-dependent gene expression patterns of key markers, including TLR3, NLRP3, CASP1, IL1B and IL6, during acute immune response. We report a significant relationship between cytokine expression (IL1B, IL6) in the intestine (local response) and brain (systemic response) that has not yet been described after viral stimulation in parrots. Peripheral IL6 expression was upregulated at 3–6 h after stimulation with poly(I:C). In the brain, multiple genes (TLR3, IL1B and IL6) showed activation early during the immune response. These findings highlight the susceptibility of parrots to neuroinflammation following viral infections, having specific relevance for basic research in neurobiology, immunology and behavioural science, and also veterinary research in psittacine birds. Our study provides a foundation for future comparative research on avian neuro-immune crosstalk and neuroinflammation-related behavioural disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b23dca0d96ff356c079d40ec7845a15398f0ccf4" target='_blank'>
              The neuro-immune crosstalk between periphery and central nervous system during acute immune response to virus-mimicking RNA in parrots
              </a>
            </td>
          <td>
            Balraj Melepat, Daniel Divín, Kateřina Marková, Tao Li, Nithya Kuttiyarthu Veetil, Eleni Voukali, Lucie Schmiedová, Martin Těšický, Michal Vinkler
          </td>
          <td>2025-10-01</td>
          <td>Royal Society Open Science</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Background/Objectives: Since its emergence, COVID-19—caused by the novel coronavirus SARS-CoV-2—has affected millions globally and led to over 1.2 million deaths in the United States alone. This global impact, coupled with the emergence of five new human coronaviruses over the past two decades, underscores the urgency of understanding its pathogenic mechanisms at the molecular level—not only for managing the current pandemic but also preparing for future outbreaks. Small non-coding RNAs (sncRNAs) critically regulate host and viral gene expression, including antiviral responses. Among the molecular regulators implicated in antiviral defense, the microRNA-processing enzyme Drosha has emerged as a particularly intriguing factor. In addition to its canonical role, Drosha also exerts a non-canonical, interferon-independent antiviral function against several RNA viruses. Methods: To investigate this, we employed q/RT-PCR, Western blot, and immunocytochemistry/immunofluorescence in an immortalized normal human lung/bronchial epithelial cell line (NuLi-1), as well as a human colorectal carcinoma Drosha CRISPR knockout cell line. Results: In this study, we observed a striking shift in Drosha isoform expression following infection with multiple SARS-CoV-2 variants. This shift was absent following treatment with the viral mimetic poly (I:C) or infection with other RNA viruses, including the non-severe coronaviruses HCoV-OC43 and HCoV-229E. We also identified a distinct alteration in Drosha’s cellular localization post SARS-CoV-2 infection. Moreover, Drosha ablation led to reduced expression of SARS-CoV-2 genomic and sub-genomic targets. Conclusions: Together, these observations not only elucidate a novel aspect of Drosha’s antiviral role but also advance our understanding of SARS-CoV-2 host–pathogen interactions, highlighting potential therapeutic avenues for future human coronavirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d740810b1af27bb32d9576cdad6a82852077e588" target='_blank'>
              SARS-CoV-2 Infection of Lung Epithelia Leads to an Increase in the Cleavage and Translocation of RNase-III Drosha; Loss of Drosha Is Associated with a Decrease in Viral Replication
              </a>
            </td>
          <td>
            Michael T. Winters, Emily S. Westemeier-Rice, Travis W. Rawson, , Gabriel M. Sankey, Maya Dixon-Gross, Olivia McHugh, Nasrin Hashemipour, McKenna L. Carroll, Isabella R. Wilkerson, Ivan Martinez
          </td>
          <td>2025-10-20</td>
          <td>Genes</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="ABSTRACT Sepsis, caused by an unbalanced host response to infection, remains a global health burden. The dysregulation between pro-inflammatory and anti-inflammatory responses is a primary driver of immune imbalance. As a central player in adaptive immunity, CD4+ T cells are crucial for maintaining this balance during sepsis by differentiating into various effector T cell subsets. Thus, elucidating the underlying mechanisms within the inflammatory and anti-inflammatory imbalance in CD4+ T cell subsets during sepsis is of great value. We first identified the proviral integration site for Moloney murine leukemia virus 1 (PIM1) as a significantly upregulated gene in CD4+ T cells from sepsis patients by conducting a comprehensive transcriptome meta-analysis. The expression of PIM1 was significantly elevated on CD4+ T cells from sepsis patients and was correlated with both SOFA and APACHE II scores. Moreover, we found that PIM1 promoted the differentiation of CD4+IFN-γ+ Th1 and CD4+IL-17A+ Th17 subsets while inhibiting the differentiation of CD25+FoxP3+ Tregs. Additionally, upon inhibiting PIM1 kinase activity in CD4+ T cells, RNA sequencing analysis revealed that the cholesterol metabolism gene, ATP-binding cassette transporter G1 (ABCG1), exhibited significant upregulation. More importantly, we found that the intracellular cholesterol content was decreased in CD4+ T cells after inhibiting the PIM1 kinase activity or knocking down PIM1. The portion of CD4+IFN-γ+ Th1 and CD4+IL-17A+ Th17 cells was recovered, and the CD4+CD25+FoxP3+ Tregs decreased after cholesterol supplementation to CD4+ T cells. These findings indicated that PIM1 may regulate the balance of Th1, Th17, and Treg subsets in a cholesterol-dependent manner in sepsis. IMPORTANCE This study aims to elucidate the mechanism of the inflammatory and anti-inflammatory imbalance of CD4+ T cell subsets during sepsis. Our study provides evidence that PIM1 serves as a crucial regulator of sepsis-induced inflammation and elucidates that PIM1 participates in regulating the imbalance of Th1, Th17, and Treg subsets, further promoting inflammatory and anti-inflammatory imbalance in sepsis. Additionally, the cholesterol metabolism, potentially mediated by ABCG1, is implicated in PIM1’s regulatory effect on the Th1, Th17, and Treg imbalance. Our study provides novel insights into the inflammatory imbalance during sepsis, which could facilitate the development of therapeutic strategies aimed at modulating the immune-inflammatory cascade in this condition.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9ee5daf196d593b7e5934f08132c38f813b783c7" target='_blank'>
              PIM1 orchestrates sepsis-associated inflammatory imbalance in CD4+ T cell subsets via cholesterol metabolism
              </a>
            </td>
          <td>
            Mei Liu, Jia-Qi Wang, Jia-Ning Wang, Yi-Ni Sun, Simin Li, Yajing Fu, Yongjun Jiang, Zining Zhang, Hong Shang
          </td>
          <td>2025-09-03</td>
          <td>mBio</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="ABSTRACT Background Kawasaki disease (KD) is a leading cause of acquired heart disease in children. Evidence suggests that microbial and nonmicrobial triggers for KD differ across geographical regions and environmental conditions. Although the precise triggers remain unidentified, KD is likely caused by microbial or environmental agents acting on genetically predisposed children. Recent Findings Insights into KD pathogenesis have also been derived from three well‐established murine models, which highlight diverse vasculitis‐inducing pathways. The diversity of microbial triggers supports the hypothesis that KD arises from immune‐mediated responses rather than direct infection. Pathogen‐associated molecular patterns (PAMPs), microbe‐associated molecular patterns (MAMPs) and inflammatory cell death‐linked damage‐associated molecular patterns (DAMPs) play critical roles in KD pathogenesis. Furthermore, genetic polymorphisms associated with KD, such as ITPKC, CASP3, and FCGR2A, contribute to immune activation by promoting inflammasome activation, pyroptosis and antibody‐dependent enhancement (ADE), thereby intensifying inflammation. Oxidative and nitrative stress further amplify inflammatory responses, with their interplay potentially driving KD onset. The relatively low recurrence rate of KD, despite its diverse triggers, may partly be explained by the presence of anti‐DAMP antibodies. Historically, reduced exposure to infections and improved sanitation may have led to lower levels of anti‐DAMP antibodies, potentially contributing to the increased incidence of KD observed over time. Conclusion Continued research into microbial and immune mechanisms is crucial to advance our understanding of KD pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f61c1670c897b96e4cf8e877e416cda634f60d89" target='_blank'>
              The Etiopathogenesis of Kawasaki Disease: Evolving Understanding of Diverse Triggers
              </a>
            </td>
          <td>
            Toshiro Hara, Yasunari Sakai
          </td>
          <td>2025-09-01</td>
          <td>Immunity, Inflammation and Disease</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="ABSTRACT: It has been five years since the first COVID-19 cases emerged in China. The infection spread extensively around the world, impacting millions and presenting a significant risk to public health, leading to the breakdown of healthcare systems in various countries. The COVID-19 is caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and is a recent emergent virus that belongs to the beta (β)-coronaviruses. The presence of comorbidities significantly influenced the mortality rate among patients infected with COVID-19. For a while, it was believed that the transmission of SARS-CoV-2 was limited to respiratory tract invasion; however, more research indicated that the infection may also affect the central and peripheral neurological systems, among many other organs and systems. Encephalopathy, encephalitis, meningitis, ischemic and hemorrhagic stroke, and cerebral venous sinus thrombosis are among the neurological side effects linked to the SARS-CoV-2 infection. Since the pandemic began, COVID-19 treatment has advanced swiftly, mostly emphasizing antiviral and immunomodulatory medications. Remdesivir and nirmatrelvir-ritonavir are examples of antivirals that have been observed to be most effective when used initially in an illness (for instance, as outpatient treatment) and in instances of milder disease. When treating serious disease or critical illness, immunomodulatory treatments like dexamethasone, Janus kinase inhibitors, or interleukin-6 are most beneficial. Mass vaccination campaigns as a preventative measure are the most effective means of preventing this pandemic. In order to mitigate or lower the rates of COVID-19 infections, hospitalizations, and fatalities, several vaccine platforms, such as vaccines based on nucleic acids (DNA and mRNA vaccines), adenovirus-vectored vaccines, inactivated vaccines, and protein-based subunit vaccines, have been created and developed. This article mainly emphasizes the taxonomy and structural virology with the probable viral immuno-pathogenesis mechanism of SARS CoV-2. It also outlines the correlation between comorbidities and neurological complications, and lastly, it mentions the prophylaxis and vaccines used for treating COVID-19 patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0a70a2923de6b03b5ba5d2f9d44e636f97663886" target='_blank'>
              An All-Inclusive Overview of COVID-19 (SARS-COV-2): Emphasising Immuno-Pathogenesis, Correlation with Comorbidities, Neurological Consequences, and Therapeutic Objectives
              </a>
            </td>
          <td>
            Joy Biswas
          </td>
          <td>2025-09-30</td>
          <td>Biosciences Biotechnology Research Asia</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/99546d3cbeaa59982f196ce29fdd9757d9013e2f" target='_blank'>
              Molecular determinants of brain-resident CD8+ T cell formation and function
              </a>
            </td>
          <td>
            T. Elmzzahi, , Mehrnoush Hadaddzadeh Shakiba, Doaa Hamada, Darya Malko, M. Köhne, Aleksej Frolov, Teisha Mason, Rebekka Scholz, Yuanfang Li, C. Osei-Sarpong, Leonie Heyden, J. Schulte-Schrepping, L. Bonaguro, K. Händler, V. Boussiotis, Annett Halle, E. Domenico, Daniel Gray, M. Fuhrmann, Zeinab Abdullah, Axel Kallies, K. Man, M. Beyer
          </td>
          <td>2025-08-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>72</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disorder of the central nervous system (CNS). Age is the strongest predictor of disease phenotype, with the majority of older adults transitioning to a progressive form marked by irreversible neurological decline. This clinical progression is associated with smoldering, CNS-compartmentalized inflammation and neurodegeneration, for which there are currently no effective disease-modifying therapies. Cellular senescence, characterized by the secretion of pro-inflammatory mediators collectively known as the senescence-associated secretory phenotype (SASP), increases with age and contributes to tissue injury. In MS, neuroinflammation can further promote cellular senescence, creating a self-reinforcing cycle of damage. Senescent microglia have been identified within MS lesions, where their SASP may impair remyelination and exacerbate neurodegeneration. Senolytic agents selectively target and eliminate senescent cells by disrupting anti-apoptotic pathways. In experimental autoimmune encephalomyelitis (EAE), a widely used model of MS, senolytic treatment reduces senescent microglia burden and attenuates disease severity in an age- and drug-dependent manner. Specifically, here we show that middle-aged mice (40–44 weeks) with EAE exhibit improved clinical outcomes and survival following treatment with either dasatinib plus quercetin (D+Q) or navitoclax. Early-phase clinical trials of senolytics in age-related diseases have demonstrated functional benefits, including improved gait speed in idiopathic pulmonary fibrosis and CNS penetrance in Alzheimer’s disease. Translating senolytic therapy to MS will require careful selection of CNS-penetrant and well-tolerated agents, identification of appropriate patient populations, and deployment of responsive biomarkers. Senolytic therapy represents a promising geroscience-based strategy to meet the urgent therapeutic need in progressive MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/833c0a2c74e7a7ab280e18c8d71dabfd9c454a2a" target='_blank'>
              Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach
              </a>
            </td>
          <td>
            Jeffrey Atkinson, Amy Dokiburra, Hayley Groover, Jonathan P Godbout, Benjamin M. Segal, Yinan Zhang
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Coronavirus Disease 2019 (COVID-19) not only causes lung damage but also induces renal damage; however, there is currently no consensus on the key molecules and signaling pathways involved. Six rhesus macaques were divided into a control group and a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection group. Meanwhile, their kidneys were segmented into three regions: renal cortex (Cor), inner medulla (IM), and outer medulla (OM), and proteomics and phosphoproteomic analysis were conducted. Subsequently, we performed a comprehensive bioinformatics analysis to identify key molecules associated with COVID-19. We established proteomic and phosphoproteomic profiles of Cor, OM,and IM of kidneys infected with SARS-CoV-2. All regions exhibited varying intensities of inflammatory reactions and metabolic perturbations, implicating pathways such as the IL-17 signaling pathway and the RIG-I-like receptor signaling pathway. Immunohistochemistry confirmed the upregulation of proteins including ISG15, and S100A8/S100A9. By utilizing DrugBank, we identified 21 FDA-approved drugs targeting predicted kinases as candidates for treatment, which need to be verified in the future. This study provides a comprehensive data set and atlas of proteomics and phosphoproteomics of SARS-CoV-2 infected rhesus macaque kidneys.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62a3ddaa7f8d1adfb73e4f08ec85d831cf543797" target='_blank'>
              Proteomic and Phosphoproteomic Profiling of Kidney in Rhesus Macaques With SARS-CoV-2 Infection.
              </a>
            </td>
          <td>
            Yizhuo Tian, Yanan Zhou, Qiaochu Wang, Xiaolu Li, Tao Ding, Yue Wu, Xiaoyue Tang, Yehong Yang, Jiangfeng Liu, Shuaiyao Lu, Juntao Yang
          </td>
          <td>2025-10-01</td>
          <td>Journal of medical virology</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/142b5f26c2f76fb27e002bd4d17b50dbd3ea1a15" target='_blank'>
              Structural insights into TLR4 activation by SARS-CoV-2 spike protein: implications for inflammatory response modulation.
              </a>
            </td>
          <td>
            Priya Prakasam, Thripthi Nagesh Shenoy, Abdul Ajees Abdul Salam, Syed Ibrahim Basheer Ahamed
          </td>
          <td>2025-09-13</td>
          <td>Molecular diversity</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c0215fd7dd05a53f20fcb27cf7775365bf744d95" target='_blank'>
              Genome-wide Screening Identifies Unique Host-Directed Drugs and Pro-viral Signalling Pathways for SARS-CoV-2
              </a>
            </td>
          <td>
            J. Q. Khan, K. Rajamanickam, F. Vizeacoumar, Mahrokh Balouchi, Yue Zhang, Hussain Elhasana, Megha Rohamare, He Dong, Kathleen Glover, Tristan Anderson-Woodsworth, Kalpana K. Bhanumathy, Jocelyne Lew, Anil Kumar, Franco J. Vizeacoumar, D. Falzarano, Joyce A. Wilson
          </td>
          <td>2025-10-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="ABSTRACT Severe Influenza A virus (IAV) infections are accompanied by a cytokine storm with type I interferon (IFN) as the main driver. Besides epithelial cells, alveolar macrophages and infiltrating dendritic cells are target cells for IAV. IAV are classified into different strains, defined by their major surface glycoproteins haemagglutinin (HA) and neuraminidase (NA). So far, 19 HA subtypes and 11 NA subtypes are known. However, it is not well understood, why infection with certain IAV strains results in a cytokine storm with severe outcomes, while other IAV strains only cause mild infections. In order to address this question, we investigated six seasonal and five highly pathogenic avian IAV (HPAIV) strains using primary human ex vivo isolated plasmacytoid dendritic cells (pDC), as well as in vitro differentiated myeloid dendritic cells (mDC) and macrophages (type M1 and M2). Our data reveal that IFN-α production by mDC and macrophages but not by pDC is dependent on productive infection with the respective IAV strain. In contrast to IFN-α production in pDCs, IFN-α production by mDC as well as M1 and M2 macrophages is mainly induced by HPAIV strains, indicating that other immune cells apart from pDC might have an impact on induction of type I interferon as the main driver of the cytokine storm in the patients and the severity of the associated disease. Our findings may provide insights into the viral tropism and host response upon infection with different IAV strains and improve the understanding of the accompanied pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2ddf4599ced5e1f533f7f42b31f1f75d30c55a6e" target='_blank'>
              Influenza A virus-induced interferon-alpha production by myeloid dendritic cells and macrophages requires productive infection
              </a>
            </td>
          <td>
            Marc A. Niles, Stefanie Kronhart, Katharina E Decker, Patricia Gogesch, B. Sawatsky, Svenja Stock, Georg Kochs, Zoe Waibler, Martina Anzaghe
          </td>
          <td>2025-09-03</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Intervertebral disc (IVD) homeostasis and function depend on the immunological privilege status, while immune cell infiltration constitutes a pivotal pathological driver of intervertebral disc degeneration (IDD). Nevertheless, the immune infiltration landscape and associated molecular targets in IDD remain elusive. We therefore integrated bioinformatic analysis of public datasets and single-cell RNA-sequencing analysis (scRNA-seq) data, flow cytometric (FACS) and experimental validation to delineate immune infiltration dynamics and identify therapeutic targets. CIBERSORT deconvolution analysis revealed significant increases in follicular helper T cells (p < 0.05) and M2 macrophages (p < 0.05) in IDD, with M1 macrophages demonstrating an upward trend. WGCNA showed that the blue module was associated with M1 macrophages infiltration (positive correlation 0.87, P < 0.001), among which VAMP8, JUN and others were mainly enriched in macrophage activation and myeloid leukocyte activation. FACS quantification established postoperative day 14 as the peak of leukocyte infiltration in rat IVDs following puncture. scRNA-seq resolved seven cellular subsets within degenerated rat IVDs: annulus fibrosus cells, smooth muscle cells, fibroblasts, macrophages, monocytes, vascular endothelial cells, and nucleus pulposus (NP) cells, with pronounced expression of Jun and Vamp8. Western blotting confirmed upregulated VAMP8 and JUN expression in TNF-α-stimulated (50 ng/ml, 24 h) NP cells. Immunohistochemistry further demonstrated elevated VAMP8 and JUN levels during rat IDD progression. This work identifies post-puncture day 14 as the critical window for peak immune infiltration in rat IVDs, and reveals VAMP8 and JUN are macrophage-associated regulators of IDD pathogenesis, thereby revealing promising targets for immunomodulatory interventions against disc degeneration. Supplementary Information The online version contains supplementary material available at 10.1186/s13018-025-06250-9.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce2d542441a087ecf2f2a4662507d8231cb1eca0" target='_blank'>
              Comprehensive profiling of immune cell infiltration and biomarker identification in intervertebral disc degeneration
              </a>
            </td>
          <td>
            Yuanhao Wang, Bingtao Hu, Lijun Tian, Guowang Li, Baoshan Xu
          </td>
          <td>2025-09-24</td>
          <td>Journal of Orthopaedic Surgery and Research</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="
 The rapid evolution of SARS-CoV-2 variants, have posed significant public health challenges due to their heightened transmissibility and varying clinical outcomes. While the impact of these variants in humans has been extensively studied, their effect on domestic animals has not been explored thoroughly. Given the close contact between humans and pets, combined with documented cases of virus transmission from humans to domestic animals and the potential for these animals to act as viral reservoirs, highlights the importance of understanding the molecular dynamics of SARS-CoV-2 infection in them. Consequently, there is an increasing demand for infection models that closely mimic viral behavior in animal tissues.
 In vivo
 infection of cats or any other non-laboratory animal species is extremely resource intensive, time consuming, require ABSL3 facilities, and animal ethical clearances which are not practically possible for the majority of researchers. In this scenario the ex vivo cultures model can be an excellent alternative. Therefore, in this study, we have utilized an ex vivo lung explant culture model derived from domestic cats to examine the host’s response to Delta and Omicron variants of SARS-CoV-2 in cat lung explant culture. Comprehensive transcriptomic profiling at multiple time points post-infection revealed significant disruptions in genes associated with cell adhesion, structural components, extracellular matrix (ECM) organization and regulation, secreted and growth factors, and immune responses. Our study revealed that the Delta variant triggered early activation of genes associated with tissue damage as early as 12 hours post-infection (hpi). By 24 hpi, both the Delta and Omicron variants showed significant activation of these genes, with the Delta variant linked to the activation of a larger number of tissue damage-related genes. Notably, we identified several hub genes, including
 MMP9
 ,
 CCL5
 ,
 MCP-1/CCL2
 ,
 VWF
 ,
 HGF
 ,
 ANGPT1
 ,
 CD34
 ,
 CD68
 ,
 SPP1
 ,
 IGF1
 ,
 CSF1
 , and
 VCL
 , involved in critical signaling pathways such as focal adhesion, PI3K-Akt signaling, and TNF signaling. These hub genes hold potential as valuable biomarkers. This study provides key insights into the pathogenesis of SARS-CoV-2 in cats and highlights the utility of ex vivo lung explant cultures as a platform for studying viral infections.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/16a62fa43a3e05e7fdf94655592782dee97b8e0c" target='_blank'>
              Comparative temporal transcriptome analyses of SARS-CoV-2 delta and omicron variants ex-vivo infection in cat lung explant culture
              </a>
            </td>
          <td>
            Anuradha Panwar, A. Raut, Sandeep Bhatia, A. Pateriya, Amod Kumar, Richa Sood, Suneela Saran, Prakriti Sehgal, Arya J. Mohan, Akash Zararia, Anamika Mishra
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Natural killer (NK) cells represent a critical component of antiviral immunity, demonstrating remarkable adaptability during infections such as human cytomegalovirus (hCMV) and SARS-CoV-2. Recent advances in single-cell transcriptomics have revealed the clonally expanding NK cell populations with distinct functional profiles, blurring the traditional boundaries between innate and adaptive immunity. However, the functional heterogeneity and immunological significance of these clones remain incompletely understood. Our aim was to dissect clonal NK cell heterogeneity using published scRNA-seq datasets from hCMV-seropositive, seronegative, and COVID-19 patients, focusing on cluster-specific gene expression patterns. Our computational pipeline employed Seurat-based integration and high-resolution clustering of datasets from hCMV-seropositive (n = 5) and seronegative (n = 2) donors, along with COVID-19 patients (n = 2). We analyzed datasets using Seurat 5 in R. Quality-controlled data were normalized (SCTransform), integrated (batch-corrected), and clustered (UMAP). Differential gene expression (Wilcoxon test, log2FC 0.25, p-adj 0.05) and annotation were performed. In hCMV-seropositive individuals, we identified 12 transcriptionally distinct NK cell clusters exhibiting KLRC2 (NKG2C)-dependent organization, with specific clones showing either enhanced cytotoxic potential (marked by GZMB/GZMA upregulation), or unique inhibitory receptor profiles (variable KIR expression patterns). The hCMV-seronegative cohort displayed a simpler clonal structure with 9 clusters showing reduced KIR diversity but maintained distinct effector gene signatures. Analysis of COVID-19 patients revealed divergent clonal patterns: one patient showed reduced KLRC2 variability with prominent KLRC1 (NKG2A) expression, while another exhibited KIR heterogeneity without KLRC2 variation. Our analysis reveals distinct clonal NK cell populations in hCMV and COVID-19 contexts, characterized by divergent expression of activating and inhibitory receptors. These findings demonstrate infection-specific dynamics of clonal NK cell populations, highlighting their adaptive potential through differential receptor expression in antiviral responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c8710e10cb35d236dca302d2bde6c2f6638a39e8" target='_blank'>
              Analysis of clonal NK cell populations using single-cell transcriptomics data
              </a>
            </td>
          <td>
            M. O. Ustiuzhanina, E. Kovalenko
          </td>
          <td>2025-09-28</td>
          <td>Russian Journal of Immunology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Background: This study aimed to analyze metabolic changes in blood samples from patients with confirmed COVID-19 to explore the correlation between metabolomics and cytokines in survivors and non-survivors of SARS-CoV-2 infection. Understanding the complex biochemical and immunometabolic mechanisms underlying SARS-CoV-2 infection is essential for elucidating the pathophysiology and virulence of COVID-19. Methods: This study included 40 hospitalized COVID-19 patients and 40 healthy controls. Serum metabolic profiles were analyzed using ultra-high-pressure liquid chromatography-mass spectrometry (UHPLC-MS), and cytokine levels were measured using ELISA. Results: Our study defined three clear metabolic phenotypes among survivors and non-survivors of COVID-19 compared with healthy controls, which might be related to mortality, severity, and disease burden. A strong relationship was observed between certain inflammatory markers, including IL-1β, IL-2, IFN-β, IFN-γ, IL-17, and GM-CSF, as well as several metabolites, particularly in COVID-19 non-survivors, such as LysoPCs, 3-hydroxykynurenine, and serotonin. Different metabolite-cytokine correlation patterns were observed according to patient outcomes, indicating unique correlations between metabolic and immune responses in survivors and non-survivors. Metabolic phenotypes were associated with clinical outcomes, comorbidities, and sex-related differences. Kynurenine and related metabolites of tryptophan metabolism were closely correlated with COVID-19 severity, age, and mortality. Compared with survivors and healthy controls, non-survivors displayed higher IL-6, together with distinct metabolic changes. These included increased kynurenine through the IDO1 pathway, elevated glucose and lactate reflecting hyperglycolysis and energy stress, and higher xanthosine from purine turnover. Stronger cytokine–metabolite correlations in this group point to tightly linked immunometabolic activation. Conclusions: Metabolomic profiling revealed distinct metabolic phenotypes that could be associated with the severity and inflammation levels of COVID-19. Correlation analysis between metabolites and cytokines demonstrated strong intercorrelations between specific metabolites and cytokines, indicating a strong interrelationship between inflammatory markers and metabolic alterations. Specific metabolic pathways associated with cytokines and their clinical relevance may serve as potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3568c4a19b85a8cabd15908c6469f35fc6eae4bc" target='_blank'>
              Metabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis
              </a>
            </td>
          <td>
            M. Banoei, Abdorazagh Hashemi Shahraki, Kayo Santos, Gregory Holt, Mehdi Mirsaeidi
          </td>
          <td>2025-09-01</td>
          <td>Metabolites</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="In response to an infection, the host T cell compartment develops immunological memory to ensure rapid responses upon re-infection with the same pathogen. However, these memory responses can also modulate immune reactions to unrelated pathogens through bystander activation. Herein, T cells are activated in an antigen-independent manner, often triggered by innate cytokines or Toll-like receptor ligands. To uncover new strategies for modulating immune responses, it is essential to deepen our understanding of this alternative mechanism of T cell activation, particularly in humans. Therefore, we studied the response of human CD8+ T cells to innate bystander stimuli in vitro. Thereby, we measured the induction of activation markers and proliferation using flow cytometry, and depleted or blocked several potential modulatory components to identify mediators of bystander CD8+ T-cell responses. Our study demonstrates that CD8+ T cells can be activated as bystander cells in response to innate stimuli present during a viral infection, including IL-15, IFN-α, and TLR7/8 and 9 agonists (R848 and CpG). Depletion experiments demonstrated that these bystander responses are dependent on monocytes and CD4+ T cells. In addition, we revealed that the bystander responses to the innate stimuli are highly reliant on IL-2 signaling. Altogether, our study underscores the pivotal role of IL-2 in mediating bystander responses of CD8+ T cells to innate stimuli, revealing a novel mechanism of immune response modulation during viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fc56083194a00b756c976473122860d219d86c29" target='_blank'>
              IL-2 mediates human bystander CD8+ T-cell responses to innate immune signals.
              </a>
            </td>
          <td>
            Tamara Johanna Cornelia Schenk, Martijn Vos, Yannick van Sleen, Jeroen Hoeboer, Debbie van Baarle, T. Guichelaar
          </td>
          <td>2025-09-22</td>
          <td>Journal of immunology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Background Pulmonary infections, ranging from mild respiratory issues to severe multiorgan failure, pose a major global health threat. The immune response in community-acquired pneumonia (CAP) and COVID-19 influences disease severity and outcomes, but molecular pathogenesis differs across pathogens. Comparisons of plasma cytokine profiles between CAP and COVID-19 are limited. Analyzing these profiles with machine learning and bioinformatics could reveal subtle patterns and improve our understanding of immune responses in both conditions. Methods We conducted a novel case–control study to profile cytokine levels in patients with CAP and COVID-19. Age- and sex-matched cohorts included 39 patients with CAP, 39 with COVID-19, and 20 healthy controls. We measured 384 plasma cytokine levels using proximity extension assays and analyzed differences between cohorts with conventional statistical methods, bioinformatics and machine learning. Results Median ages of the cohorts were comparable (P = 0.797). COVID-19 patients exhibited a higher prevalence of hematologic disease (P = 0.047), increased corticosteroid use (P = 0.040), and reduced antibiotic use (P = 0.012). Clinical outcomes, including mortality, ICU admission, invasive mechanical ventilation, renal replacement therapy, acute respiratory distress syndrome, and acute kidney injury, were similar between groups. Both cohorts showed comparable absolute circulating cytokine profiles but distinct profiles relative to healthy controls. Machine learning identified a model of twelve cytokines that distinguished CAP from COVID-19 with a classification accuracy of 0.71 (SD 0.20). Gene ontology and enrichment analysis revealed differences in cytosolic and nuclear functions, intracellular signaling, stress responses, and cell cycle processes between patient cohorts and healthy controls. Enriched GO pathways showed that CAP pathways were positively associated with leukocyte counts and ARDS development, while COVID-19 pathways were negatively associated with ARDS and positively with platelet counts. Conclusions This case–control study provides insights into cytokine profiles related to CAP and COVID-19 pathogenesis. Although absolute circulating cytokine levels showed no significant differences between the groups, machine learning identified a model of twelve proteins that effectively distinguished the cohorts. Gene ontology and enrichment analyses also revealed distinct dysregulated pathways with differing associations with clinical variables in each cohort. These findings underscore the complexity and variability of cytokine responses in pulmonary infections. Supplementary Information The online version contains supplementary material available at 10.1186/s12931-025-03331-5.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d1138a6aadbdfa32425793c70f16ddbd610d3a29" target='_blank'>
              Divergent biological pathways distinguish community-acquired pneumonia from COVID-19 despite similar plasma cytokine profiles
              </a>
            </td>
          <td>
            D. Fraser, L. V. Van Nynatten, David Tweddell, Mark Daley, J. Russell, , K. Tran, P. Asfar, M. Cheng, J. Demiselle, J. Singer, Terry Lee, D. Sweet, J. Boyd, K. Walley, G. Haljan, Guillaume Géri, J. Auchabie, J. Quenot, Todd C. Lee, J. Tsang, F. Meziani, F. Lamontagne, V. Dubée, S. Lasocki, D. Ovakim, G. Wood, A. Turgeon, Y. Cohen, E. Lebas, M. Goudelin, D. Forrest, A. Teale, J. Mira, R. Fowler, Nick Daneman, Neil K. J. Adhikari, M. Gousseff, P. Leroy, G. Plantefeve, Patrick Rispal, Roxanne Courtois, B. Winston, S. Reynolds, Peter Birks, Boris Bienvenue, J. Tadié, J. Talarmin, S. Ansart, Anusha Karna, Julia Kong
          </td>
          <td>2025-08-31</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to far-reaching consequences. The changes caused in COVID-19 patients may persist for more than 6-12 months after acute phase of the disease promoting post-COVID disorders of immune system. Patients who have had acute COVID-19 in both mild and severe forms suffer from various manifestations of post-COVID syndrome. However, the severity of these manifestations is quite variable. The aim of the study was to assess the effect of lung damage extent in acute period of COVID-19 on the severity of clinical manifestations in post-COVID syndrome as exemplified by immune-mediated syndromes, i.e., autoimmune disorders, proliferative conditions, and allergopathology. 131 patients who had who had a history of SARS-CoV-2 infection were examined. Anamnestic data from outpatient cards of patients were used for the study. Using the ELISA diagnostics method, IgA, IgM, IgG specific to SARS-CoV-2, complement components C1q, C3a, C5a were determined. The studies revealed a connection between the severity of post-COVID syndrome and the severity of the acute COVID-19 course. The SARS-CoV-2 virus is able of activating complement, and this activation persists for a long time (more than six months). This finding explains presence of clinical manifestations of post-COVID syndrome in individuals who have had a mild acute form of COVID-19 without CT-detected lung damage without phenotypes of immune system damage that we have previously identified (congenital – decreased expression of CD46 on T lymphocytes and decreased expression of CD46 on NK cells, and acquired – decreased level of T-cytotoxic lymphocytes and impaired level of B-cells CD45+CD3-CD19+CD5+CD27+). The data obtained indicate that the examination of post-COVID patients should be carried out not only by their clinical characteristics, but also by assessing markers of their immune system in order to make a correct diagnosis and prescribe etiological and pathogenetic therapy, including immune therapy. Conclusions: 1. Autoimmune, proliferative and allergic diseases are directly related to disorders of the immune system. The severity of autoimmune disorders in the post-COVID period is more associated with basic corticosteroid therapy (GCS) both for the treatment of autoimmune processes and for the treatment of COVID-19 (except of treating autoimmune thyroiditis). GCS treatment used in acute period of infection reduced the number of recurrenct disorders. The situation is the opposite in rheumatoid arthritis: the use of GCS in the acute period of infection in patients already on basic corticosteroid therapy subsequently leads to an increase in the number of relapses in post-COVID patients. 2. In post-COVID patients, we revealed a trend towards an increase in the most clinically severe allergopathology: firstly, in all groups (52%) in the post-COVID period, exacerbations of such pathologies as Quincke’s edema, urticaria, anaphylaxis, vasculitis, alveolitis, and bronchiolitis became more frequent. These findings suggest that the worse condition of these patients in the post-COVID period was influenced by the past SARS-CoV-2 infection Allergic skin lesions were in second place in terms of the frequency of exacerbations (about 28%). 3. There is a tendency towards an increased frequency of proliferative diseases exacerbations in patients with more severe forms of acute COVID-19 infection. It should also be noted that the percentage of such patients is quite high, from 31.6% to 48%. 4. The SARS-CoV-2 virus may affect the complement activation system, thus explaining clinical manifestations of post-COVID syndrome in the persons who had a mild form of COVID-19 without evidence of lung damage immune system affection. Our data indicate that the examination of post-COVID patients should be carried out not only by assessing their clinical characteristics, but also by examining the state of the immune system in such patients in order to make a correct diagnosis and administer etiological and pathogenetic therapy, including immune therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8d41f15334750c21373a3dd9aef03c20fbc05b95" target='_blank'>
              Immune-mediated disorders in post-COVID patients and their relationship with impaired complement system activity
              </a>
            </td>
          <td>
            Mariya A. Dobrynina
          </td>
          <td>2025-09-18</td>
          <td>Russian Journal of Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Introduction Toll-like receptors 7 and 8(TLR7/8) recognize purine-rich single-stranded RNA from pathogens, triggering immune responses. Although TLR7/8 agonists are emerging as potential novel adjuvants, their impact on the adaptive B cell response, particularly antibody repertoire, remains unclear. Methods Six Indian rhesus macaques(IRMs) and six African green monkeys(AGMs) were stimulated with a TLR7/8 agonist. Peripheral blood samples were collected pre-stimulation and multiple timepoints within one week post-stimulation for flow cytometry and antibody repertoire sequencing. Results B cell activation was observed at 24 hours. Significant increases in antibody repertoire diversity were detected at 48 and 72 hours in both species; however, diversity remained elevated at one week in IRMs but returned to baseline in AGMs. Analysis of antibody lineage distributions revealed a marked increase in increased lineages at 48 and 72 hours, characterized by higher frequency, a greater number of antibody clonotypes, and increased mutation rates. The identified expanded lineages, induced by the TLR7/8 agonist, exhibited λ chain bias and divergent antibodies across individuals, and primarily originated from highly mutated antibodies, likely corresponding to memory/effector-like B cells. Conclusions Our findings demonstrate that the TLR7/8 agonist rapidly induces a divergent expansion of B cells, establishing an immune foundation supporting vaccine responses and offering new insights into the dynamic B cell modulation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5daef9f40e9473cb595d9f22ac1da398eeaebc35" target='_blank'>
              Toll-like receptor 7/8 agonist stimulation rapidly skews the antibody repertoire of B cells in non-human primates
              </a>
            </td>
          <td>
            Shi-Yin Wang, Michael Citron, Lihua Luo, I-Ming Wang, Xiao Liu, Wei Zhang
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Chronic neuroinflammation and neurodegeneration are critical but unresolved drivers of disability accumulation in progressive multiple sclerosis (MS). Chronic active white matter lesions, identifiable radiologically as paramagnetic rim lesions (PRL), indicate progression-relevant chronic neuroinflammation. Using single-cell transcriptomics (scRNAseq) and T-cell receptor sequencing (scTCR-seq), we profiled cerebrospinal fluid (CSF) and blood immune cells of 34 radiologically characterized adults with MS (17 untreated, 6 treated with B-cell-depletion) and 5 healthy controls. Coupled with proteomics, we found PRL-associated enrichment of interferon (IFN) signaling and upregulation of TCR signaling in CSF and blood. This was accompanied by clonal expansion of CD8+ T effector memory (TEM) cells, with the highly expanded clonal cells exhibiting T helper type 1 (TH1)-like and cytotoxic profiles. Validating the cytotoxic immune profile in blood using flow cytometry, we identified a cellular correlate of PRL exhibiting features of CD8+ TEMRA cells. Despite chronic B-cell depletion, PRL-associated neuroinflammation, driven by myeloid activation and CD8+ T-cell cytotoxicity, persisted. Serum and CSF proteomic networks showed PRL-pertinent signatures, including networks unaffected by B-cell depletion. CSF:serum protein ratios revealed compartmentalized myeloid activation in cases with PRL. Using in silico perturbation, we nominated therapeutic targets, including MYD88, TNF, MYC, TYK2, JAK2, and BTK, for alleviating chronic neuroinflammation in MS. Our findings highlight mechanisms of chronic neuroinflammation in MS and point to potential biomarkers for monitoring disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1fa3caa3cc29a10980dc0ec5a031cd39c41d34cf" target='_blank'>
              Maintenance of chronic neuroinflammation in multiple sclerosis via interferon signaling and CD8 T-cell-mediated cytotoxicity
              </a>
            </td>
          <td>
            D. Reich, Syed Ali Raza, Yoshimi Enose-Akahata, Anna S Blazier, Lauren M. Guerra, E. Beck, M. Gaitán, Nyater Ngouth, Jefte M. Drijvers, E. Dammer, Devan Moodley, Kory Johnson, Martina Absinta, V. Ramaglia, J. Gommerman, Timothy J. Turner, Richard M. Ransohoff, Steven Jacobson, D. Ofengeim, Ellen Cahir-McFarland
          </td>
          <td>2025-09-25</td>
          <td>Research Square</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="Neuroinflammation and neurovascular dysfunction are two major pathologies in Alzheimer’s disease (AD), yet their interplay remains poorly understood. Astrocytes are central players in both brain immunity and neurovascular coupling. In this study, we induced neuroinflammation through systemic administration of lipopolysaccharide (LPS) in 12-month-old APP/PS1dE9 mice and simultaneously monitored the astrocyte Ca2+ signaling and the brain hemodynamics with two-photon microscopy. We showed that the spontaneous release of Ca2+ in astrocytes was elevated in AD mice and decreased by 14 days of LPS administration. The effects of LPS-induced inflammation on astrocytic Ca2+ signaling varied substantially between brief 3 sensory stimulation and sustained 30 second sensory stimulation with modest effects on vascular responses. These findings highlight the nuanced impact of neuroinflammation on astrocytic Ca2+ dynamics and brain hemodynamics in AD, shedding light on mechanisms that link these pathologies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d49fd26d8a2f6de84986c028cf6eb88e8573551" target='_blank'>
              Prolonged systemic inflammation worsens impairments to astrocyte Ca2+ and functional hyperemia in Alzheimer’s disease
              </a>
            </td>
          <td>
            Chang Liu, K. Sakha, Jaime Anton, Alfredo Cárdenas-Rivera, Mohammad A. Yaseen
          </td>
          <td>2025-09-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Pyroptosis is a mode of inflammatory cell death, characterized by cell membrane rupture and the release of pro-inflammatory cytokines and damage-associated molecular patterns (DAMPs). Pyroptosis is a critical part of the innate immune response and acts as a defense mechanism against different types of pathogens, including viruses. Several respiratory viruses, including influenza virus, respiratory syncytial virus (RSV), human metapneumovirus, and SARS-CoV-2, have been shown to trigger pyroptosis through distinct mechanisms. While pyroptosis is beneficial to the host by controlling virus replication and eliminating infected cells, the exaggerated induction of pyroptosis can be harmful and cause significant tissue damage, such as that to the lung tissue during infection with respiratory viruses. Therefore, understanding the mechanisms and the role pyroptosis plays during respiratory virus infections could lead to the development of novel therapeutic approaches to reduce the morbidity caused by these infections. In this review, we discuss the recent knowledge obtained on the pathophysiological role of pyroptosis during different respiratory viral infections as well as some experimental approaches to regulating its detrimental effects to the host.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cefe2eccc974211f9771f04bc4c3513a27ae2c60" target='_blank'>
              Pyroptosis in Respiratory Virus Infections: A Narrative Review of Mechanisms, Pathophysiology, and Potential Therapeutic Interventions
              </a>
            </td>
          <td>
            Runqi Lin, Barbara N. Porto
          </td>
          <td>2025-09-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Background Patients with hemato-oncological malignancies may respond insufficiently to vaccination, especially in terms of antibody titer. The antibody response depends on the type of malignancy as well as the type and timing of treatment. We intended to evaluate this using real-world data from patients of our regional hospital. This study also considers the role of immune status, including T-cell activation markers, in predicting vaccination success. Methods Seventeen patients of our hospital having a hematological malignancy were included in this study, including myeloma, lymphoma, as well as acute myeloid leukemia (AML) and chronic lymphoid leukemia (CLL). All patients were vaccinated against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) using Tozinameran following current recommendations. Circulating antibodies directed against the spike protein of SARS-CoV-2 were determined by a commercial immune assay. Immune status was determined from peripheral blood by flow cytometry. Both parameters were followed in fifteen patients who provided sufficient follow-up data for up to one year. Patients were categorized as responders or non-responders, and differences in diagnosis, treatment, and immune status were analyzed. Results Antibody response depended on both diagnosis and treatment. Active treatment directed against B-cells, such as anti-Cluster of Differentiation 20 (CD20) therapy, was associated with weak seroconversion. For CD38-as well as proteasome-directed therapies, the data suggest that responders as well as non-responders exist. Notably, low peripheral B-cell numbers and high CD3+HLADR+cell counts correlated with weak seroconversion upon vaccination. Conclusions We suggest that peripheral immune status can be applied as a predictive biomarker for seroconversion upon vaccinations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e7f74a654c2ac969b229d3154861b1bbafc62507" target='_blank'>
              SARS-CoV-2 Vaccine-Induced Seroconversion and Immune Correlates in Patients with Hematological Malignancies. A Real World Study
              </a>
            </td>
          <td>
            Norbert Nass, Mohamad-Kamal Yaakoub, Alexandra-Victorita Simion, Hartmut Kroll, Sabine Westphal, Judith Pannier, Gerhard Behre
          </td>
          <td>2025-09-26</td>
          <td>Oncology Research</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="COVID-19 has caused more than 7 million deaths worldwide, and according to the World Health Organization, it continues to result in more than 1000 reported deaths per month at the time of this writing. It is crucial to understand the immune response to COVID-19 since the virus continues to persist. Natural killer (NK) cells play a critical role in the immune defense against viral infections, including COVID-19. While it is well documented that infected patients have a reduction in lymphocytes and NK cells, gaps in knowledge exist regarding the function of NK cells. To study the function of NK cells in patients hospitalized with COVID-19, peripheral blood was obtained from patients admitted to the medical (non-ICU) wards at a large tertiary hospital. We demonstrated a decrease in the mature cytotoxic subset of NK cells within the peripheral blood of patients hospitalized with COVID-19. We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. We examined the mechanisms leading to NK cell killing. We found reductions in the intracellular levels of effector molecules, the degranulation of cytotoxic granules, and the extracellular concentrations of released effector molecules. We identified dysfunctional intracellular granule trafficking required to position the granules for degranulation, which would be consistent with the reduced release of effector molecules. We found clusters of inhibitory receptors were upregulated in subsets of NK cells, in keeping with inhibition of cytotoxicity. Additionally, males with COVID-19 showed NK cell defects compared to healthy males, while no significant differences were observed in females. Our findings highlight defects in cytolytic effector molecules, granule trafficking and release, and increased expression of inhibitory receptors on NK cells in patients hospitalized with COVID-19, in addition to a sex difference in cytolytic function, which contributes to defective NK cell function in COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/01cdfabb81491ce2cba0ee7f56a0d8dd7e9e7d8a" target='_blank'>
              The effect of COVID-19 and sex differences on natural killer cell cytotoxicity
              </a>
            </td>
          <td>
            Arushi Dagar, Maria J Polyak, Adley C. H. Mok, David D Feehan, Michael Potemkin, Alain Tremblay, Christopher H. Mody
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Toll-like receptor 7 (TLR7) is crucial for recognizing single-stranded viral RNA and initiating type I interferon signalling, which initiates antiviral immune responses. DNA methylation and other epigenetic controls may affect TLR7 expression and play a role in immune dysregulation in post-COVID syndrome. Objectives: To assess the association between immune dysregulation in people with post-COVID syndrome and epigenetic regulation of the TLR7 gene, specifically DNA methylation patterns. Methods: Patients with post-COVID-19 symptoms (≥12 weeks’ post-infection) and age- and sex-matched recovered controls participated in a case-control study. The purpose of peripheral blood mononuclear cells (PBMCs) was to use bisulfite pyrosequencing to analyze the DNA methylation of TLR7 promoter CpG sites, to use qRT-PCR to quantify TLR7 mRNA, and to use flow cytometry to immunophenotype immune cell subsets and type I interferon (IFN-α) production. Analysis was done on statistical relationships among immune parameters, gene expression, and methylation status. Results: In comparison to controls, post-COVID patients showed notable changes in TLR7 promoter methylation patterns, with site-specific hypo- and hyper-methylation associated with corresponding changes in TLR7 expression. Anomalies in B-cell and plasmacytoid dendritic cell (pDC) profiles and dysregulated IFN-α levels were linked to aberrant expression, suggesting persistent innate immune activation. Conclusions: TLR7 epigenetic changes could be a factor in post-COVID-19 persistent immunological dysregulation. These results emphasize TLR7 methylation as a possible therapeutic target and biomarker. To confirm these correlations, more long-term research is needed.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9614460bd9b458a97ea3bceb49565b7aab8a8dcb" target='_blank'>
              Epigenetic Regulation of the TLR7 Gene and Its Correlation with Immune Dysregulation in Post-COVID Syndrome
              </a>
            </td>
          <td>
            Beenish Khalid, Saeeda Baig, Aliya Jafri, G. Farrukh, Sobia Khan Nabeel, Hina Faisal
          </td>
          <td>2025-09-30</td>
          <td>Pakistan Journal of Health Sciences</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Multiple sclerosis is a chronic, immune-mediated neurodegenerative disorder of the central nervous system, characterized by widespread demyelination, axonal injury, and progressive neurological impairment. The pathophysiology of multiple sclerosis involves complex interactions between immune cells and central nervous system resident cells, with oligodendrocytes (the myelin-producing glial cells) occupying a central role in both the disease’s onset and progression. Oligodendrocyte dysfunction, including diminished regenerative capacity, heightened vulnerability to inflammatory cytokines, and increased susceptibility to oxidative stress, contributes significantly to the failure of remyelination observed in chronic multiple sclerosis lesions. Key factors such as microglial activation, T-cell-mediated cytotoxicity, and altered signaling pathways affecting oligodendrocyte progenitor cell maturation are explored in depth. Some therapeutic strategies under investigation encompass the use of pharmacological agents, cell-based interventions, and modulation of both the extracellular matrix and the immune microenvironment. Advancing our understanding of oligodendrocyte biology, along with the intrinsic and extrinsic factors that impede effective remyelination, is critical for the development of innovative, targeted therapies aimed at attenuating neurodegeneration and enhancing long-term clinical outcomes in patients with multiple sclerosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/66c75d730dc275c08705db773316b8c79af4a534" target='_blank'>
              White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
              </a>
            </td>
          <td>
            Mario García-Domínguez
          </td>
          <td>2025-09-01</td>
          <td>Cells</td>
          <td>1</td>
          <td>4</td>
        </tr>

        <tr id="Background Extensive research has demonstrated the detrimental effects of COVID-19 on maternal-fetal outcomes. However, few studies have examined the impact of SARS-CoV-2 infection before and during organogenesis on human embryo implantation and subsequent development. Additionally, the influence of SARS-CoV-2 on the endometrial microenvironment, which is critical for embryo implantation, remains poorly understood. This study seeks to address these gaps in knowledge. Methods and findings We prospectively enrolled 971 participants undergoing frozen-thawed embryo transfer (FET) during the final two months of 2022, coinciding with the nationwide COVID19 outbreak following the end of China’s Zero-Covid policy. Patients undergoing FET during this period were at high risk of SARS-CoV-2 infection before and during organogenesis. Based on self-reported symptoms and nucleic acid testing, 520 individuals were confirmed to have SARS-CoV-2 infection, while 451 were uninfected. Consistent with existing literature, our study reinforced that SARS-CoV-2 infection negatively impacted pregnancy outcomes, as evidenced by reduced clinical pregnancy (52.69% vs. 76.50%, RR = 60.506, [95%CI, 0.259 ~ 0.452]) and live birth rates (46.54% vs. 60.09%, RR = 17.865, [95%CI, 0.448 ~ 0.746]), alongside an increase in obstetric complications (35.89% vs. 27.37%, RR = 4.380, [95%CI, 1.055 ~ 2.223]). Seven fetal congenital heart defects (CHDs) were observed in the infected group versus one in uninfected population. Bioinformatic analysis of endometrial mRNA profiles showed SARS-CoV-2 infection significantly downregulated key endometrial receptivity molecules, increased natural killer cell and mast cell infiltration, and disrupted the balance of cytokine and chemokine. Moreover, our findings demonstrated that SARS-CoV-2 infection downregulated the transcriptional activity of endometrial SLC6A, a serotonin transporter, and ErbB-2, a mediator of serotonin-regulated differentiation in cardiac development. This disruption in serotonin signaling may underlie the pathogenesis of congenital heart disease. Conclusions SARS-CoV-2 infection before and during organogenesis negatively impacts embryo implantation and development, primarily through mechanisms involving compromised endometrial receptivity and disruption of the local immune microenvironment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/22aebb582a12b91ab3622e67dd4c3284becdc0c4" target='_blank'>
              Influence of SARS-CoV-2 infection before and during organogenesis on embryo implantation and development outcomes: A prospective cohort observational study
              </a>
            </td>
          <td>
            Yanping Li, Xuan Lu, Jing Fu, Fan Yang, Z. Mao, Hongqing Liao, Juan Zhang, Xianghong Huang, Qiong Zhang
          </td>
          <td>2025-09-11</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="We and others have reported evidence of T cell exhaustion in children with perinatal HIV with increased expression of inhibitory receptors PD-1, CD160, and TIM-3, but there is limited data on the virologic functional consequences of this immune exhaustion. We address this by using an immune database from Kenyan children with perinatal HIV and unexposed controls. We computationally integrate T cell profiles of differentiation, activation and exhaustion in an agent-based model (ABM) to predict how T cell exhaustion impacts viral control following HIV exposure in vitro. Our ABM includes macrophages, CD4 and CD8 T cells, cytokines, and HIV. Model mechanisms include viral dynamics, macrophage activation, T cell activation and proliferation, cytotoxic T cell killing, and cytokine/HIV diffusion and degradation. Participants are grouped by HIV plasma viremia and by age, less than 5 years or 5-18 years. Our findings indicate that cells from virally active participants, who have the highest levels of exhaustion, have lower predicted viral concentrations and infected cells compared to other participant groups during new infection. However, this coincides with higher cell death, suggesting that short-term viral control is associated with excessive inflammation, which could be detrimental long-term. Cells from virally suppressed participants older than 5 years can maintain lower viral concentrations while limiting cell death, reflecting a more sustainable short-term immune response. In virally suppressed children younger than 5 years, immune response patterns strongly resemble the age-matched healthy control group, suggesting early viral suppression may preserve antiviral immune responses. Our model predicts unique patterns of cell death for each participant group, with CD8 T cell death being dominant in virally active groups and CD4 T cell and macrophage death being dominant in healthy and virally suppressed groups. Finally, exhausted CD8 T cells are predicted to contribute significantly to CD8 T cell killing, proliferation, and activation in the virally active group, indicating partially functional CD8 T cells can still contribute to short-term viral control. Our analysis functionally integrates participant-specific immunophenotypic data to allow quantification of the extent, mechanisms, and impact of immune dysfunction in perinatal HIV and could inform pediatric HIV remission and cure strategies. Author Summary Cytotoxic CD8+ T cells are vital for our ability to kill infected cells. However, chronic stimulation of CD8+ T cells can result in T cell exhaustion, leading to cellular dysfunction and reduced ability to fight infections. Here we ask: What impact does CD8+ T cell exhaustion have on the ability to control HIV replication over the short term? We answer this using a computational model, anchored in experimental data from children with perinatal HIV. We use participant-specific data on dozens of immune markers that characterize the state of their immune system. We carefully map these markers to known immune cell functions and use our model to predict how immune cells with these participant-specific markers would respond to HIV infection. Our results suggest that earlier viral suppression can lead to better immune function in children with perinatal HIV. Our findings also suggest that exhausted CD8+ T cells could still contribute to fighting HIV infection, but only if there are enough of them to compensate for their reduced functionality. Our work uses computational models to put valuable participant-specific data into context, allowing us to predict short-term infection outcomes and better understand immune function in children with perinatal HIV.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/feef85b43caeefacd242e0fed705966cf8ef6533" target='_blank'>
              Partially-functional exhausted CD8+ T cells can contribute to short-term viral suppression: a computational prediction for children with perinatal HIV
              </a>
            </td>
          <td>
            Alexis Hoerter, Alexa Petrucciani, Fatma Marshed, Mussa Mwamzuka, Aabid Ahmed, Alka Khaitan, Elsje Pienaar
          </td>
          <td>2025-09-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Background: Influenza A virus (IAV) is a major human pathogen, contributing to substantial morbidity and mortality during seasonal outbreaks and pandemics. Human infection with IAV can lead to pneumonia and acute respiratory distress syndrome (ARDS), and numerous clinical and basic research studies have established an association between IAV and pulmonary fibrosis (PF). However, the treatment of IAV-induced PF fibrosis has not been studied and discussed. Methods: An IAV-induced PF mouse model was established. Herbacetin (HBT) was identified as the most effective compound in the in vitro study of seven components of Rhodiola rosea L. (R. rosea L.). The effect of HBT on IAV-induced lung injury and PF was evaluated in vivo and in vitro. The binding between HBT and neuraminidase (NA) protein was investigated by biological layer interferometry (BLI) and cell thermal shift assay (CETSA). Results: Following IAV infection, the TGF-β/Smad3 pathway is activated, leading to the upregulation of fibrosis-related proteins that promote fibrosis. HBT exhibited a significant ability to reduce influenza virus-induced lung injury and fibrosis both in vitro and in vivo. Mechanistically, HBT binds to the NA protein of the influenza virus, reducing viral infection and the activation of the TGF-β/Smad3 pathway, thereby mitigating the formation of lung injury and PF. Conclusions: HBT represents a promising therapeutic agent for modulating influenza virus-induced lung injury and PF, marking a significant step toward the development of effective treatments for influenza-induced PF.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2e9433f1039214a5d3d917de979a5066d74d4f46" target='_blank'>
              Herbacetin Alleviates Influenza Virus-Induced Lung Injury and Fibrosis by Targeting the Neuraminidase Protein
              </a>
            </td>
          <td>
            Feng Liao, Sha Li, Liumei Wu, Jiafan Chen, Ziqing Luo, Ming Zhong, Qiuhong Li, Wenbiao Wang, Geng Li
          </td>
          <td>2025-08-30</td>
          <td>Pharmaceuticals</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4da5b4b9505c812408a6d3c66eab78fd4c953bb1" target='_blank'>
              The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration
              </a>
            </td>
          <td>
            Duncan J. Hart, , R. Dodd, S. Brovero, Claire Fleming, G. B. Moreau, Nick R. Natale, Barbara J. Mann, T. Sutherland, , Anthony J. Day, W. A. Petri
          </td>
          <td>2025-10-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Empirical data from survivors of Lassa fever and experimental disease modelling efforts, particularly those using mouse models, are at odds with respect to T cell-mediated pathogenesis. In mice, T cells have been shown to be imperative in disease progression and lethality, whereas in humans, an early and robust T cell responses has been associated with survival. Here, we assessed the role of CD4+ and CD8+ T cells on disease progression and severity of Lassa virus infection in a non-human primate model. Using an antibody-mediated T cell depletion strategy prior to and post-inoculation, we were able to examine Lassa virus infection in the absence of specific T cell responses. In animals depleted for either CD4+ or CD8+ T cells, Lassa virus infection remained uniformly lethal, with only a slight delay in disease progression observed in the CD4-depleted group when compared to non-depleted controls. Milder pulmonary pathology was noticed in the absence of CD4+ or CD8+ T cells. Overall, our findings suggest that T cells have a limited impact on the development of Lassa fever in non-human primates.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd5239ecbf6e602e94f9d819f5db6cb827db29fd" target='_blank'>
              CD4+ and CD8+ T-cells are not the main driver of Lassa fever pathogenesis in macaques.
              </a>
            </td>
          <td>
            Jérémie Prévost, Nikesh Tailor, G. Soule, J. Audet, Yvon Deschambault, Robert Vendramelli, Jessica Prado-Smith, Kevin Tierney, Kim Azaransky, D. Kobasa, Chad S Clancy, H. Feldmann, K. Rosenke, David Safronetz
          </td>
          <td>2025-09-25</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="People living with HIV-1 (PWH) and chronically using opioids have elevated risks of developing HIV-associated neurological disorders (HAND) that are often correlated with persistent inflammation. Microglia, innate immune cells in the brain, are the principal HIV-1 reservoir in the central nervous system and regulate neuroinflammation. Our group previously showed that HIV-1 infection of induced pluripotent stem cell (iPSC)-derived microglia and viral intron-containing RNA (icRNA) expression triggers inflammatory responses. Microglia express μ opioid receptor, MOR, yet the immunomodulatory effects of opioids on HIV-1 infection in microglia are unclear. Here, we report that MOR activation impacts HIV-1 infection establishment and HIV-1-induced innate responses in microglia. Morphine pretreatment enhanced reverse transcription (RT), integration, viral transcription, and p24Gag secretion in HIV-1-infected iPSC-derived microglia, which was blocked by treatment with naloxone, a MOR antagonist. In contrast, morphine treatment did not impact HIV-1 infection in MOR-deficient monocyte-derived macrophages, although, induced exogenous expression of MOR in macrophages conferred morphine-mediated enhancement of HIV-1 infection. Interestingly, viral transcriptome analysis by digital-drop PCR revealed selective enhancement of HIV-1 icRNA expression in morphine-exposed iPSC-derived microglia, which correlated with enhanced HIV-1 icRNA-induced secretion of IP-10 in MOR+ cells. Further, PI3K inhibitor, wortmannin, blocked morphine-mediated enhancement of HIV-1 replication and HIV-1 icRNA-induced IP-10 secretion, suggesting that MOR signaling and HIV-1 icRNA expression synergistically activate the PI3K-Akt signaling pathway in microglia to exacerbate virus-induced inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33120b856a2b6c63c61e9bfd1c234edbc64bb007" target='_blank'>
              Mu opioid receptor activation in microglia enhances HIV-1 infection and HIV-infection-induced inflammatory responses
              </a>
            </td>
          <td>
            Chelsey A. Skeete, Gabriel M. Sgambettera, Aldana D. Gojanovich, Xianbao He, Daniel Bryant, Mengwei Yang, Shreya Banerjee, Andrés A. Quiñones-Molina, H. Akiyama, Gustavo Mostoslavsky, Andrew J. Henderson, S. Gummuluru
          </td>
          <td>2025-10-06</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Meningitis caused by Streptococcus suis serotype 2 (SS2) in humans and pigs is an acute nervous disorder associated with serious sequelae. Bacterial meningitis is tightly associated with immune cell responses and the local immune microenvironment. However, the dynamic changes of the immune system during the disease progression in the brain remains unclear. Here, single-cell mass cytometry analyses are used to comprehensively profile the composition and phenotypes of female mouse brain immune cells at different stages of SS2 meningitis. Ten major immune cell lineages are identified among which T cells and dendritic cells significantly increased during meningitis, with B cells increasing in the late stage. Specifically, SS2+PD-L1+ neutrophils with strong phagocytosis, bactericidal and apoptotic effects accumulate in the acute phase of SS2 infection. Microglia sequentially display the features of homeostasis, proliferation, and activation (enhanced MHCII and TLR2 signals and TNF-α secretion) during the process of meningitis. Both border-associated and monocyte-derived macrophages contribute to the process of SS2-induced meningitis, exhibiting upregulation of CD38 and MHCII. Interestingly, CD11c+CD8+T cells are the main contributor of IFN-γ and specifically appeared during SS2 infection. In addition, the appearance of other lymphocytes such as CCR6+/lo B cells, CX3CR1+ NK and MHCII+ ILC3 are related to the progression of meningitis. Moreover, correlation analysis between the composition of immune cell clusters and the SS2 infection process yield a dynamic immune landscape in which key immune clusters, including some previously unidentified, mark different stages of infection. Together, these data reveal the unique infection-stage immune microenvironment during the progression of meningitis caused by SS2 and provide resources for the analysis of immunological pathogenesis, potential diagnostic markers and therapeutic targets for bacterial meningitis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c148317aa40b91f4939d3fc0df3bf8ec9ad3159" target='_blank'>
              A single-cell atlas of mouse central nervous system immune cells reveals unique infection-stage immune signatures during the progression of meningitis caused by Streptococcus suis
              </a>
            </td>
          <td>
            Xuan Jiang, Jikun Mei, Junhui Zhu, Yanyan Tian, Tong Wu, Ziheng Li, Zengshuai Wu, T. Abdelaal, Fengyang Li, Na Li, Liancheng Lei
          </td>
          <td>2025-08-30</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b556e821e2f0af61116f24fcfc2836a19c71a89c" target='_blank'>
              Microbial isolates and cellular pattern of bronchoalveolar lavage in COVID-19 survivors
              </a>
            </td>
          <td>
            Marwa Salah Ghanem, Tamer A. Elhadidy, Dalia Abdellateif Abdelghany, A. Eladl, M. Mortada, Mohammad El-badrawy
          </td>
          <td>2025-09-17</td>
          <td>The Egyptian Journal of Bronchology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) initiates a prolonged and complex immune response that critically shapes both secondary injury and long-term recovery. Among adaptive immune cells, CD4⁺ T cells have emerged as central regulators of neuroinflammatory processes, acting as a double-edged sword that can be either neuroprotective or neurotoxic. This review focuses on the roles of major CD4⁺ T cell subsets-Th1, Th2, Th17, and Tregs-in modulating the immune landscape following TBI, with an emphasis on their temporal dynamics, phenotypic plasticity, and therapeutic potential. We examine how blood-brain barrier disruption and innate immune activation facilitate T cell infiltration into the central nervous system, and outline the cytokine networks and signaling pathways that orchestrate CD4⁺ T cell differentiation and functional polarization. Advances in single-cell RNA sequencing (scRNA-seq) have provided new insights into the transcriptional heterogeneity of CD4⁺ T cells post-TBI, offering novel angles for therapeutic targeting. In addition, we assess current strategies for targeting CD4⁺ T cells therapeutically and examine translational challenges, particularly the translational gap between animal models and human disease. To provide a focused synthesis, this review does not delve into all immune cell types or other aspects of neuroinflammation that may also play significant roles in TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5bb08683dbcd2c252e04f0b54a89e13ce83a8999" target='_blank'>
              The immunological paradox of CD4⁺ T cells in traumatic brain injury (Review Article).
              </a>
            </td>
          <td>
            Qian Zhao, Bo-Ao Chen, Wen-Qing Ai, Nadezhda Brazhe, Dan Liu, Ling-Qiang Zhu, Ming Wen
          </td>
          <td>2025-10-15</td>
          <td>International journal of surgery</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="The COVID-19 pandemic, though no longer classified as a global emergency, persists as a major public health challenge in 2025 due to the continued emergence of SARS-CoV-2 variants with enhanced transmissibility and immune evasion. This paper reviews the evolving epidemiology of COVID-19, the critical interplay between obesity and disease severity, and advances in precision vaccination and therapeutics. Epidemiological and meta-analytic evidence highlights obesity as a significant independent risk factor for infection, hospitalization, ICU admission, mechanical ventilation, and mortality, underpinned by mechanisms such as immune dysfunction, chronic low-grade inflammation, and obesity-related comorbidities. Moreover, obesity is shown to impair vaccine-induced immune responses, complicating long-term protection. In parallel, updated mRNA and protein-subunit vaccines, alongside emerging monoclonal antibody and antiviral strategies, reflect the shift toward precision medicine tailored to vulnerable populations, particularly the immunocompromised. While monoclonal antibody efficacy has been undermined by viral evolution, novel agents such as pemivibart and vilobelimab demonstrate promise in targeted settings. Collectively, the findings underscore the importance of sustained surveillance, equitable vaccine distribution, integrated obesity prevention, and personalized medical interventions. As SARS-CoV-2 continues to adapt, long-term mitigation will require scientific innovation, public health vigilance, and commitment to global health equity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68d4e44390e18300b8bdd2a581827b1121d05424" target='_blank'>
              From Pandemic to Persistence: Obesity, Immunity, and Next-Gen COVID-19 Vaccines
              </a>
            </td>
          <td>
            Kallol Kanti Mondal, Md. Shihab Uddin, Tanvir Mahmud
          </td>
          <td>2025-09-05</td>
          <td>International Journal of Innovative Science and Research Technology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="BACKGROUND
Emerging studies link COVID-19 to adverse multi-organ outcomes. To better estimate psychiatric and physical illness after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, we analyzed a nationally representative cohort with minimal prior infection (>99% uninfected) and low vaccination coverage (<1%) in Taiwan.


METHODS
We conducted a cohort study comprising 11,185 individuals who survived the first 30 days following SARS-CoV-2 infection (alpha variant) between May 1, 2021, and September 30, 2021, confirmed by reverse transcription polymerase chain reaction, along with three age- and sex-matched comparison groups: a contemporary control group (n = 223,700) with no COVID-19 diagnosis, a historical control group (n = 223,700) predating the pandemic, and seasonal influenza group (n = 44,740). We calculated the adjusted incidence rate ratios (aIRRs) of specific psychiatric and physical illnesses to compare their occurrence between the COVID-19 cohort and comparison groups.


RESULTS
During the 6 months after the first COVID-19 diagnosis, aIRRs for psychiatric illnesses in the COVID-19 group were higher across diagnostic categories than those of comparison groups. Moreover, aIRRs of physical illnesses in the COVID-19 group were higher across nearly all major organ systems compared to the comparison ones. The absolute rate difference for overall psychiatric illnesses was 7921.0 (COVID-19 vs contemporary control) and 7226.9 per 100,000 person-years (COVID-19 vs historical control), respectively.


CONCLUSIONS
SARS-CoV-2-immunologically naïve individuals have heightened risks of psychiatric illnesses across diagnostic categories and physical illnesses spanning nearly all major organ systems after the infection. Future studies warrant to explore the pathogenesis of these postacute effects.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7bbf49dd31fbcf0ec3e92876ed1390e7c1e2c610" target='_blank'>
              Risk of post-COVID-19 mental and physical health outcomes among SARS-CoV-2-immunologically naïve people.
              </a>
            </td>
          <td>
            Pao-Huan Chen, Pao-Yu Chen, S. Tsai, Yueh-Pin Lin, Sheng-Siang Su, C. Chen, Chian-Jue Kuo
          </td>
          <td>2025-09-26</td>
          <td>Psychiatry and clinical neurosciences</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Autoimmune diseases are driven by a breach of self-tolerance, leading to chronic inflammation and organ damage. While the Th1 and Th17 paradigms have long dominated our understanding of T-cell-mediated pathology, a distinct subset of CD4+ T helper cells defined by the production of granulocyte-macrophage colony-stimulating factor (GM-CSF) has emerged as a central and non-redundant pathogenic driver. These GM-CSF-producing Th cells orchestrate autoimmune pathology across a spectrum of diseases, including multiple sclerosis, rheumatoid arthritis, and type 1 diabetes, among others. Mechanistically, they act as critical amplifiers of inflammation by activating and recruiting myeloid cells, which in turn mediate tissue destruction. Furthermore, they establish vicious feedback loops, enhancing their own differentiation and promoting the function of other effector T cells. Despite their established importance, significant heterogeneity and plasticity exist in their phenotype and regulatory networks, with context-dependent variations across different diseases and species. This review synthesizes our current understanding of these pivotal cells, critically evaluating their classification, molecular identity, and the signaling pathways governing their differentiation. We further dissect their specific roles in major autoimmune diseases and provide a forward-looking perspective on their immense translational potential, from novel therapeutic strategies targeting the GM-CSF axis to their use as biomarkers for patient stratification and monitoring.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a4e6daed52915c02f33af0850503172340f333d9" target='_blank'>
              GM-CSF+ Th: a central player in autoimmunity
              </a>
            </td>
          <td>
            Sha-Sha Fan, Xuan Xu, Yu-Bin Luo, Xiang-Yu Meng, Yi Liu
          </td>
          <td>2025-09-12</td>
          <td>Theranostics</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="The COVID-19 pandemic, caused by SARS-CoV-2, has profoundly affected global health and the economy. The emergence of variants with spike mutations, particularly within the receptor-binding domain (RBD), has reduced the efficacy of many neutralizing antibodies (nAbs), and recent variants, including KP.3 and other circulating strains, show partial escape from infection- or vaccine-induced immunity. To overcome this, developing broad-spectrum nAbs that target the conserved S2 subunit of the spike protein is crucial. Unlike the highly mutable RBD, the S2 region remains structurally conserved, providing a promising foundation for universal protection. Deeper insight into S2 structure and function, together with advances in bispecific antibody design, could facilitate the development of next-generation therapeutics resilient to viral evolution. This review examines the structural evolution of the SARS-CoV-2 spike, focusing on the therapeutic potential of S2-targeting antibodies and strategies to overcome antibody resistance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f288c70bcad7957340622e07e2151e878c14a5e4" target='_blank'>
              Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance
              </a>
            </td>
          <td>
            Yuichiro Yamamoto, Kohji Noguchi
          </td>
          <td>2025-10-22</td>
          <td>Biomolecules</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The simultaneous occurrence of tuberculosis (TB) and COVID-19 posed a major public health challenge, particularly in regions heavily impacted by both diseases, due to their shared effects on the lungs, immune system dysfunction, and the possibility of more severe clinical outcomes. The role of immunopathogenesis is crucial in influencing the progression of co-infection, which is marked by heightened inflammation, immune exhaustion, weakened T-cell responses, and unregulated cytokine production. To better understand the intricate interactions between host and pathogen and the immune disruptions associated with this dual epidemic, multi-omics approaches such as genomics, transcriptomics, proteomics, metabolomics, epigenomics, and microbiomics have proven to be effective methods. These comprehensive strategies provide detailed insights into the mechanisms of disease, help identify potential biomarkers, and aid in the identification of therapeutic targets. This review emphasizes the importance of immune responses and systems biology in comprehending the TB-COVID-19 syndemic and highlights the promise of multi-omics in advancing precision medicine and enhancing disease management.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d3df397da3ddeae07ab95bd6589b7a3a1244d20" target='_blank'>
              Insights into Molecular Interplay in Tuberculosis–COVID-19 Co-Infection via Integrated Multi-Omics Strategies
              </a>
            </td>
          <td>
            Megha Chaudhari, Sunita Verma, Sushanta Deb
          </td>
          <td>2025-10-22</td>
          <td>J</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Abstract BACKGROUND. Cerebrovascular and neurological diseases are frequent co-morbidities among people with HIV. Our laboratory has described that brain pericytes (BP) can harbor HIV infection and function as a reservoir of viral latent infection in the Central Nervous System. Given that the interaction between pericytes and endothelial cells in the blood-brain barrier (BBB) are necessary for proper formation, development, stabilization, and maintenance of the BBB, we investigated whether active and/or latent HIV-1 infection can differently modulate inflammatory response in BPs, with a focus on RNA sensor and type I interferon (IFN) pathways. METHODS. Primary cultures of human brain vascular pericytes were infected with 60 ng/ml of p24 HIV (NL4-3 strain). Three and 7 days post-infection (dpi), which were previously shown to correspond to active and latent infection, respectively, protein and total RNA were extracted from infected and uninfected control cultures. Expression or protein content of RNA sensors and downstream activators and members of type I IFN response and IFN response genes were determined by RT-qPCR and western blotting, respectively. RESULTS. At 3 dpi, HIV gag transcripts were detected at high levels in infected cultures, which dropped significantly at 7 dpi. RIG-1 protein levels were significantly increased at 7 dpi (2.3-fold), whereas MDA5 was decreased by 0.5-fold. Similarly, STING (Stimulator of IFN genes) mRNA and protein levels were increased at 7 dpi, accompanied by increased expression of MAVS and of TBK1 (TANK-binding kinase 1, 1.7-fold), and phosphorylation of IRF3 (interferon regulatory factor 3). The IFN-α/β receptor type I (IFNAR1) and STAT1 transcripts were selectively increased at 7 dpi. Expression of interferon-induced protein with tetratricopeptide repeats-1 (IFIT1) was transiently increased at 3 dpi and reduced at 7 dpi. No changes in the cGAS, TRAF3, IFN-stimulated gene 15 (ISG15) and Interferon-induced GTP-binding protein Mx1 were observed at the mRNA levels in infected cultures, as compared to controls. CONCLUSIONS. HIV-1 differentially modulates IFN responses in BPs, which can affect BBB integrity in chronic infections. Interestingly, latently infected BPs can contribute to long-term neuroinflammatory stimuli in the CNS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/332e7f25a23ba1b16f7ddbd5861f8f39a8776f89" target='_blank'>
              HIV-1 latent infection modulates RNA sensors and innate immunity signaling in human brain pericytes
              </a>
            </td>
          <td>
            Daniel Adesse, Gabriella Mezzich, Prem Parikh, Roberto Labrada, Paloma de Carvalho Vieira, Anne Caroline Marcos, S. Torices, Michał Toborek
          </td>
          <td>2025-09-22</td>
          <td>Research Square</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Abstract Sepsis represents a dynamic, dysregulated host immune response to infection in which unconventional T cells—γδ T cells, mucosal-associated invariant T (MAIT) cells, natural killer T (NKT) cells, and double-negative T cells—actively shape the balance between early hyperinflammation and subsequent immune paralysis across time and tissues. These cells employ unique antigen recognition mechanisms to trigger rapid immune responses. γδ T cells facilitate early pathogen elimination and immune regulation, whereas MAIT cells detect microbial metabolites and modulate the systemic inflammation. NKT cells balance immune homeostasis through dual pro- and anti-inflammatory cytokine production. This review classifies these subsets and examines their sepsis-related functions alongside immunotherapies targeting them, such as cytokine manipulation, immunomodulators, and checkpoint inhibitors. Elucidating the precise mechanisms underlying sepsis could advance therapies that restore immune equilibrium and potentially improve clinical outcomes. Future studies should unravel the interactions between unconventional T cells and broader immune networks while translating the findings into practical treatments. Understanding the dynamic roles of these cells provides pathways for tailored interventions in sepsis management.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e02d71c5ff720386186f8e984abd6a59f0ff0b56" target='_blank'>
              The Emerging Roles and Therapeutic Potential of Unconventional T Cells in Sepsis
              </a>
            </td>
          <td>
            Shuaipeng Gu, Peidong Zhang, Cong Zhang, Tingxuan Tang, Teding Chang, Liming Dong, Wei Gao, Zhao-Hui Tang
          </td>
          <td>2025-09-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="The COVID-19 pandemic has unveiled the pivotal role of systemic inflammatory responses in neurological complications, particularly parainfectious encephalopathy. Accumulating evidence has established innate immune overreaction—distinct from direct viral neuro-invasion or autoantibody-mediated reaction—as the fundamental mechanism. The clinical manifestations of parainfectious encephalopathy are highly diverse, spanning from mild cases, such as mild encephalopathy with or without a reversible splenial lesion (MERS or ME), to catastrophic syndromes like acute necrotizing encephalopathy (ANE) and febrile infection-related epilepsy syndrome with or without a claustrum lesion (FIRES-C or FIRES). In this article, we summarize the phenotypes, diagnosis, and treatment strategies for parainfectious encephalopathy to enhance clinical recognition and understanding of this re-emerging disorder.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b57c17f056c085569008b64542ebef6fe32b7cc1" target='_blank'>
              Rediscovering parainfectious encephalopathy in the post-COVID-19 era
              </a>
            </td>
          <td>
            Lin Bai, Chang Geng, Hongzhi Guan
          </td>
          <td>2025-09-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a progressive, chronic, and highly disabling neuroinflammatory disorder characterized by demyelination and T cell–driven inflammation. Pathogenic T cells play a central role in MS, but effective therapeutic targeting remains challenging. Here, we identified ankyrin repeat domain–containing protein 55 (ANKRD55) as a key regulator of T cell function by single-cell transcriptomic analysis of cerebrospinal fluid and blood from MS patients. ANKRD55 was predominantly expressed in CD4+ T cells in both compartments. Genetic ablation of Ankrd55 led to a robustly reduced disease severity and neuroinflammation in experimental autoimmune encephalomyelitis (EAE), a widely used animal model for MS. Furthermore, T cell–specific deficiency of Ankrd55 significantly impaired Th1 polarization and Th17 differentiation, reducing EAE pathogenicity. Mechanistically, we found that Ankrd55 deficiency disrupted T cell receptor (TCR) signaling integrity. We demonstrated that ANKRD55 regulates the formation of the immune synapse, an essential prerequisite for TCR activation, by interacting with subunits of the chaperonin-containing TCP1 (CCT) complex and modulating its activity, enhancing its assembly by competing with CCT5 for binding to TCP1, CCT3, and CCT6. This facilitates proper microtubule organization and TCR activation. These findings establish ANKRD55 as a critical regulator of TCR signaling and highlight its therapeutic potential in pathogenic T cell–driven autoimmune diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/865b26367cf4f5ce2ee12fb7cd224a9d528add57" target='_blank'>
              ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis
              </a>
            </td>
          <td>
            Chuyu Wu, Mei-Ling Jiang, Xue Yang, Yixuan Liu, Bin Huang, Yi Guo, Runjing Cao, Zhihui Cui, Guozhen Deng, Weiyan Wang, Mengdi Guo, Zhiyong Lin, Jiahui Fan, Lin-ming Zhang, Lorenzo Di Cesare Mannelli, Tao Pang, Chenhui Wang, Cun-Jin Zhang
          </td>
          <td>2025-10-15</td>
          <td>The Journal of Clinical Investigation</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a7c1bcdf8df1de49bfbb1eb95692322813eb40f1" target='_blank'>
              Immunological and non-immunological features specific to Long-COVID: multiple overlapping aetiologies and potential biomarkers
              </a>
            </td>
          <td>
            F. Ponchel, UNLOCK-LC consortium
          </td>
          <td>2025-09-23</td>
          <td>None</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9ed31c585f2a83dd506b82c4f52c8f2d60c32aa5" target='_blank'>
              Long COVID and the kidney.
              </a>
            </td>
          <td>
            Vanja Ivković, U. Anandh, Samira Bell, A. Kronbichler, M. Soler, Annette Bruchfeld
          </td>
          <td>2025-09-04</td>
          <td>Nature reviews. Nephrology</td>
          <td>1</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62a7046e53aa7828325fcbe7a57e5422fd94bc21" target='_blank'>
              Cytokines of the Interleukin-1 superfamily and Interleukin-6 are associated with neuroinflammation and brain injury in Herpes Simplex Virus Encephalitis
              </a>
            </td>
          <td>
            Franklyn N. Egbe, C. Dunai, Claire Hetherington, S. Boardman, Laura Bricio Moreno, B. Facer, Cory Hooper, David Haw, Alexandra-Chloé Villani, Luca Lenzi, Sam Haldenby, Steve Patterson, Evelyn Kurt-Jones, A.D. Luster, Tom Solomon, M. Ellul, B. Michael
          </td>
          <td>2025-10-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="The COVID-19 pandemic posed a challenge for clinical management of a new lung disease that was characterized by inflammation, endothelial cell dysfunction, and thrombosis, which occur after the replication phase of infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are many laboratory models of active SARS-CoV-2 infection in mice, reflecting an acute lung injury in an otherwise healthy animal, but there is a lack of accurate animal models of the postviral inflammatory phase of the COVID-19 lung reflecting severe disease. The monocrotaline (MCT)-treated rat is a widely used laboratory model of pulmonary hypertension (PH). Not often discussed, however, are the observed changes in inflammation, edema, fibrosis, and microthrombosis in the lung prior to PH. At the cellular level, there is loss of pneumocytes and endotheliopathy, and at the molecular level the MCT rat lung is characterized by a pro-inflammatory cytokine profile, namely elevated interleukin 6, transforming growth factor β and tumor necrosis factor, M1 macrophage phenotype, and dysregulation of the angiotensin converting enzyme (ACE)/ACE2 balance. The systems-level pathophysiology of the MCT-treated rat includes progressive cardiopulmonary dysfunction. The MCT-treated rat clearly differs from the COVID-19 lung in terms of the triggers for pathology, but there are many parallels apparent in both the MCT-treated rat and the COVID-19 lung. The MCT-treated rat lung as a model of the COVID-19 lung may provide an in-depth understanding of the factors that drive the lung to more severe pathology, treatments that benefit lung recovery, or the factors that prove a useful research platform for future emerging respiratory threats of similar pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec672c9231109cab5705320583f7c515ee016dcc" target='_blank'>
              Revisiting the monocrotaline-treated rat as a model of inflammatory lung disease: COVID-19 and future pandemic threats?
              </a>
            </td>
          <td>
            Luke P. Kris, D. Dixon, S. Bihari, Jillian M. Carr
          </td>
          <td>2025-10-17</td>
          <td>Animal models and experimental medicine</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="BACKGROUND
Metal allergies are prime examples of delayed-type hypersensitivity divided into two phases: in the sensitization phase, initial contact with an allergen leads to activation of skin-resident cells and formation of metal-reactive T cells. during elicitation, these T cells mount an immune response resulting in clinically apparent eczema within 72 h after exposure. Two main mechanisms have been implicated in the initiation of metal hypersensitivity: direct or indirect activation of innate immune receptors such as Toll-like receptor 4, and conditional innate immune activation via the NLRP3 inflammasome. Yet, the responsible cell type(s) mediating these responses are unknown. Moreover, it is unclear whether the elicitation phase is mainly dominated by infiltration of circulating metal-responsive T cells or if tissue-resident T cells contribute.


METHODS
Here, we analyzed the relevance of different cell types in human nickel hypersensitivity by single-cell RNA sequencing and immunofluorescence analysis of skin samples of nickel-sensitized donors epicutaneously exposed to diluent and nickel for 8 or 72 h.


RESULTS AND CONCLUSION
Nickel specifically activated distinct populations of endothelial cells, suprabasal keratinocytes, fibroblasts, and CCR7+ dendritic cells, co-expressing the TLR4-interacting proteogylcan DCN and CCR7 ligand CCL21 within 8 h. Skin-resident T cells were not involved in the early hypersensitivity response, as their gene expression remained unaltered 8 h after nickel exposure. However, substantial changes in the cutaneous T cell compartments occurred after 72 h, with massive infiltration of KLF2+ central memory T cells being a recurrent feature of both nickel-sensitized patients and individuals allergic to the glucocorticoid contact allergen budesonide.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/121ea0962fb1aea4066738681c1db8ea26885430" target='_blank'>
              Single Cell Analysis Reveals Dynamic Changes of Distinct Cell Populations in Human Nickel Allergy.
              </a>
            </td>
          <td>
            Marc Schmidt, Andrea Knorz, Katharina Meder, Simon G. Goller, Fabian Imdahl, Yamila Rocca, Matthias Goebeler, Pierre Khoueiry
          </td>
          <td>2025-10-15</td>
          <td>Allergy</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by unexplained fatigue, post-exertional malaise (PEM), and cognitive dysfunction. ME/CFS patients often report a prodrome consistent with infection. We present a multi-omics analysis based on plasma metabolomic and proteomic profiling, and immune responses to microbial stimulation, before and after exercise. We report evidence of an exaggerated innate immune response after exposure to microbial antigens; impaired energy production involving the citric acid cycle, beta-oxidation of fatty acids, and urea cycle energy production from amino acids; systemic inflammation linked to lipid abnormalities; disrupted extracellular matrix homeostasis with release of endogenous ligands that promote inflammation; reduced cell-cell adhesion and associated gut dysbiosis; complement activation; redox imbalance reflected by disturbances in copper-dependent antioxidant pathways; and dysregulation of tryptophan-serotonin-kynurenine pathways. Many abnormalities were worse following exercise and correlated with the intensity of symptoms. Our findings may inform development of targeted therapeutic interventions for ME/CFS and PEM.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d3a217c7ae44dfddddf81deb958af798edc62066" target='_blank'>
              Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFS
              </a>
            </td>
          <td>
            X. Che, A. Ranjan, C. Guo, Keming Zhang, R. Goldsmith, S. Levine, K. J. Moneghetti, Y. Zhai, L. Ge, N. Mishra, M. Hornig, L. Bateman, N. Klimas, J. Montoya, Daniel L. Peterson, S. L. Klein, O. Fiehn, A. Komaroff, W. I. Lipkin
          </td>
          <td>2025-09-03</td>
          <td>npj Metabolic Health and Disease</td>
          <td>1</td>
          <td>66</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d47d3032b58edef3f10d011f1f7ed8598258bb99" target='_blank'>
              Viral evolution during primary infection in immunocompromised hosts
              </a>
            </td>
          <td>
            Morgan Craig, Xiaoyan Deng, David V. McLeod
          </td>
          <td>2025-09-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Respiratory viral infections pose a major global public health challenge, with pathogens such as influenza viruses, novel coronaviruses, and respiratory syncytial virus exerting serious threats to human health. These infections often progress to severe disease in children, the elderly, and individuals with compromised immunity. Due to their anatomical exposure and relatively weak mucosal defenses, the upper respiratory tract—including the nasal cavity and throat—serves as a primary portal of entry for these pathogens. Such infections can lead to otolaryngological conditions such as anosmia and otitis media, and may further exacerbate illness in susceptible populations. After viral invasion, the host perceives pathogens through pattern recognition receptors (PRRs), rapidly activating the expression and signaling pathways of type I and type III interferons (IFN). This plays a core role in antiviral defense. Notably, viral infection profoundly reshapes the host cell’s metabolic network, involving widespread alterations in carbohydrate, lipid, amino acid, and nucleotide metabolism. During this process, key metabolic products are released or generated. These are the products of metabolic reprogramming and important immune regulatory molecules that can directly or indirectly modulate the host’s antiviral immune response, particularly the interferon pathway. These findings reveal that viral invasion, host metabolic reprogramming, and interferon-mediated antiviral immunity form a tightly intertwined, and dynamically interact a regulatory network of”virus-metabolism-IFN”. This profoundly elucidates the underlying regulatory logic of the metabolic microenvironment in antiviral immunity. Understanding this mechanism offers new perspectives for diagnosis and treatment: targeting metabolic nodes or utilizing metabolic modulators, as well as combined strategies with IFN, and may become novel approaches for the prevention and treatment of upper respiratory viral diseases. This review focuses on the core role of IFN-mediated innate immunity in viral defense and its interactive regulation with metabolic reprogramming. It reviews the progress of studies on how metabolic products regulate the IFN pathway and antiviral responses through various mechanisms, and explores the potential clinical application prospects of metabolic regulation in local immune defense and the prevention and treatment of viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dac410e89881f1ee7d80977d969d5f48a7563738" target='_blank'>
              Metabolic regulation of interferon-mediated innate antiviral immunity
              </a>
            </td>
          <td>
            Tian Zhong, Qi Cao, Zhiyue Ma, Caiyu Jiang
          </td>
          <td>2025-10-08</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system (CNS) characterized by oligodendrocyte (OLG) degeneration, myelin loss, and impaired remyelination. Apolipoprotein D (Apo D), a glia-derived lipocalin, has emerged in recent decades as a neuroprotective molecule involved in lipid transport, oxidative stress regulation, and inflammation control during aging and neurodegenerative diseases like MS. However, its role in demyelination/remyelination dynamics remains poorly defined. In this study, we used the cuprizone (CPZ)-induced demyelination model in C57BL/6 mice to analyze Apo D expression patterns in the corpus callosum during de- and remyelination. We also assessed whether the atypical antipsychotic clozapine (CLO), previously shown to upregulate Apo D in vivo, could modulate its expression and influence myelin recovery in this pathological context. Using a combination of magnetic resonance imaging, Luxol fast blue staining, and double immunohistochemistry, we demonstrated that CPZ treatment for 3 or 6 weeks led to significant demyelination, hydrocephalus, and reduced motor cortex thickness, which were partially reversed after treatment cessation. Apo D expression in OLGs was significantly reduced by CPZ exposure, both at the protein level and in terms of immunoreactive cell counts, but was restored following treatment withdrawal. Notably, co-administration of CLO prevented the CPZ-induced reduction in Apo D expression in OLGs, although it did not attenuate myelin loss. In this way, our results reveal a strong correlation between Apo D expression and OLG/myelin integrity in vivo. While CLO did not exert remyelinating effects, it preserved Apo D levels under demyelinating conditions, suggesting a potential indirect neuroprotective mechanism. These findings support the relevance of Apo D in CNS myelin homeostasis and highlight its potential as a molecular target for therapeutic intervention in demyelinating diseases such as MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/24479384af2d55a3d6c38b84ed8c05c763355c19" target='_blank'>
              Apolipoprotein D Expression Dynamics During Cuprizone-Induced Demyelination and Remyelination in a Mouse Model of Multiple Sclerosis
              </a>
            </td>
          <td>
            E. Martínez-Pinilla, Nuria Rubio-Sardón, Gemma Fernández-García, Sandra Villar-Conde, Carlota Menéndez-Pérez, J. Tolivia, E. D. Del Valle, Ana Navarro
          </td>
          <td>2025-09-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Background Long COVID is a complex, multisystem syndrome with significant cardiopulmonary implications. Persistent inflammation, endothelial dysfunction, and microvascular injury contribute to prolonged symptoms such as dyspnea, chest pain, and exercise intolerance. Despite growing recognition of these complications, the underlying mechanisms of cardiopulmonary interactions remain poorly understood. Methods A comprehensive literature search was conducted on PubMed, Scopus, Google Scholar, and Web of Science covering studies from 2019 to 2025. Keywords included “Long COVID”, “cardiopulmonary interaction”, “pulmonary fibrosis”, “myocardial inflammation”, and “endothelial dysfunction”. A total of 102 articles were included, comprising 65 original research studies and 37 review articles. Results Pulmonary sequelae, such as fibrotic remodeling, persistent hypoxia, and microthrombosis, impose significant strain on the cardiovascular system, exacerbating myocardial inflammation, arrhythmias, and endothelial dysfunction. Shared mechanisms, such as oxidative stress, immune dysregulation, and neurohumoral activation, create a vicious cycle of sustained cardiopulmonary impairment. The disruption of the renin-angiotensin-aldosterone system (RAAS) further contributes to systemic vascular dysregulation. Conclusion A deeper understanding of cardiopulmonary interactions in Long COVID is essential for developing effective management strategies. Targeting inflammatory pathways, restoring endothelial function, and addressing autonomic instability may provide therapeutic benefits. As the long-term impact of this syndrome continues to evolve, further research is needed to refine treatment approaches and mitigate its burden on global health. Supplementary Information The online version contains supplementary material available at 10.1186/s12872-025-05185-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0794ad0a622bb95186ed6c2df37d53cb3580c965" target='_blank'>
              Cardiopulmonary crosstalk in Long COVID: a systematic review of emerging evidence
              </a>
            </td>
          <td>
            Zohreh Arab, Niayesh Shayanfar, Melika Rahbardar Mojaver, Maryam Khormali, M. Boskabady, Saeed Niazmand
          </td>
          <td>2025-10-15</td>
          <td>BMC Cardiovascular Disorders</td>
          <td>0</td>
          <td>54</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/932fe6cdc96c019b2a9640b9078b5edf5fa6fdce" target='_blank'>
              The NLRP3 inflammasome as a key pathway in the affective and chronic fatigue symptoms of Long COVID
              </a>
            </td>
          <td>
            Long Covid, Yingqian Zhang, H. Al-Hakeim, H. Al-Jassas, Michael Maes
          </td>
          <td>2025-09-08</td>
          <td>None</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Cell death pathways play contrasting roles in physiological processes such as responses to viral infections and vaccinations, potentially exerting either detrimental or beneficial effects. On one hand, uncontrolled cell death accompanied by the release of damage-associated molecular patterns (DAMPs) can lead to excessive inflammation and tissue damage. On the other hand, when properly regulated, these processes help establish an immunocompetent environment by activating innate immunity, which in turn stimulate antiviral immune responses. These mechanisms have emerged as promising targets for the development of effective antiviral therapeutics, immunotherapies, and vaccines. Recent advances have elucidated key aspects of cell death and DAMP pathways, highlighting their association with upstream viral sensors, their capacity to regulate immune responses, and their potential as therapeutic targets in the context of respiratory viral infections such as influenza virus and SARS-CoV-2. In this review, we discuss the advantages and disadvantages of cell death and DAMP pathways, focusing on their roles in antiviral immunity and pathogenesis of respiratory viral infections, and vaccine immunogenicity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2841b0ea0cbbf6db185eb49b73c514efbeae98a7" target='_blank'>
              The role of cell death pathways in respiratory viral infection and vaccination: two sides of the same coin
              </a>
            </td>
          <td>
            Sun Min Lee, Eui Ho Kim
          </td>
          <td>2025-09-05</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background/Objectives: Low levels of lysophosphatidylcholine (LPC) in the blood can be used as a diagnostic marker for sepsis. SARS-CoV-2 infection, a more recent cause of sepsis, shares similarities with non-SARS-CoV-2 sepsis but also exhibits distinct features. We have recently shown that plasma cholesteryl ester levels are higher in patients with SARS-CoV-2 infection than in patients without, and this study analysed whether this may extend to differences in LPC, a bioactive constituent of lipoproteins. Methods: The plasma levels of 13 LPC species were measured by flow injection analysis tandem mass spectrometry (FIA-MS/MS) in 157 patients with systemic inflammatory response syndrome (SIRS), sepsis or septic shock. Of these patients, 24 had SARS-CoV-2 infection. Results: Patients with SIRS exhibited higher plasma levels of the minor LPC species LPC 15:0 and 22:4 compared to those with sepsis or septic shock. Five LPC species were also reduced in the plasma of 31 patients with liver cirrhosis; therefore, patients with cirrhosis or SIRS were excluded from subsequent analyses. Compared to 76 non-COVID-19 patients with sepsis or septic shock, SARS-CoV-2 infection in 21 patients was associated with significantly higher plasma levels of ten individual LPC species and total LPC concentration. In patients with sepsis/septic shock, LPC species showed negative correlations with procalcitonin and interleukin-6, and positive correlations with gamma-glutamyltransferase and cholesteryl ester levels. In contrast, no significant associations were observed between LPC levels and C-reactive protein, aminotransferases, or free cholesterol. Conclusions: Differential LPC levels, despite comparable disease severity, may serve as metabolic biomarkers to distinguish SARS-CoV-2 sepsis from other causes of sepsis and inform targeted therapeutic approaches.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/717cdadcd4afdb5c1647aa39ab69af0ac945981c" target='_blank'>
              Distinct Plasma LPC Signatures Differentiate COVID-19 Sepsis from Other Sepsis Aetiologies
              </a>
            </td>
          <td>
            V. Pavel, P. Mester, Marcus Hoering, Gerhard Liebisch, S. Schmid, M. Müller, C. Buechler
          </td>
          <td>2025-08-29</td>
          <td>Biomedicines</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bafd993e0b224c67ac0c7bb80c427491f7b31907" target='_blank'>
              Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo.
              </a>
            </td>
          <td>
            Beatrice Angi, T. Varanita, M. Puthenparampil, Valentina Scattolini, M. Donadon, Mitra Tavakoli, Marta Favero, Maguie El Boustani, Matthias Soddemann, L. Biasutto, Diletta Arcidiacono, Alberto Ongaro, Andrea Mattarei, L. Trentin, Gregory C. Wilson, Erich Gulbins, Paolo Gallo, Ildiko Szabo
          </td>
          <td>2025-09-29</td>
          <td>EMBO molecular medicine</td>
          <td>1</td>
          <td>56</td>
        </tr>

        <tr id="Background/Objectives: Understanding the durability of immunity induced by mRNA COVID-19 vaccines, especially in individuals with chronic health conditions, remains essential for guiding booster strategies. We conducted a longitudinal study to evaluate humoral and cellular immune responses up to 21 months after a primary two-dose BNT162b2 vaccination followed by a booster, either homologous (BNT162b2) or heterologous (mRNA-1273). Methods: Twenty-eight adults, mostly with chronic conditions, were assessed at approximately 9, 12 and 21 months post-primary vaccination. Serum anti-trimeric Spike IgG levels were quantified, and peripheral blood mononuclear cells were analyzed at 21 months for Spike-specific memory B-cell and T-cell responses by flow cytometry. Results: Participants were stratified by booster type, prior SARS-CoV-2 infection and health status. Anti-Spike IgG persisted in all participants but declined over time. The heterologous mRNA-1273 booster induced higher antibody titers at 9 months, while the homologous BNT162b2 booster led to more sustained antibody levels and higher frequencies of Spike-specific memory B cells at 21 months. Prior infection significantly enhanced antibody titers, particularly in homologous booster recipients. Surprisingly, individuals with chronic health conditions exhibited equal or higher antibody levels compared to healthy participants at all time points. At 21 months, robust Spike-specific class-switched memory B cells and polyfunctional CD4+ and CD8+ T-cell responses were detected. Conclusions: These findings demonstrate that BNT162b2 vaccination elicits durable, multi-layered immunity lasting nearly two years, even in individuals with chronic conditions, and support the use of both homologous and heterologous mRNA boosters to sustain protection in diverse populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/89481772992766fff7568e99ee152ae890cc2530" target='_blank'>
              Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions
              </a>
            </td>
          <td>
            Chiara Orlandi, Ilaria Conti, Davide Torre, Simone Barocci, Mauro Magnani, Giuseppe Stefanetti, A. Casabianca
          </td>
          <td>2025-10-02</td>
          <td>Vaccines</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Coronavirus Disease 2019 (COVID-19) has resulted in over 6 million deaths worldwide in fewer than four years and is a result of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The protein that mediates SARS-CoV-2 host cell entry is the angiotensin-converting enzyme 2 (ACE2), which is highly expressed on the membrane of gastrointestinal (GI) cells. Consequently, infection can lead to direct damage to the GI tract and gut dysbiosis, which is associated with an imbalance of microbiota, inflammation, and other systemic infections and diseases. In this review, we will focus on the impact of COVID-19 on the GI system. We will examine the pathophysiology of gut dysbiosis in COVID-19 patients, as well as emphasize the significance of probiotics in addressing this condition. Additionally, we will identify key areas of interest that warrant further investigation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/15a8c10c04bc5c6851f09e3f26f86d11ccd8a60b" target='_blank'>
              Impact of COVID-19 on the Gut Microbiome: A Review
              </a>
            </td>
          <td>
            Andrea Pedraza, Sabrina Bonnice, Michelle N Won, Marc M. Kesselman, Michelle Demory Beckler
          </td>
          <td>2025-09-01</td>
          <td>Cureus</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic highlighted the critical need for broad-spectrum antivirals with high resistance barriers. Here, we demonstrate that SB431542, a selective TGF-β receptor I (ALK5) inhibitor, exhibits potent antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through unprecedented multitargeted mechanisms. Through comprehensive in vitro, isothermal titration calorimetry, and in silico analyses, we identified that SB431542 directly binds to SARS-CoV-2 ORF3a and disrupts its canonical function in inhibiting autophagosome-lysosome fusion. This interaction restored lysosomal acidification and normalized perinuclear LAMP-1 localization, significantly impairing virion assembly as evidenced by disrupted nucleocapsid-RNA association and reduced intracellular viral titers. Additionally, SB431542 downregulated the CLEAR network genes responsible for lysosomal biogenesis, further restricting viral egress pathways. Our temporal analyses revealed that at later infection stages (36–48 hours post-infection [hpi]), SARS-CoV-2 exploits TGF-β-induced lysosomal membrane permeabilization (LMP) and apoptosis for viral release—processes effectively inhibited by SB431542 through suppression of GADD45b and BAX expression. These multiple mechanisms resulted in an exceptional EC50 of 751.8 nM against SARS-CoV-2. In vivo efficacy was demonstrated in embryonated chicken eggs, where SB431542 conferred dose-dependent protection against lethal infectious bronchitis virus (IBV) challenge, with a favorable therapeutic index of 34.54. Remarkably, sequential passaging of SARS-CoV-2 for 50 generations under SB431542 selection pressure failed to generate resistant variants, contrasting sharply with the rapid resistance emergence typical of direct-acting antivirals. These findings establish SB431542 as a promising broad-spectrum coronavirus inhibitor with a unique triple-mechanism approach that simultaneously targets viral entry via TGF-β/Smad modulation, disrupts ORF3a-mediated lysosomal dysfunction affecting assembly, and attenuates TGF-β-induced apoptosis during late-stage infection, collectively imposing multiple selective constraints that impede escape mutation development. IMPORTANCE The COVID-19 pandemic highlighted the urgent need for antiviral drugs with high barriers to resistance. This study reveals that SB431542, a drug previously developed to inhibit TGF-β signaling, exhibits remarkable effectiveness against SARS-CoV-2 through an unprecedented triple-mechanism approach. Unlike conventional antivirals that target a single viral component, SB431542 simultaneously disrupts viral entry, assembly, and release by binding to the viral ORF3a protein and modulating host cellular processes. Most importantly, SARS-CoV-2 failed to develop resistance against SB431542 even after 50 generations of exposure—a significant advantage over current therapeutics that quickly lose effectiveness due to viral mutations. Our findings also uncover that coronaviruses exploit both lysosomal dysfunction and programmed cell death to spread efficiently, providing new targets for therapeutic intervention. This research establishes SB431542 as a promising broad-spectrum coronavirus inhibitor and demonstrates the value of targeting host-virus interactions to overcome antiviral resistance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0e563d74d542fad6aac4569198bcdcb1896b0fc" target='_blank'>
              TGF-β inhibitor SB431542 suppresses SARS-CoV-2 replication through multistep inhibition
              </a>
            </td>
          <td>
            Assim Verma, Himanshu Kamboj, Garvit Kumar, Nitin Khandelwal, Benjamin E. Mayer, Jitender Rathee, Y. Chander, Alka Nokhwal, Shweta Dhanda, Ram Kumar, R. Dedar, Sandeep Kumar Bejjanki, Deepti Parashar, Gayathri Pananghat, B.N. Tripathi, Riyesh Thachamvally, Shalini Sharma, Naveen Kumar
          </td>
          <td>2025-08-29</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2ef36c96aa300274968dc8eb89e1049941362b19" target='_blank'>
              A novel modelling framework for immunity-driven epidemics of non-sterilising infections
              </a>
            </td>
          <td>
            D. Stocks, A. C. Thomas, L. Danon, E. Brooks-Pollock
          </td>
          <td>2025-10-10</td>
          <td>None</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Since the beginning of the COVID-19 pandemic, research has been ongoing to find the best diagnostic parameters to identify patients with a high risk of severe infection. Numerous studies have examined chemokine biomarkers in COVID-19 as a biomarker for high risk patients. The four main structural proteins of the SARS-CoV-2, spike protein, membrane protein, envelope protein and nucleocapsid protein enable the virus to penetrate host cells and stimulate the immune system. SARS-CoV-2 enters host cells via ACE2 in upper respiratory tract the virus entries by binding to the spike protein. Uncontrolled activation and enhancement of the immune response leads to massive release of cytokines and chemokines known as cytokine storm (CS). Chemokines are described as important cytokines in COVID-19 with a potential role as prognostic factor particularly for the severity of the infection and the risk of death from complications, to identify high-risk patients. Our review contains chemokines (CCL2, CCL3, CCL5, CXCL8, CXCL10), which level is significantly higher in patients with COVID-19 infection vs control individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ae9cac6f353784b6344609748313da2a334d3aa8" target='_blank'>
              Chemokines as potential biomarkers for predicting the course of COVID-19 – a review of the literature
              </a>
            </td>
          <td>
            Blanka Wolszczak-Biedrzycka, Beata Cieślikiewicz, Filip Studniarz, Łukasz Dąbrowski, Mateusz Fąs, Krystyna Matyszkiewicz–Suchodolska, Monika Harasimowicz, Justyna Dorf
          </td>
          <td>2025-09-23</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Lupus nephritis (LN), a serious complication of systemic lupus erythematosus (SLE), involves complex immune dysregulation that leads to chronic renal inflammation and progressive tissue damage. Despite decades of use of standard immunosuppressive therapy, treatment responses remain variable, and many patients experience relapses or develop end-stage renal disease. This review synthesizes emerging insights into the immunopathogenesis of LN, drawing on studies from single-cell transcriptomics, signaling pathway analyses and renal tissue immunology. It examines the role of both innate and adaptive immune cells in mediating disease. The therapeutic landscape is rapidly evolving with novel biologics targeting B cell survival and cytokine signaling, small-molecule inhibitors modulating intracellular pathways, and promising developments in cell-based interventions. Notably, recent clinical case series have demonstrated that CD19-directed chimeric antigen receptor (CAR) T-cell therapy can induce durable drug-free remission in LN, representing a transformative approach to immune modulation. These advances are further supported by the application of multi-omics platforms to refine biomarker-driven disease monitoring and personalized treatment. Integrating immunologic and technological innovations holds the potential to redefine therapeutic strategies in LN. Precision medicine approaches that leverage targeted therapies, immune resetting modalities, and biomarker-guided clinical decisions may significantly improve long-term renal outcomes and patient quality of life.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/35ff2db4e53fbfcd732533753d66bb27b0333d4a" target='_blank'>
              Taming renal inflammation: signaling pathways and therapeutic advances in lupus nephritis
              </a>
            </td>
          <td>
            Marsela Braunstein
          </td>
          <td>2025-09-01</td>
          <td>BMC Nephrology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="BACKGROUND
Women are disproportionately affected by neuropsychiatric symptoms following recovery from acute COVID-19. However, whether there are central nervous system-specific changes in gene expression in women with neuropsychiatric Long COVID (NP-Long COVID) remains unknown.


METHODS
Twenty-two women with and ten women without NP-Long COVID were enrolled from New Haven, CT, and the surrounding region and consented to a blood draw and large volume lumbar puncture. Total RNA was extracted from cerebrospinal fluid (CSF) cells and peripheral blood mononuclear cells (PBMC). Polyadenylated RNA was sequenced, and differential expression analyses were performed.


RESULTS
Both CSF and PBMC samples showed differential gene expression associated with Long COVID status. There were CSF-specific differentially expressed genes (DEGs) in people with Long COVID, including in genes related to oxidative stress, reactive oxygen species, and P53 response, indicating compartment-specific immune responses. Some pathways were dysregulated in both the CSF and PBMC of Long COVID compared to controls, including those related to androgen response, MTORC1 signaling, and lipid metabolism.


CONCLUSIONS
Women with NP-long COVID show compartment-specific, transcriptional profiles in the CSF with evidence of enrichment in cellular stress pathways. These results underscore the importance of examining CSF-specific molecular profiles to better understand post-viral neurological syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/12f97cfe08d664d8aad875eb3549bafd12890f6b" target='_blank'>
              CSF immune cell alterations in women with neuropsychiatric Long COVID.
              </a>
            </td>
          <td>
            Benjamin Orlinick, Sameet Mehta, Lindsay McAlpine, Saba Khoshbakht, Sofia Fertuzinhos, Allison Nelson, J. Chiarella, Bibhuprasad Das, Vansh Patel, P. Filippidis, Michael J Corley, Serena Spudich, S. Farhadian
          </td>
          <td>2025-09-08</td>
          <td>The Journal of infectious diseases</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently defined neurological autoimmune condition. The pathogenesis of the disease remains poorly understood, and no specific therapies are currently approved. Here, a comprehensive single-cell immunophenotyping of peripheral blood mononuclear cells from two independent cohorts of patients with MOGAD revealed pronounced immune perturbations in MOGAD when compared with healthy controls and patients with multiple sclerosis. Patients with MOGAD displayed an expansion of CXCR5-CD21- activated naïve and double-negative B cell subsets, a feature shared with patients with systemic lupus erythematosus. In addition, we observed altered Fc gamma receptor expression in natural killer cells, monocytes, and dendritic cells. Within the T cell compartment, CXCR3+CD4+ memory T cells were reduced in the circulation of patients with MOGAD compared with healthy controls, and this result was mirrored in a transgenic mouse model that showed retention of these cells in the inflamed central nervous system. Together, these results demonstrate profound systemic immune cell alterations in MOGAD and contribute to a better understanding of this distinct disease entity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/98763a82350ba4af3ac6181fd6a78412c1865a35" target='_blank'>
              Immune signatures link myelin oligodendrocyte glycoprotein antibody-associated disease to other autoantibody-mediated conditions.
              </a>
            </td>
          <td>
            Jonas Schmid, Chiara Alberti, Laura Power, Nicolás Nuñez, Donatella De Feo, Sofia Tyystjärvi, L. Kulsvehagen, Victor Kreiner, Ana Beatriz Ayroza Bleher, Patrick Lipps, S. Swinnen, F. Ingelfinger, C. Ulutekin, Camille Chaubet, Susanne Unger, Stefanie Kreutmair, Romain Marignier, Thomas Korn, A. Pröbstel, Roland S Liblau, Burkard Becher
          </td>
          <td>2025-10-08</td>
          <td>Science translational medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Trained immunity (TRIM) is a form of long-lasting functional reprogramming of innate immune cells and their progenitors that enhances responsiveness to subsequent stimuli. Although first characterized in myeloid cells, TRIM was recently extended to nonmyeloid cell types, including endothelial and glial cells, which also exhibit stimulus-driven, memory-like behavior. While initially recognized as a protective mechanism, particularly in the context of vaccines and acute infections, TRIM can also become maladaptive, promoting chronic inflammation, immune dysfunction, and disease. This Review focuses on virus-induced TRIM while also addressing microbial, metabolic, and endogenous inducers. We examine key ligands and receptors that initiate TRIM and dissect the associated signaling and epigenetic pathways. Importantly, we argue that maladaptive TRIM arises not from a specific ligand, receptor, or molecular event, but from contextual factors such as stimulus persistence, dose, tissue microenvironment, and preexisting inflammation. The nature of the secondary challenge also shapes whether a trained response is adaptive or maladaptive. We further discuss TRIM induction in the bone marrow, involvement of both myeloid and nonmyeloid cells, and the role of lipid rafts in sustaining TRIM. We review maladaptive TRIM’s potential contribution to systemic diseases, such as atherosclerosis, diabetes, sepsis, cancer, and autoimmunity, along with its influence on viral vaccine responses. Finally, we outline potential strategies to redirect maladaptive TRIM and propose key outstanding questions for future research.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/54bd530d610905355157e5da9dfc245505760a43" target='_blank'>
              Maladaptive trained immunity in viral infections
              </a>
            </td>
          <td>
            D. Sviridov, Mihai G. Netea, Michael I Bukrinsky
          </td>
          <td>2025-09-02</td>
          <td>The Journal of Clinical Investigation</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b16d4b1145b6df2c32a048951face98e103d9cb4" target='_blank'>
              Microglial NLRP3 inflammasome activation leads to perineuronal net loss in cocultured neurons.
              </a>
            </td>
          <td>
            Emre Tarakcioglu, K. Tufekci, Şermin Genç
          </td>
          <td>2025-10-13</td>
          <td>Molecular biology reports</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Macrophages are highly plastic immune cells that adopt diverse functional states in response to the local microenvironment. The traditional M1/M2 polarization model that has long been used to describe macrophage activation is insufficient to capture the full spectrum of macrophage diversity observed in vivo. Advances in single-cell RNA sequencing (scRNA-seq) have revealed that macrophages exist in a continuum of transcriptional states formed by tissue-specific and disorder-specific cues. This insight has led to the recognition of disorder-specific macrophages, defined as macrophage subpopulations that emerge in response to pathological stimuli and play unique roles in disease progression. These macrophages exhibit distinct transcriptional signatures, epigenetic modifications, and functional properties shaped by their ontogeny and microenvironmental signals, arising from the reprogramming of resident macrophages or the differentiation of bone marrow–derived progenitors. Notable examples include macrophages in chronic infections (e.g., tuberculosis), immunosuppressive tumor-associated macrophages, lipid-associated macrophages in obesity, and disease-associated microglia in neurodegeneration. These subsets exhibit unique regulatory mechanisms, including enhancer remodeling driven by histone H3 lysine 27 acetylation in non-alcoholic steatohepatitis, CCAAT enhancer binding protein α-mediated differentiation in obesity, and Jmjd3-IRF4 axis control in allergic inflammation. Additionally, their function and fate are strongly influenced by their subtissular niche, as evidenced by crown-like structures in adipose tissue, tumor microenvironments, fibrotic lesions, and granulomas, where distinct microenvironmental cues shape macrophage behavior. Furthermore, interindividual heterogeneity in macrophage function, driven by genetic polymorphisms, is increasingly recognized, highlighting the role of host genetic background in disease susceptibility and macrophage-driven pathology. Here, we review the conceptual evolution of the disorder-specific macrophage, tracing its origins from the limited M1/M2 model to its refinement through scRNA-seq-based classification. We summarize the ontogeny, transcriptional regulation, and spatial heterogeneity of these macrophages across various disorders, emphasizing how the subtissular niche dictates functional specialization. Finally, we discuss potential therapeutic strategies targeting disorder-specific macrophage subsets, highlighting the need for integrative multi-omics approaches to refine their classification and functional characterization. Understanding the regulatory networks that govern disorder-specific macrophages will advance our knowledge of macrophage biology while facilitating the development of precision medicine for immune-related disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9feef19310b98a25e6e67c81bcaeb9daa262ec04" target='_blank'>
              Functional diversity of disorder-specific macrophages involved in various diseases
              </a>
            </td>
          <td>
            Yuichi Mitsui, Takashi Satoh
          </td>
          <td>2025-10-01</td>
          <td>Inflammation and Regeneration</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Emerging evidence suggests brain-resident myeloid cells, including perivascular macrophages and microglia, provide a reservoir for HIV infection in the central nervous system (CNS), and their inflammatory activation is a proposed pathogenic mechanism in HIV-associated neurocognitive disorders (HAND). We investigated whether cannabinoid receptor 2 (CB2), an immunomodulatory receptor expressed in myeloid cells, regulates viral replication and inflammation in HIV-infected macrophages and microglia. Using the synthetic CB2-specific agonist JWH-133, we found that CB2 activation reduced HIV replication in primary human monocyte-derived macrophages (MDMs) and human induced pluripotent stem cell-derived microglia (iMg) at differing doses, corresponding to the basal expression of CNR2, which encodes CB2, and related endocannabinoid transcripts in each cell type. JWH-133 broadly reduced release of cytokines from HIV-infected MDMs but not iMg. RNA-seq revealed that CB2 agonism primarily altered interferon and integrated stress response pathways in MDMs while altering homeostatic pathways, including synapse maintenance and phagocytosis, in iMg. Further analyses in iMg revealed that NLRP3 inflammasome activation, but not priming, was reduced by CB2 activation, which did not inhibit HIV-induced nuclear factor kB activation. This study identifies key differences in CB2 response between myeloid lineage cell types and implicates CB2-specific agonists as promising candidates for the regulation of HIV-associated neuroinflammation. Graphical Abstract Created in BioRender. Espinoza, C. (2025) https://BioRender.com/mxfla3i Supplementary Information The online version contains supplementary material available at 10.1007/s11481-025-10254-x.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71c568f55c0cf3f5f771b5d05ce139396b2d6389" target='_blank'>
              Differential Effects of Cannabinoid Receptor 2 Agonists on HIV Replication and Inflammatory Activation in Monocyte-Derived Macrophages and Induced Pluripotent Stem Cell-Derived Microglia
              </a>
            </td>
          <td>
            Alexander Starr, Sara Rathore, Marzieh Daniali, P. J. Gaskill, C. Akay-Espinoza, Kelly L Jordan-Sciutto
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroimmune Pharmacology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="The circulatory and immune systems function in close coordination to maintain homeostasis and act as a frontline defense against infections. However, under certain conditions, this interaction becomes dysregulated, leading to thromboinflammation, a pathological process marked by the concurrent and excessive activation of coagulation, inflammation, and endothelial dysfunction. During viral infections, this phenomenon can markedly worsen clinical outcomes. Evidence indicates that viruses such as dengue, chikungunya, influenza, and SARS-CoV can trigger thromboinflammatory responses involving platelet activation, the release of procoagulant and pro-inflammatory mediators, and the formation of thrombi within blood vessels. While this response may initially help contain viral dissemination, in cases of high viremia it can progress to disseminated intravascular coagulation (DIC), hemorrhage, and multiple organ failure. This review compiles current evidence on thromboinflammatory mechanisms induced by arboviral and respiratory viruses and examines how these processes contribute to diseases’ pathogenesis and clinical severity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c68b9f2087b67b802d02b7c999021c7797bce0f8" target='_blank'>
              Mechanisms of Thromboinflammation in Viral Infections—A Narrative Review
              </a>
            </td>
          <td>
            Viviane Lima Batista, J. Martins, C. Queiroz-Junior, E. D. Hottz, M. Teixeira, Vivian Vasconcelos Costa
          </td>
          <td>2025-09-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>32</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2025'],
    y: [10],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>